Based on audited FY2025 financials, the company possesses around RMB 2.25 billion in net financial assets, which equates to roughly HK$2.47 billion. With shares priced at approximately HK$2.20 (based on the underlying research), its entire market capitalization amounted to only around HK$2.3 billion.

Translation: The market was essentially pricing the entire operating business at nearly zero, perhaps even imputing negative enterprise value.

Of course, Zen Game Technology isn’t exactly a cash shell. Far from it. It has an actual gaming business on its hands that still produces hundreds of millions in renminbi profits per year, requires minimal capital expenditures, and generates cash from profits.

If there’s one question to be asked about Zen Game going forward, it’s no longer:

“What are these assets worth?”

Rather, it’s:

“How much of that value will ultimately trickle down to ordinary shareholders?”

Zen’s Aging Mahjong Machine Still Prints Cash

Zen Game’s most valuable asset is neither its tech nor a particularly complex gaming franchise. Zen Game’s most valuable asset is the commercial machine that Fingertip Sichuan Mahjong has built over the years.

Revenue from the card- and board-game business alone totaled roughly RMB 1.305 billion in FY2025, and still accounts for the vast majority of the company’s total revenues. There were around 460,000 paying users on the core platform as of last year, spending an average of about RMB 272 each per month.

That’s an extremely odd freemium business.

Most players never spend money. Their function within the economy is simply to populate the matching pool to the size necessary that paying players can always find someone to play against. The revenue side of the equation consists of the small fraction of players who are willing to spend real money buying virtual currency in order to preserve their game “rank”, skill level, and sense of identity within the community.

Mahjong also enjoys another huge advantage over your typical mobile game: it doesn’t need to constantly develop new maps, characters, storylines, or blockbuster-quality cutscenes.

Because the rules of mahjong provide hours of entertainment value on their own. Maintenance is low. Game updates are primarily limited to rule variants, tournament infrastructure, anti-cheat measures, live operations, and standard tech support.

No wonder why Zen Game is able to convert such a high proportion of profits into cash.

Of course, the machine isn’t nearly as explosive as it once was.

In fact, the company is moving past peak user growth rate. Over the last two years, we’ve seen both Monthly Paying Users come down, as well as ARPPU recede from its highs. The original flywheel – Douyin streamers, inflated virtual currency units, frenzied livestream fueled customer acquisition – is no longer working as well as it used to.

Operate mahjong tournaments. Release new game variants. Maintain streamer relationships. Just to decelerate user decline.

The spending necessary to do the above is starting to resemble digital CapEx. The company isn’t necessarily spending money to grow the top line. It’s spending money just to keep revenues from dropping at an even more rapid rate.

As such, investors should not be modeling Fingertip Sichuan Mahjong as a perpetually growing asset, nor should it be given the same multiple you’d typically assign to a stable gaming business.

Think of it more as a cash-flow-positive toll road that’s slowly but surely losing traffic.

Fishing Is Not a Second Mahjong—At Least Not Yet

Zen Game’s proposed second growth engine is Fishing Master.

Revenue from fishing and “other casual games” hit roughly RMB 241 million in FY2025, more than doubling YoY. On a revenue line only, this allows you to tell yourself a very attractive growth story.

But there is one key way fishing games are different from mahjong.

Mahjong is primarily a player-versus-player system. Virtual chips flow from one player to another while Zen Game provides the platform, rules, and services.

Fishing games skew more player-versus-system. Their economics revolve around paid user acquisition, advertising spend, payout ratios, and lifetime value.

Translation: You can’t judge the value of the fishing business by looking at revenue alone. Instead, you want to know how much of that revenue sticks after the company cuts back on or eliminates advertising.

Until customer acquisition spending flattens or declines—or at least no longer rises almost as quickly as game revenue—fishing is not yet a cash generative machine. It remains a growth project whose unit economics have yet to be proven.

Option value, not a big revenue multiple, is therefore the appropriate treatment.

Could be great. Could also be how the company spends the mahjong cash looking for growth.

The Cash Is Real—But It Needs an Exit Route

Zen Game’s net financial assets—around market cap or higher—is the biggest, flashiest thing on the balance sheet.

These funds are predominantly held in bank deposits, money-market products, structured deposits, and relatively conservative wealth-management products. The company has negligible interest-bearing debt and hasn’t repeatedly raised capital, conducted heavily dilutive rights issues, or made large unrelated acquisitions.

If we’re talking about asset authenticity and historical capital discipline, Zen Game’s history looks a lot better than your average HK micro-cap.

The problem is that as minority shareholders we can’t walk up to the banking apps and demand our cut.

Zen Game is incorporated offshore but conducts the majority of its business and holds its cash onshore in China. Founders hold majority voting power. The company has not relied on outside capital markets.

Shareholders cannot force liquidation, compel a special dividend, or otherwise mandate management to give back capital.

Cash on the company’s balance sheet is not automatically a dollar of cash in shareholder hands. It needs to be distributed via dividend, share buyback, privatization, or another credible method of exit.

This is why we care about the 2022 dividend incident.

The board originally included a proposal for a final dividend. The resolution was overwhelmingly voted down at the AGM. The stock dropped precipitously soon after. While Zen has reinstated and even increased its dividend payouts since then, the incident served to highlight:

Shareholders are not automatically entitled to dividends. Dividends are a policy decision that can be changed by controlling shareholders.

The positive takeaway is that behavior has materially changed since then.

Total dividends declared for FY2025 equaled HK$0.40 per share. At a recent price of ~HK$2.20, that’s an annual dividend yield of ~18%. It also exceeded annual net profit.

Raising the dividend while profits fall is practically speaking more meaningful than any management presentation slide or verbal assurance.

Also consider that the two founders collectively own >50% of the company. Dividends aren’t some gift to outside shareholders. Frankly, it’s the largest (and most scalable) way for the founders to take cash out of the company.

Issuing dividends lets minority shareholders benefit indirectly because the two founders chose to build a withdrawal channel we can also use.

Zen Game Technology: Management Is Neither a Classic Fraudster nor Costless Steward

Zen Game’s (02660.HK) valuation paradox is rooted in the complexity of its governance. Investor sentiment alternates between thinking management is either fundamentally good or fundamentally evil. Neither mindset paints an entirely accurate picture.

One argument holds that Zen Game has cash on its balance sheet, pays meaningful dividends, and hasn’t conducted a rights issue. Ergo, management must be shareholder-friendly since it has not repeatedly stuck investors with expensive capital raises.

The opposing argument holds that executive pay is too high and equity incentives are growing. Ergo, management will inevitably milk the cash balance and use it for things that don’t benefit minority shareholders.

Reality falls somewhere in between these extremes.

The good news is that there is some positive evidence. Zen Game hasn’t raised money repeatedly since listing. The founders haven’t sold a lot of shares. There’s no blatant evidence of related-party cash draining. Financial investments have been mostly plain-vanilla. Dividends have been paid with actual cash.

But bad news should also count.

The founders’ aggregate annual pay hasn’t come down much. More significantly, the share-option and award program has materially increased.

Note the proposed incentive package consists of newly issued options, newly issued share awards, and shares that are bought in the market with company money and transferred to insiders.

Taken individually, these are not as pernicious as a highly discounted rights issue. Still, they extract a continuing governance toll.

Stock options can be extremely asymmetric at a depressed share price. If the company keeps going south, management can just let the options lapse. If the stock gets repriced higher, insiders reap the benefits and existing shareholders get diluted.

Zen Game shouldn’t be considered a net-cash stock that carries no governance penalty.

Rather, think of it as owning tangible financial assets and a cash-generating business that perpetually extracts from minority shareholders via executive compensation, dilution, and uncertainty regarding how fast distributions will continue.

Changing the Question

Trying to value Zen Game from “What is the company worth?” to “What will minority shareholders ultimately receive?” helps focus attention on these hidden costs.

Sum-of-the-parts valuing of the core mahjong business, fishing option, the small plays, and net financial assets can get you to a value around HK$5/share.

Of course, that is theory-land.

It assumes you can monetise the cash promptly, management doesn’t take too many tolls, and minority shareholders get their fair share of the value.

The real world is messy and several deductions must be made.

Here are four of them:

1. Above-market compensation paid to management

2. Dilution from current and future stock option plans

3. Risk that dividends will be cut, cash is trapped, or the company goes private at less than intrinsic value

4. Speed of liquidity

Getting RMB 2.25 billion in cash tomorrow is worth far more than receiving those funds spread out over 10+ years. The company may earn ~2% on its financial investments, but the investor’s opportunity cost is much greater than that. The longer the timeframe for distribution, the less valuable those cash balances are to common shareholders.

That’s why “cash > market cap” doesn’t always lead to a risk-free trade.

Adjusting for governance, timing, and regulatory risk, I arrive at a valuation range for Zen Game’s minority interest of HK$3.00 to HK$3.70 per share. The lower bound of that range assumes heavier discounts for distribution speed and regulatory tail risk. The upside assumes the cash on hand is genuine, that historical dividends should be weighted more heavily, and that controlling shareholders have incentives aligned with keeping that channel open.

HK$3.00 to HK$3.70 is well below the ~HK$5 “gross asset value.”

But it’s still above the ~HK$2.20 share price used in this analysis.

Conclusion

Zen Game Technology does trade at a “cheap” valuation… but not for the reasons investors think.

The real bargain isn’t RMB 2.3 billion in cash and a mahjong money-press. The really cheap part of the deal is the market pricing in risk of distribution policy, management incentives, and regulatory intervention.

Long 02660.HK isn’t buying a mattress of cash they can rip open tomorrow. They’re betting on whether dividends will be maintained and whether the value created by the company can flow through its governance structure quickly enough to reach minority shareholders.

I don’t think 02660.HK is a net-cash arbitrage. I think it’s better viewed as a governance-risk trade with a very large asset cushion. And at ~HK$2.20, it looks like a good price to me… but again, only as a small odds-squeeze play. Not as a high-conviction core position that relies on certainty.

I don’t think the key unknown is whether mahjong can resume growth.

Instead, I think the key issue is whether Zen Game will continue to distribute the cash from the mature business to shareholders, and how much damage the company will do along the way with equity incentives and new business investments.

Cautionary Note: This article should not be relied upon as investment advice, nor should it be considered a recommendation, purchase offer, sell offer, or an indication of future performance. Some numbers contained herein were compiled from public sources. The article may also contain user-submitted research material and estimates. These numbers may be inaccurate, incomplete, or subject to different accounting treatment. All forward-looking statements, including but not limited to statements about future operations, expectations about future dividends, regulation and future value are subjective. Actual results may vary. Please do your own research before making any investment decisions. Investment decisions should be made based on your individual financial situation, goals, and risk profile. You should consult with your financial advisor.

To some investors, FIS is a payments company. To others, it’s a bank-software vendor.

Today’s FIS contains three businesses with very different economics tied together by one thing in common: a highly leveraged balance sheet and a management team with a checkered history of capital allocation decisions.

You can’t understand the company by looking at its consolidated EBITDA multiple. Instead, ask: What exactly does each business do? How much free cash can it reliably generate? How much competitive strength will it have a decade from now? Will management use that cash to fund an expensive acquisition?

How a Failed Acquisition Reshaped FIS

In 2019, FIS paid roughly $43 billion to acquire payments processor Worldpay, positioning the combined company to own both banking technology and merchant acquiring. FIS’ pitch to investors was that it could create an integrated payments platform spanning the entire payments ecosystem.

It didn’t work.

Worldpay ceded market share to newer competitors like Stripe, Adyen, Square, and Toast. FIS took $26 billion of accounting losses related to Worldpay’s deterioration. More importantly, the deal broke the market’s confidence in management’s ability to allocate capital.

FIS has since unloaded most of Worldpay. In a deal announced in 2025 and completed in early 2026, FIS sold its remaining stake in Worldpay and acquired Global Payments’ Issuer Solutions business — the former TSYS issuer-processing platform — for approximately $13.5 billion.

FIS now has three standalone economic assets:

• Core banking systems

• Total Issuing

• Capital Markets software

Each business serves different customers, has different growth rates, competitive dynamics, and capital requirements. Treating FIS like one company with one valuation multiple obscures more than it reveals. Here’s a deeper look at what each segment actually does.

Banking Core: Not Just Software, But a Ledger That Can Never Fail

A core banking system tracks every deposit account balance, loan balance, interest rate accrual, posted transaction, and general ledger entry for the bank. Every balance you can see in online banking is backed up by core.

If a bank wanted to replace its core system today, it would take years. Regulators would scrutinize the process. Any bug in the system could cause deposit accounts to show the wrong balances, loan accruals to be miscalculated, or errors in the bank’s financial reporting.

Migration is expensive. It’s professionally risky for the bank executives responsible. And that’s why FIS has a moat, not because of its software’s elegant interfaces.

Contracts tend to last for years, generating steady revenue from account fees, transaction fees, and premiums for additional software modules. Most of that revenue is recurring.

It explains why FIS’ Banking segment generates adjusted EBITDA margins of more than 40% and why customers just don’t leave.

Platforms like Q2 and Alkami are seizing control of the digital-banking frontend. nCino is eating loan origination workflows. Independent payment vendors are trying to disintermediate core providers’ payment connectivity platforms. Banks can, and are, starting to replace modules around the core without switching core providers.

At the same time, FIS is stuck maintaining several legacy core platforms while pouring money into the cloud, real-time payments, cybersecurity, and regulatory reporting. Capital expenditures in Banking have neared 10% of revenue, which means segment’s juicy reported EBITDA number doesn’t translate into copious cash flows for shareholders.

This is a very robust business. However it is one that could become progressively hollowed out over time. Assuming a 10% required return and considering CapEx, taxes and long-term competitive dynamics, this is more of a ~7x EBITDA asset vs. a high quality software company worthy of a high teens multiple.

Total Issuing: Someone Has To Run Billions of Card Accounts

It might say a bank’s name on your credit card. But few banks actually run their own card platforms.

Cards require purchase authorization, credit-limit checks, fraud scoring, interest-rate assignment, rewards management, dispute processing, statement generation and much more. A bank provides the brand, funding, and credit risk capital. The processor powers the engine behind the account.

TSYS did that business. Today it lives inside FIS under the name Total Issuing.

The revenue under Total Issuing is mostly driven by the accounts held and transactions processed. Even dormant cards generate data-retention, servicing, and compliance expenses. As long as the account remains open, most processors can charge a base fee.

Processing cards benefits from enormous economies of scale. Because so much of the cost is fixed (systems, security, compliance), unit economics expand as customers add more accounts. That is why the old large bank issuer-processing market has long been dominated by just a few massive platforms.

But you’re not selling unlimited scale software here.

Big bank customers bargain hard on renewal. Processors need to win growth and offer higher-value services like fraud scoring and loyalty services to justify lower unit prices. Concentration also creates risk. One losing large issuer can wipe out years of projected synergy.

FIS paid a 12.3x multiple on pre-synergy EBITDA for Total Issuing and committed to more than $150 million of net EBITDA synergies in three years. The issue is FIS already paid for a lot of the future synergies upfront.

Cost synergies are relatively achievable. Consolidate data centers. Renegotiate with vendors. Eliminate duplication. Revenue synergies are much more challenging. FIS has thousands of bank customers. Convincing those banks to move their previously agent-issued credit cards into self-managed card programs forces them to take on credit risk, collections risk, and more regulatory responsibility.

The debate isn’t whether or not management can execute on the integration. It’s how much cross selling will realistically happen.

Factoring in a probability weighted assessment for seamless integration, mid-tier execution, and a significant failure case pulls Total Issuing value down towards $9.3 billion. Materially below net purchase price.

That isn’t to say its a bad asset. It means FIS once again paid upfront for growth it has to realize.

Capital Markets: Encoding Financial-Market Conventions

Capital Markets is FIS’ highest quality business—though likely its most misunderstood.

Thanks in large part to the 2015 SunGard acquisition, Capital Markets consists of products that service derivatives clearing and back-office processing, syndicated loans, corporate treasury management, fund accounting, and private markets administration.

Unlike front office trading systems, Capital Markets technologies don’t place trades. They help ensure that a trade can eventually be cleared, reconciled, recorded, margined, and reported to the relevant regulators.

GMI is used by futures commission merchants to reconcile trades with exchanges, calculate margin requirements, apply fee schedules, and generate customer reports. Pricing is often based on contract volume. More active markets = higher revenue.

ACBS is the long-lived ledger for syndicated loans. Who owns each piece? When do rates reset? How are draws/repayments allocated? How do the records get amended when the loan changes? ACBS keeps track.

Investran records investor capital calls/distributions, fund accounting, and private fund administration.

The moats on these businesses aren’t just that migration is painful. These applications encode years—decades—of market conventions, exchange rules, contractual edge cases, and regulatory nuance. Clients could theoretically rewrite the software to work with another vendor. It’s far more difficult to hire a permanent team to stay current on every rule change across all global financial markets.

ION Group’s accelerated price increases are a live experiment. Despite significant price hikes, the majority of customers still renewed their contracts. Clients are stuck. That creates a larger top line “bubble” that FIS can extract revenue from going forward.

Capital Markets has two legitimate growth opportunities.

The first comes from converting perpetual licenses to subscriptions and managed services. The short-term revenue recognition suffers, but the long-term recurring revenue is higher quality and stickier.

The second opportunity is private credit. Private credit funds are growing fast. They are also starting to need bank-grade systems for loan servicing and fund administration. Private credit is a completely new set of customers that traditional bank-software companies haven’t fully cracked.

Risk here is that Capital Markets is essentially dozens of legacy products banding together. Some of the code bases are old. Resource allocation is spread thin. Niche-focused cloud-native competitors are taking market share in individual segments. Current margins are not infinitely sustainable.

Normalizing for inflated transaction volume, capital expenditures, and assuming gradual erosion of niche-market advantages, the business is worth about $12.9 billion on a stand-alone basis, or roughly 8x EBITDA.

That could prove to be too low if management converts the subscription trend and private credit opportunity into recurring revenue. But investors shouldn’t be paying multiples of a strategic acquirer till they do.

The Market Is Discounting More Than the Businesses

Taken strictly on an operating level, FIS is not actually a badly run company.

It has lengthy contracts, mission critical systems, sticky customers, and significant free-cash-flow generation. The problem lies in who controls that cash—and what they choose to do with it.

For the better part of the last decade, FIS has demonstrated a consistent pattern of behavior:

• Large acquisitions trump buybacks and debt reduction

• Flexibility is rebuilt into the balance sheet—only to be rapidly consumed again

• Shares are repurchased aggressively, even at elevated prices

• Acquisition-related integration costs are described as “transient” year after year

Management incentives have rewarded similar behavior by tying awards to adjusted earnings that exclude much of these costs.

Worldpay is the extreme example of this trend, but it is far from the only example.

As a result, the market is not just discounting Banking, Issuing, and Capital Markets. It is taxing the company’s capital- allocation practices as a whole.

Investors buying FIS shares today need to think not just about how much cash these businesses will generate. They need to think about whether that cash will once again be spent on a large, narratively attractive acquisition that produces mediocre returns.

For leveraged companies like FIS, this risk is magnified by the balance sheet.

When net debt approaches the company’s market value of equity, a relatively small change in enterprise value can lead to a massive change in per-share equity value. A large portion of the current disagreement between bulls and bears on FIS can therefore be attributed to capital-structure optics: a low-double-digit difference in operating value can become several times that difference in value per share of equity residual.

Why FIS Should Not Be Valued With a Single Industry Multiple

The solution is not to apply a peer-group average multiple to consolidated adjusted EBITDA. FIS should be valued using sum-of-the-parts.

First, EBITDA needs to be converted into real free cash flow to the firm. Capitalized software development, cash taxes paid, recurring integration expenses, and stock-based compensation should all be deducted.

Second, corporate overhead and equity compensation do not magically evaporate because they are not assigned to a business segment. These are legitimate expenses that are ultimately paid for by shareholders.

Finally, net debt should be subtracted.

I use a fixed 10% required return and relatively conservative estimates for long-term cash flow. Banking Core is worth roughly $22.8 billion. Total Issuing has a probability-weighted value of approximately $9.3 billion. And Capital Markets is worth about $12.9 billion.

After backing out corporate expenses, stock-based compensation, and approximately $20.4 billion of net debt and bridge items, baseline equity value comes to roughly $36 per share. Lower discount rates, higher long-term conversions, and greater synergy realization could push the valuation into the low-$40s.

Pushing the share price towards $60 to $80 per share requires several favorable assumptions to come true at the same time:

• A lower discount rate

• Significant realization of the projected synergies

• Broad banking client conversion to the new modules

• Long-term maintenance of current margin and pricing power

All of the above are possible outcomes. But none of that value has been proven to shareholders through cash flow.

Conclusion

FIS is not a deeply undervalued stock that is suffering from temporary market pessimism. It is not a premium growth compounder that can be bought and owned without concern.

The stock is better described as three groups of financial-infrastructure assets with real competitive moats that are being held back by high leverage, complicated accounting, and a capital-allocation discount baked into the share price.

The current valuation—using a fixed 10% required return—already prices in much of the value the current businesses have proven they can create. It provides little margin of safety for execution risk. Significant upside will have to be proven by operating results— not by lowering your discount rate, inflating terminal value, or using the acquisition price to justify the purchase price.

FIS is a stock where the company has to prove the value to investors, and investors should pay up for it later— not an investment that becomes attractive because the headline multiple is low.

Disclaimer: This article is intended for research, educational and informational purposes only. It should not be construed as investment advice, a securities recommendation or offer to buy or sell any security, nor does this article provide any assurance of future returns. All valuations mentioned are subject to change based on new information and are derived using public information and many subjective assumptions. Actual results could vary materially from those presented. The author or publisher of this article may hold long or short positions in any of the securities mentioned herein at any time without notice. All information is presented “AS IS”, with all conclusions subject to change without notice. Please consult a licensed professional after independently confirming all information and decide what is best for your individual financial situation, goals and risk tolerance.

That is simply not what the business is.

In reality, Alltronics Holdings is four economically distinct assets: anchor customer order stream facing significant customer risk, legacy electronics businesses that are slowly declining but still cash generative, an ex-China manufacturing platform yet to prove its profitability and finally a cash rich balance sheet with asset quality that is riskier than it appears on paper.

Each deserve their own return profile, risk analysis, and valuation method. Buckling them into one multiple because it feels easier to calculate can result in a neat answer that isn’t actually meaningful.

Below therefore values Customer A, legacy electronics, the ex-China platform, provides overlap adjustments, estimates corporate costs and builds the equity bridge separately rather than applying a blanket valuation to the entire company.

Customer A Is Worth HK$320 Million. Here’s Why.

Alltronics’ biggest asset is also its biggest risk. The company derives most of its earnings from manufacturing irrigation controllers for a single customer in the United States.

Revenue from this customer totaled around HK$547 million in FY2025, equal to nearly 48% of group revenue. This is severe customer concentration. It’s the kind of commercial reliance that can determine the valuation of a company.

Fortunately, this business looks like it can generate approximately HK$42 million of normalized annual free cash flow. But unlike most businesses included in a corporate valuation, this is not a risk-free cash flow stream.

Specifically, the company discloses almost nothing about the contracts term, order backlog, product level margins, minimum guarantees, rebate structure, or pricing escalators. Investors can see the relationship has existed for many years, but not whether it’s well protected by contract or economics.

One encouraging sign is that the customer did not fire Alltronics and award all business to a new supplier in Southeast Asia. Instead it gave its incumbent supplier an order to setup manufacturing capacity outside of China.

For engineered products that require qualification testing, new tooling investments, production validation and long-term reliability checks, sourcing continuity is usually a sign that the customer wants the incumbent supplier to succeed. Even if production moves abroad.

It still doesn’t mean the risk goes away. A big customer can keep you as its supplier while slowly moving some volume to a second source. For an EMS company, meaningful downside often doesn’t come from suddenly losing all orders. Instead, the customer starts allocating portion of its wallet to other suppliers and the contract is slowly squeezed out of existence over a two to three year period.

Valuing the order stream as if it will perpetually generate the same level of cash isn’t appropriate given the uncertainty. Instead it’s better to model the different outcomes up front – customer retention, customer partially migrates to second source, customer completely withdraws – while also modeling cash until the exit period, receivables collection, inventory recovery, equipment salvage value, and shut down expenses.

By those assumptions, the probability adjusted value of the Customer A business is around HK$320 million.

The customer stream isn’t a stable, single outcome asset. In the base case it acts likes a long duration cash flow franchise. In the downside case it converts to an orderly wind down with several years of declining cash generation followed by a recovery residual value. The expected value sits somewhere in the middle.

Legacy Businesses Have Little Story—But Real Economic Value

Alltronics produces electronic components, walkie-talkies, plastic parts and moulds, and other finished electronics products outside of irrigation controllers.

Legacy revenues are roughly HK$610 million, supporting normalized annual free cash flow of about HK$30 million.

This is not a growth engine. But it also is not a basket of assets that should be written down to zero.

The key is that not all product lines should be valued the same way.

Electronic components are cyclical businesses. Revenue flows with customer inventory levels and peaks and troughs along with them. As a result, neither peak-year earnings nor trough-year earnings are meaningful. The solution is to normalize for the cycle: estimate mid-cycle revenue and margins rather than extrapolating any given year.

Walkie-talkies face a different issue. Revenue has declined for years. This does not look like a temporary inventory correction. Instead, product/end-customer life cycles may be ending.

Applying an otherwise-stable perpetuity multiple to a declining cash flow stream would value it too highly. A declining-annuity approach is more suitable.

Parts, moulds, and other finished products appear to be more project-driven. While growth is probably limited, they can generate cash provided that customers continue to introduce new products and place follow-on production orders.

When valued separately, the legacy electronics business is worth approximately HK$245 million, or about eight times normalized free cash flow.

Price is not the issue here. That multiple is not generous, but it is reflective of the economics of that business.

Alltronics does not own a consumer brand, distribution channel, or visibility into end-market pricing. Its competitive advantage is in manufacturing: product engineering introduction, tooling, production quality, timeliness of delivery, and flexibility to move production locations if necessary.

Its cash flows reflect manufacturing economics, not the ability to capture the largest share of profits from the end-product sold to consumers.

Overseas Platform Is Options, Not Earnings

Over the past two years, Alltronics has made investments to build what it calls an overseas platform. The company has completed three transactions: one in Malaysia, one in Europe, and one in Vietnam.

Winner Sky, the Malaysian operation, is really a shell with manufacturing capacity. Alltronics owns 100%. Winner Sky did not bring customers or earnings when it was acquired. It brought a Penang production base, factory infrastructure, and assembly capacity.

EME, meanwhile, is closer to the platform’s front end. It provides European customers, product designs, and research and development talent associated with Edwin McAuley Electronics. Alltronics owns a majority stake of 51%.

Ideally, Alltronics would originate and manage customer relationships through EME, but shift production to China, Malaysia, or Vietnam as needed to balance cost, tariff exposure, and customer requirements.

Momentum, the Vietnam operation, is the option-iest asset in the group. It generated almost no revenue at the time of acquisition, has negative net assets, and goodwill in excess of total purchase price paid.

Instead, it represents the possibility of future capacity additions and customer wins.

Taken together, the three assets give Alltronics a “front office, back factory” setup.

EME provides customers, product designs, and commercial access. Penang and Vietnam offer outsourced manufacturing capacity outside of China. Alltronics can use the platform to serve dual demand: existing customers in the U.S. that need a China+1 supply chain solution, as well as European customers interested in lower cost manufacturing.

The strategy makes sense.

The results do not.

Winner Sky eked out very little revenue in FY2025 and remained unprofitable. EME had standalone revenue of roughly HK$190 million but had never yet shown profitability. Vietnam was still a pre-revenue operation.

None of the three pieces should be valued as if they were part of an existing, profitable EMS platform.

Instead, it makes sense to model success and failure outcomes for each investment independently, apply probabilities to each based on current evidence, and then multiply those results by Alltronics’ actual ownership percentage.

The outcome of that exercise is that Alltronics’ overseas platform is worth approximately HK$64 million to shareholders.

To be fair, that valuation is roughly equal to the cash the company has already invested in the projects.

The best way to interpret that result is not that Alltronics’ expansion has already created significant value. Rather, it has not yet been destroyed, and any creation is still ahead of the business.

A Large Cash Balance Is Not Distributable Cash

On the surface, Alltronics looks like it has a lot of downside protection.

The company reports roughly HK$445 million of cash and pledged deposits on its balance sheet, compared to about HK$166 million of borrowings.

But we can’t value balance sheets by mechanically subtracting liabilities from assets.

Alltronics needs some of that cash to fund its day-to-day cash-conversion cycle, which currently stands at roughly 80 to 100 days. Some of it may also be stuck in mainland China, where remitting money back to the listed parent company incurs withholding taxes and other frictions.

Cash will also be consumed by the ramp-up of the overseas factory, acquisition payments and contingent consideration, working-capital builds, and regular dividends.

The company also holds amounts of unlisted investments, other financial assets, and deferred tax assets, none of which are as liquid or debt-like as cash or bank borrowings.

Given Alltronics’ track record of writing down non-core assets, we would not be comfortable assigning full book value to every soft asset on the balance sheet, either.

We’ve also got an issue on the liability side of the balance sheet.

Operating free cash flow, which we use to value each of the businesses above, already accounts for the recurring cash costs associated with leases. If we build a valuation bridge and then deduct the full amount of lease liability from cash and deposits, we are essentially double-counting the same economic obligation.

Adjusting for operating cash needs, giving discounts to softer assets, accounting for tax friction, minority interests, other liabilities, and the potential double-counting of leases, we arrive at an equity bridge of approximately HK$190 million.

Notice that this is surprisingly close to what we would get if we mechanically subtracted liabilities from assets to arrive at book equity. There is just one problem: we arrived at both numbers for completely different reasons.

The mechanical approach doubly subtracts lease liabilities after arriving at an after-lease cash flow valuation. It also treats several dubious assets at full book value. The two mistakes move in opposite directions, just happen to cancel each other out around the midpoint.

Where the point estimate may seem stable, the underlying distribution is anything but.

To summarize: the balance sheet provides real support to this valuation, but the downside protection is not as simple as “cash minus debt” would imply.

Two Costs Disappear Unless the Valuation Explicitly Includes Them

When valuing Customer A’s retention value and the overseas platform, there is an additional cost that disappears if we don’t explicitly include it in the valuation.

Business Overlap

Part of Customer A retention value is derived from Malaysia’s ability to redeploy production outside of China. But the value of the overseas platform also depends on the utilization of that same manufacturing capacity.

Adding the two together in full would double-count part of the economic benefit.

We would estimate an overlap adjustment of roughly HK$40 million.

Corporate Overhead

The operating-unit cash flows above show each division’s economics pretty cleanly. But Alltronics as a listed company still has to pay audit fees, board expenses, listing fees, and holding-company office costs.

These expenses do not belong to any particular operating segment, but they are still recurring annual costs that the company has to pay.

Capitalizing that annual corporate overhead comes to roughly HK$65 million of equity value.

Too often, when we see small-cap sum-of-the-parts valuations, every business looks reasonable when valued on its own. The trouble is none of them are assigned responsibility for supporting the public-company overhead above.

Conclusion

As mentioned earlier, we’d estimate gross operating value of HK$629 million based on:

• Customer A order stream: HK$320 Million

• Legacy electronics business: HK$245 Million

• Overseas platform: HK$64 Million

We would then subtract HK$40 million for overlapping value and HK$65 million for capitalized corporate costs, and add back our adjusted equity bridge of HK$190 million to get estimated equity value of:

HK$714 Million or about HK$1.51 per share.

That is not a stock you can understand as “cash-rich and cheap.”

The largest driver of value in this company is a highly concentrated customer relationship. The biggest source of upside comes from an overseas platform that has yet to prove sustainable profitability. Downside protection comes from a balance sheet whose quality and liquidity we feel is less transparent than the HK$445 million of cash and deposits implies.

All three major components of value have real tangible benefits to shareholders. But all three also contain significant evidence gaps that need to be considered.

The most appropriate classification for us would therefore be a potentially discounted watchlist opportunity, not an unconditional deep-value buy.

We would only buy this if the market price gave us a sufficiently large margin of safety. And if we felt comfortable underwriting not only customer concentration and overseas execution risk, but also the company’s historical capital allocation decisions.

Disclaimer: This article is intended for informational, educational and research-discussion purposes only. It should not be relied upon as investment advice, a recommendation to buy or sell any securities, offer or solicitation to buy or sell any security, a valuation guarantee or a promise of future profits. Historical financial information may be inaccurate or incomplete. All financial forecasts, probability estimates and assumptions are based on hypothetical scenarios. There may be material uncertainties in making assumptions regarding the valuation of securities. Securities prices may rise and fall. Investors may lose some or all their invested capital. The author and related parties may have positions in, may buy or sell, securities mentioned in this article. The author has no obligation to update any information presented in this article. Investors should perform their own due diligence and consult with their licensed financial, legal and tax advisors prior to making any investment decision.

NetDragon’s gaming business is a cash cow. It’s been operated at a profitable scale for close to two decades, and today it generates both strong profit and strong free cash flow. On top of that, the company sits on plenty of cash and liquid investments, all while dispensing an unusually high dividend.

At the same time, NetDragon’s capital allocation record is less than stellar. It threw billions of renminbi at education. Many of the businesses it acquired along the way lost nearly all their value upon changing hands. It has poured money into crypto coins, non-fungible tokens, movies, private equity funds, and more—all questionable uses of capital with dubious strategic merit.

As a result, understanding NetDragon entails grasping this contradiction.

Is Eudemons Online a secular growth business? A mature asset? Something in between?

On one hand, NetDragon’s gaming business is clearly valuable. NetDragon suffers from a persistent governance discount, leaving investors to question how much of that value will ultimately accrue to outside shareholders.

What Kind of Asset Is Eudemons Online?

NetDragon’s gaming business pulled in roughly RMB 2.9 billion in revenue during 2025. This was about 15% lower than the year prior. Yet core segment profit came in near RMB 900 million, declining only slightly.

This matters. When a growth business matures into a cash cow, revenue usually falls much faster than profit.

This implies that NetDragon’s gaming business has entered a new stage of development. The business is no longer growing quickly. Today, it better resembles a high-margin cash-flow asset. One supported by cost discipline and a massively entrenched user base.

While the company does not disclose cash flow figures directly, we can back into them by deducting taxes, corporate overhead, and the recurring investments made to maintain and improve its games. By my estimation, NetDragon’s gaming division generates about RMB 500 million to RMB 600 million of annual cash flow that ultimately accrues to shareholders.

I consider this figure to be the appropriate starting point for any valuation analysis on the company. Not its headline segment profit.

Eudemons Online benefits from decades of player engagement, but the game is far from the only reason why it has stuck around for so long.

Players who’ve stuck with the game for years have accumulated in-game characters, equipment, status, guild connections, rivals, reputations, and social identities. Quitting Eudemons Online is not like discontinuing consumption of any ordinary entertainment product. For many players, it would mean giving up years of accumulated digital assets and social capital.

As such, the effective switching cost for players is extremely high. During its ~20 year lifetime, only a small handful of Chinese online games have exhibited a similar level of durability.

These include classics like Fantasy Westward Journey, Westward Journey Online II, Legend of Mir, Wendao, and yes, Eudemons Online.

Nobody is suggesting for a second that revenue won’t decline. In fact, we should expect the core player base to shrink over time. The players who power its engine today are getting older. They’re earning more disposable income, have more entertainment options at their disposal, and will likely spend less time gaming moving forward.

Mobile spinoffs, mini-games, “nostalgia” servers, and paid reactivation campaigns can help restore at least a portion of this lost engagement. But these measures don’t expand the overall addressable market. They merely provide additional avenues for re-engaging existing players.

The most realistic long-term outlook is not flat growth or a quick death spiral. It is gradual revenue decline mitigated by occasional product, platform, or monetization resets.

What Is the Gaming Division Worth?

The easiest way to think about NetDragon’s gaming value is to completely disregard the existing management team. Pretend for a second that this division belongs to a rational independent investor. Do not apply a governance discount. Do not attempt to value potential new games until they prove themselves.

Under this scenario, value only cash flows that are already known to exist.

Using largely the same assumptions as above, we can say with some degree of confidence that NetDragon’s gaming division starts with roughly RMB 550 million of annual cash flow that accrues to shareholders, declines at a low- to mid-single-digit rate for the foreseeable future, and should be discounted back at roughly 10% to reflect risk.

The end result is a standalone gaming-business value of roughly RMB 3.6 billion.

While certainly open to interpretation, a bear case could probably justify value dipping down towards RMB 2.4 billion. This would involve severe deterioration in monetization trends and a continued weakening of the player ecosystem.

On the other hand, if spending power stabilizes and the mobile version successfully retriggers lapsed users, the gaming division could justify a valuation nearing RMB 6 billion.

For what it’s worth, RMB 3.6 billion in standalone gaming value corresponds to about six to seven times shareholder cash flow. This is not aggressive, especially when you consider that it:

1. Already factors in a mature, high-margin cash cow with declining revenue

2. Trades primarily on the value of a single franchise

3. Should probably account for further erosion of its player ecosystem going forward

This also assumes that NetDragon’s growing game portfolio produces zero value today. In practice, the company has announced potential game titles over the years. Only a handful ever reached sufficient scale to meaningfully impact revenue.

Until proven otherwise, new games should be treated as options rather than assets.

Why NetDragon Should Not Trade at G-bits’ Multiple

NetDragon is frequently compared to G-bits Network Technology because Eudemons Online and Wendao were both shipped circa 2006 and are two of just a handful of Chinese gaming franchises that have operated for close to two decades.

However, the companies offer investors very different assets.

NetDragon offers a long-lived but mature cash-flow stream.

G-bits offers an organization that has proven capable of generating new cash-flow streams time and again.

Beyond simply keeping Wendao alive, G-bits expanded into Wendao Mobile, Yi Nian Xiao Yao, 杖剑传说, and several other products. G-bits has demonstrated a capacity to reach new users and open new categories. More importantly, it has proven capable of building material revenue outside of the Wendao franchise.

The market is not rewarding G-bits with a higher multiple because Wendao is a better product than Eudemons Online.

It is rewarding G-bits with a higher multiple because investors believe G-bits might be able to replace an aging franchise with another long-lived product.

NetDragon has yet to prove that it can renew itself in the same way.

Its flagship franchise is still a valuable asset. However, the company has gone decades without developing a second gaming entity of comparable size. Management will have to build another large software asset before the gaming division can justifiably be valued as a growth enterprise. Until then, I view the gaming division as a long-duration, high-yielding, slow declining asset.

The Real Issue: Capital Allocation

NetDragon built most of its successful businesses from scratch.

NetDragon developed Eudemons Online internally. It incubated 91 Wireless before selling it to Baidu for an industry-defining exit. By all accounts, NetDragon built one of China’s most successful technology companies. The company’s early success suggests that it has genuine talent for product development and entrepreneurial execution.

NetDragon has fared much worse when buying and operating non-core assets.

In or around 2014, NetDragon declared education technology its next major growth driver. NetDragon acquired or invested in companies like Promethean, Edmodo, JumpStart, and a host of other education technology assets.

These assets were eventually consolidated into Mynd.ai. Today, Mynd’s market capitalization is only a small fraction of the implied valuation at the time of the original investment.

Edmodo was shuttered years after its acquisition. Accounting for acquisition costs, operating losses, restructuring charges, employee severances, and ongoing maintenance, NetDragon’s education strategy may have cost shareholders well into the billions of renminbi.

Capital has also been earmarked for Ether investments, non-fungible tokens, film productions, private equity, and a variety of other assets that bear little clear relationship to the business of gaming.

Together, these investments tell a revealing story:

NetDragon has consistently excelled at starting businesses, but fumbles when the time comes to buy and manage them.

At this point, I am less concerned with capital allocation than I am with understanding where investments are going. Some of NetDragon’s riskier investments can be justified if they earn sufficient returns for shareholders. However, several of the company’s larger investments appear to have been made with the founder’s personal interests in mind, ambitions in new technology, or desire to execute on a broader strategic vision.

Allocate enough capital toward “strategic” investments, and conventional return thresholds and exit discipline start to lose their importance.

Can the Dividend Really Protect Investors?

NetDragon’s strongest defense is that the company has paid cash back to shareholders on multiple occasions.

That is a fair point.

NetDragon issued a special dividend of HKD 7.77 per share after selling 91 Wireless back in 2013. More recently, the company has increased dividends and buybacks again. NetDragon has also gone so far as to guarantee shareholders at least HKD 600 million worth of liquidity through dividends and buybacks over the course of a 12-month period.

Furthermore, the controlling shareholder owns a meaningful percentage of the company. Cash dividends do represent a tacit alignment of interests between company insiders and minority shareholders.

However, when reviewing NetDragon’s complete capital allocation history, it is necessary to disaggregate by time period.

NetDragon was investing billions of renminbi into education assets at the height of its expansion. Acquisition costs, operating losses, and strategic investments far exceeded the cash returned to shareholders.

Shareholders only returned to a high-dividend model after the education strategy had been largely abandoned. With very few exceptions, the strategy destroyed shareholder value.

This history suggests that dividends have been paid historically not because they were sacrosanct but because there were no major strategic investments requiring capital.

Operating cash flow in 2025 was below dividends plus repurchases.

It does not mean the dividend is fictitious. NetDragon has balance-sheet funds available for shareholder distributions.

However, part of the payout was at the expense of existing assets instead of new cash.

Deploying balance sheet capital to supplement dividends for a single year is not necessarily a problem. My concerns begin if gaming cash flow continues to fall year-over-year, if Mynd continues losing money, and if management initiates another sizable strategic investment.

Under those circumstances, dividend payments would begin to compete with both operating requirements and strategic investments for liquidity.

Not All Cash Should Be Valued Equally

NetDragon lists approximately RMB 2 billion of net cash and short-term investments on its balance sheet. As a result, investors treating nearly every aspect of this company as undervalued treat the balance sheet as the cornerstone of their theses.

Much of NetDragon’s net cash position consists of cash deposits and short-term financial investments. I haven’t seen any evidence these assets are fake. Nor does the company have any track record of issuing fake dividends. NetDragon’s long history of paying out real cash dividends makes the classic “we invested in fake companies and have fake cash to prove it” fraud far less likely.

But investors can’t afford to treat all liquidity as equal.

Cash Deposits Are Not Created Equal

Some of NetDragon’s liquidity is in deposits used to pledge against bank loans. These deposits could theoretically be part of a cross-border financing structure that enables an offshore listed company to pay dividends and satisfy its foreign-currency obligations while waiting for the onshore business to generate positive net cash flow.

If these assets are being used as loan collateral, management might also have less discretion to redirect those funds towards speculative investments. Loose capital allocation and poor corporate governance often go hand-in-hand, but they are not perfectly correlated.

Management has much more discretion over NetDragon’s remaining cash deposits and short-term investments.

That’s where investors should focus their governance risk.

NetDragon already put its discretionary capital allocation tendencies on display when reporting its liquid asset pool:

Private investments Film-related investments Cryptocurrency Loans to employees, officers, other related parties, and supposedly unrelated third parties

Collateral free. Interest free. Payable on demand rather than on a predetermined schedule.

As measurements, these loans are immaterial to the overall picture. Taken individually or collectively, they don’t prove that management engaged in serious asset diversion or accounting fraud.

They do prove, however, that management operates relatively loose guidelines around the corporate use of funds.

Poor capital allocation can destroy money through bad investments.

Loose governance creates risk that not every dollar spent will be aligned with shareholder value maximization.

Investment versus Stewardship

Here’s how I see it:

Capital allocation is a question of competence.

Corporate governance is a question of stewardship.

What Is the Market Currently Pricing?

Absent another discount for poor capital allocation or corporate governance, NetDragon’s gaming business could be worth approximately RMB 3.6 billion. Add roughly RMB 2.1 billion of net liquid assets, some property, its stake in Mynd, and various smaller holdings. Account for ongoing corporate expenses and you’re left with roughly RMB 5.8 billion or HKD 6.4 billion of total asset value.

NetDragon trades with a market capitalization of roughly HKD 4 billion.

One could argue investors are giving the company close to full value for its gaming business while assigning zero value to its non-gaming assets.

Or one could argue investors think management will simply divert most of those assets away from outside shareholders.

Fair enough.

NetDragon’s history suggests it can produce excellent products. NetDragon’s history also suggests it can and will invest billions into businesses unlikely to reach similarly lofty valuations.

Its management guidance has been weak at times. And investors should hold NetDragon’s financial assets to a higher standard given how loose management appears willing to be with those assets.

Fair enough twice.

That doesn’t leave investors with a lot of room to price in future bad capital allocation. The market has been pretty skeptical already.

Conclusion

NetDragon has an excellent gaming asset. It has not shown excellent capital allocation skills.

Eudemons Online and NetDragon’s suite of legacy games remain a robust source of cash flow. Absent any discount for governance concerns, NetDragon’s gaming division could be worth approximately RMB 3.6 billion. The company as a whole, could have approximately HKD 6.4 billion of asset value.

At current prices, NetDragon trades significantly below that amount. Its shares are meaningfully undervalued based on enterprise value.

But the current level of undervaluation is not sufficient to make the path to doubling your money obvious.

Recognizing that NetDragon is worth RMB 3.6 billion in gaming business and HKD 6.4 billion in total value would not cause the stock to double. Even if the stock captured all that value, it would rise about 60%. For shares to double, something else would have to change.

NetDragon would have to launch another successful title. Mynd would need to stop consuming cash. NetDragon would have to show lasting improvement in capital allocation. The company would need to institute a regular dividend policy. Investors would have to become less concerned about management’s motives.

That is precisely where NetDragon underperformed. If given a mulligan, history suggests management may repeat those mistakes.

NetDragon shares have much to prove. That said, the shares trade at a sufficiently high yield that a buy-and-hold strategy could generate positive expected value even if management makes the same mistakes again.

For an investor who is not comfortable cherry-picking NetDragon’s upside and waiting for proof of improvement, the stock may not be a fit.

NetDragon is cheap relative to its tangible book value. And yet, not cheap enough that we can ignore management.

Disclaimer: This article is intended for informational and research purposes only. It should not be construed as investment advice, a recommendation to buy or sell any security, or a guarantee of future performance. Valuations and conclusions herein are based on publicly available information, historical data, and estimates. They may be wrong. Prices can go up or down. Always do your own research, and consider your financial situation, investment goals, and risk appetite before making investment decisions. Views may change at any time and the author accepts no liability for damages incurred from the use of this or any information.

But the picture begins to look very different once you dig below the top line. TapTap has a gross margin of 86.2% versus the games segment’s 67.4% and its growth does not require XD continuously gambling on whether the next game will be another blockbuster. Net of risks explained below, TapTap may already be contributing more after-tax operating profit than games on a normalized basis and is also likely to represent a majority of XD’s enterprise value on a sum-of-the-parts basis. Look past the headline revenue figure and you’ll see a business whose economics are increasingly driven by a high-margin platform selling services to the broader games industry.

TapTap Does Not Sell Downloads

TapTap has been compared to Apple’s App Store, traditional Android app stores, and even Steam but those aren’t great points of comparison from a monetization perspective. Traditional app stores take a cut by sitting directly in the transaction flow. TapTap largely avoided that model. Outside of a relatively small payment processing fee for paid games sold in mainland China, XD allows developers to keep game revenue, instead generating the majority of its platform revenue by selling performance-based advertising, pre-registration, download, activation and user acquisition services to game companies.

In other words, what TapTap actually sells is not software distribution. It sells access to an audience of players who have already shown strong intent to download, engage and spend on games. That distinction is important because it means we can stop thinking about TapTap strictly as a distributor. The value of TapTap is not determined by how many apps it sells, but by whether game companies think users acquired through TapTap drive better returns than users acquired through other advertising channels.

We can see that clearly in the operating results from the past year. Monthly active users in mainland China only grew about 2.1% to 45 million during FY2025, while platform revenue grew 24.7%. Annualized advertising revenue per monthly active user (MAU) increased to approximately RMB 42.5, up roughly 22%. An even more revealing year was FY2023 when MAUs declined 13.5% but platform revenue grew by 32.6%. If TapTap relied on constantly growing its audience to drive revenue growth, those two metrics would have moved much closer together.

Instead, the data suggests TapTap’s commercial engine can extract greater value from a fixed set of users over time through better targeting, higher user intent, greater engagement, and an advertiser willingness to pay more. Advertisers pay TapTap because they think gaming users on TapTap are better than the users they could acquire at comparable prices on other platforms.

That’s why investors should not treat TapTap as a traditional consumer internet platform that needs endless growth just to maintain its position. TapTap is increasingly acting like mature vertical advertising asset: the user growth rate can decelerate because each user is now generating more economic value than ever before.

The Simple Reason Why an 86% Gross Margin Is Sustainable

To some, TapTap’s high gross margin must look unsustainable. If it costs so little to operate TapTap why doesn’t everybody just do it themselves? What keeps competitors out? The answer: network effects.

TapTap’s high gross margin is not a testament to temporary cost discipline. Rather, it is encoded into the underlying economics of the platform. TapTap does not need to buy most of its content because game developers want their games on TapTap. It does not need to pay for much of the guides, reviews, ratings, and discussion because users will voluntarily create that content for free. Finally, TapTap can maintain high margins because it does not have to pay large revenue-sharing fees to game publishers like a traditional distributor would.

Put simply: Users → create content for free, Developers → give TapTap free access to their products, All while Advertisers → pay TapTap for conversions.

The business primarily has to service the cost of servers, bandwidth, moderation, product development and advertising technology. By economic standards, TapTap is monetizing an externality: a huge gaming ecosystem where most of the supply side value is created entirely outside of its own cost structure.

Digging in even deeper, that also creates an incredibly valuable intangible asset on TapTap’s balance sheet that most investors completely overlook: ever-growing library of game guides, historical ratings, version updates, player discussions, and game knowledge. Any individual piece of content (a review here, a gameplay guide there) is probably worthless on its own. However, if you step back and view TapTap as a whole you can start to see how a comprehensive archive of thousands of games can create search traffic, switching costs, user habit, and access to unparalleled interest data.

As users spend more time on TapTap, it learns more about their individual preferences. As more users join and create content, the archive gets richer for the next user who joins. You can view this mechanism as network effects if you’d like. We view it as a powerful, virtuous cycle.

And lastly, TapTap benefits from being cross publisher neutral. Tencent, NetEase, and other large game publishers can and do build loyal communities around their own products. But those communities can only be interested in those publishers’ games. TapTap can host that interest and engagement across rival publishers and game genres. It has the potential to serve as an infrastructure layer between games companies and players instead of just another first-party marketing channel.

Potential is the key word in that previous sentence.

High gross margins aren’t proof that TapTap has attained any sort of network effect or industry infrastructure status just yet.

Risks Are Asymmetrically Loaded to the Advertiser Side

Management disclosed that XD had a single customer that represented 18% of group revenue in FY2025. In pure revenue terms, that equates to more than RMB 1 billion. XD has neither named that customer, disclosed how much of that spending was linked to TapTap specifically, or shared any details about advertiser count, repeat purchasing, retention, concentration risks, or any of the other metrics you would normally use to assess demand side health.

If a majority of that RMB 1 billion was spent through XD’s online marketing services business then yes, one advertiser represents a very large portion of TapTap revenue. That is materially different than how most investors discuss TapTap today and should change how you think about the business’s valuation. A diversified advertiser base means recurring revenue, more pricing power distributed throughout the ecosystem, and longer duration metrics can credibly be applied to the valuation. A stable of large advertisers can still power an excellent business, but that business is less sticky than its peers and should trade at a significantly lower multiple as a result.

This leads us to the biggest unanswered question for TapTap bulls. While we love the user-side economics (deep engagement, rising monetization per user, accelerating revenue despite monthly active user declines), we are not quite there yet on the advertiser side of the business. If most of that RMB 1 billion comes from one or two advertisers then Stop. Using. The. Phrase. “Platform infrastructure.”

Until we know more about how diversified TapTap actually is on the demand side, we view this as the largest risk to the thesis.

Games Performance Needs More Accounting Discipline Than Headline Profit Indicates

XD’s headline FY2025 performance looked good. Net profit attributable to shareholders totaled RMB 1.66 billion, up 86%, and operating cash flow was RMB 1.71 billion. Cash of around RMB 3.69 billion at year-end and negligible borrowings left XD with a pristine balance sheet and strong cash conversion.

The underlying game economics are less clear cut. Monthly active users of online games and monthly paying users of online games both decreased by approximately 20%. Contract liabilities decreased by 22.9%. Contract liabilities principally consist of player payments received that have not yet been fully recognized as revenue because the associated virtual currency or items remain unused. A declining contract-liability balance can signal that previously stored up deferred revenue is being released at a faster rate than it is being replenished by current player spending. In other words, some of today’s revenue may be buoyed by releasing an older pool of revenue.

Game revenue recognized on a net basis also increased to 13.5% of total game revenue, up from 4.3%. This partly reflects XD’s international publishing and agency deals. Revenue recognized net records only XD’s commission or economic share of revenue, rather than the full player payment, while developer and channel fees paid by XD are neither included in revenue nor cost of sales. There’s also a distortion on the tax rate line. XD’s effective tax rate for FY2025 was just around 3.6%. This is almost certainly aided by tax credits and research-and-development expenditures. That may be completely legitimate, but it’s not a conservative rate to apply forward for purposes of calculating normalized earnings. Applying a valuation multiple directly to reported net profit risks treating both an anomalously low tax year and an exceptionally strong point in the product cycle as the new normal.

For that reason the games segment should be dissected game by game instead of being valued as a monolith. Ragnarok M and its subsequent Classic variations are closer to cyclical monetization of a persistent intellectual property franchise. Nostalgia can be monetized multiple times but shouldn’t be treated as multiple launches of perpetual annuities. Go Go Muffin and several other titles seem more like launch-driven products whose revenue naturally peaks early then fades. Torchlight: Infinite and Heartopia are the two games most likely to have staying power.

Torchlight: Infinite exhibits seasonality you’d expect from a live-service title and now benefits from XD’s ownership of the Torchlight IP to limit future royalty leakage while creating potential for sequels and expansions. Heartopia has elements of the social elements, housing, customization mechanics, and simulation that can foster lasting user lifetimes. Both games have qualities you like to see in evergreen franchises, but demonstration of potential is not the same as demonstrated performance. Just because a game has been operated for two or three years does not mean it should be afforded the same valuation posture as a franchise with 10 years of stable cash flow.

The difference is massive. The average mobile game is a project-based asset. Publishers front load on user acquisition costs, revenue peaks upon launch, and profits reverse course as retention drops off and acquisition costs must be repeated or increased to maintain peak output. An evergreen game operates more like a long-duration asset that continually trades on user relationships, recurring seasons, vanity progression, cosmetic purchases, and community ties. A large share of the upside in XD’s games valuation thesis hinges on Torchlight: Infinite and Heartopia eventually meeting that standard.

PC Maker and Developer Services Shouldn’t Be Considered Established Earnings

TapTap is diversifying or looking to diversify across PC distribution, game-making tools, developer services, and geographic expansion. PC is the natural first extension. PC gamers care more about detailed reviews, guides, ratings, social discussion, and cross-platform discovery than mobile gamers tend to. Independent developers, likewise, have stronger incentives to embrace a low- or zero-commission distribution alternative. If TapTap can transplant its existing user and advertising economics into PC gaming it could meaningfully expand its addressable universe without sacrificing core DNA.

TapTap Maker is an even more exciting prospect. Empowering users and small teams to create, publish, and monetize games natively inside TapTap could allow the platform to begin supplying its own games rather than exclusively distributing third-party content. There’s significant commercial and regulatory uncertainty to work through, however. Likewise the current operating proof added by TapTap Maker is minimal.

TapTap’s new businesses certainly have option value, but they shouldn’t be mixed into the multiple applied to XD’s established advertising business. This is important. I think one of the more common mistakes made in platform investments is immediately capitalizing a hypothetical future business as if it possessed the same economic risk profile as the core business. I’d be more comfortable valuing XD’s advertising engine by its current metrics, then separately modeling PC, Maker, developer services, and geographic expansion with probability-weighted outcomes.

The Reported P/E Looks Cheaper Than the Normalized Business Really Is

Because XD’s reported earnings were lifted by a very low effective tax rate, favorable revenue-recognition mix, and outsized contributions from titles at temporarily attractive points in their cycles, the reported price-to-earnings ratio makes shares seem cheaper than normalized earnings would suggest. Separating TapTap, the underlying game portfolio, the optional businesses, and excess cash provides a better framing for discussion.

Based on assumptions outlined in the underlying research, TapTap’s normalized after-tax operating profit is roughly RMB 650 million. This assumes that the platform bears meaningful spending on PC, Maker, artificial intelligence (AI), and developer services, so it is conservative relative to a strict calculation of what the advertising business would contribute on its own. Applying average revenue growth of approximately 12% per year over five years and discounting future cash flows at ~10.5% produces an enterprise value for the mature TapTap advertising asset of roughly RMB 12 billion. Including the expected value of PC, Maker, developer-service, and international expansion options increases enterprise value by a further estimated RMB 1.7 billion.

Valuing the game portfolio title by title according to the stage of each title’s product life cycle and its durability produces an estimated RMB 4.2 billion value in the base case. Cash and other non-operating net assets contribute roughly RMB 3.5 billion. Summing these components produces a base-case equity value of approximately RMB 21.4 billion or HKD 49.4 per diluted share.

Discounting the base case to account for downside risks produces an implied equity value of approximately RMB 19.8 billion, or HKD 45.7 per share. The base case assumes that the worst case outcome for each of TapTap/advertising revenue concentration, the game portfolio, and the success of optional businesses does not occur, but rather that: the largest advertiser remains, TapTap’s monetization grows at a high rate that gradually moderates, the core game portfolio experiences an orderly decline that is manageable within broader corporate overhead, and the various optional businesses ultimately create some value without needing heroic growth assumptions to do so. Once the implied equity value of each possible outcome is weighted by its probability of occurring, estimated equity value falls to roughly RMB 19.8 billion.

At the June 13, 2026 reference price of approximately HKD 50.4 used in the price discovery section of the underlying research, XD was trading near the base-case valuation but about 10% above the probability-weighted estimate of fair value. While the market was not ascribing an extreme premium to the fully realized platform story, it was already trading at a slight premium to expectations for a relatively orderly set of operating outcomes.

Conclusion

XD’s business has undergone a genuine step change in quality. By building TapTap, management has reduced the company’s dependence on the success or failure of any single internally developed title. Excessive dependence on blockbuster titles has been replaced by meaningful exposure to game industry-wide user acquisition spending, concentrated within a single scalable product. In addition to solid cross-platform game development expertise, high gross margin, light capital requirements, and large scale moat built on deep community content contributions are real structural advantages that should help the company earn above-average returns on invested capital going forward.

From a value perspective, XD increasingly resembles a vertical advertising platform with an attached game studio (albeit one with a shallower pool of durable titles than the average game publisher) and a large cash balance rather than a conventional game publisher monetizing intellectual property while also operating a small community app. Those strengths notwithstanding, the remaining gap between current share price and the sum of XD’s parts is a proof gap.

TapTap has not yet proven that it is sufficiently diversified for investors to treat its advertising revenue as infrastructure-like. In similar fashion, Torchlight: Infinite and Heartopia have not yet been proven to have earned fully evergreen status, while PC and Maker offer significant potential but have yet to prove themselves as established profit pools.

While management is working to prove up the value of the company’s ad-serving capabilities, investors buying at or around current levels are doing likewise. The investment conclusion is more nuanced than reported earnings might indicate: XD’s business model is improving and TapTap is meaningfully upgrading the quality of the business, but around the reference valuation used in this research, you are already paying for most of the base case. Remaining upside is tied primarily to outcomes that are positive but not yet fully proven, rather than to any obvious undervaluation of the business already in place.

Disclaimer: This publication is intended for informational, educational, and research purposes only. It should not be construed as investment advice or a recommendation to purchase or sell any security, or as an offer or solicitation of any kind. All financial data and valuation estimates, as well as assumptions underlying various scenarios, are based on information that may be incomplete, subject to errors and omissions, and reflect our judgments at a particular point in time. Actual outcomes may vary significantly from expected results due to factors such as operating performance, customer concentration, product lifecycle, regulation and competition, foreign exchange fluctuations, and general market conditions. Individuals should make their own investment decisions based on their own research and financial situation.

But it’s not the most important question. The biggest issue facing SMPL stock is how much of today’s earnings will stick. Plus, will investors pay for a temporarily impaired growth platform or a basket of brand assets entering secular decline?

SMPL Is Three Businesses, Not One Cash Flow

SMPL is a protein-snacking company on the surface. But economically, it is a basket of three businesses with varying levels of quality, growth and duration.

Quest is SMPL’s core asset. It produces roughly two-thirds of company revenue and most of its operating value. Atkins is an older brand that still churns out cash flow, but is losing relevance with consumers and retail shelf space. OWYN is a newly acquired brand whose growth turnaround is far from proven due to serious execution issues.

Putting all three businesses together on one income statement creates a distorted picture. Consolidated EBITDA still looks juicy. But not all of the assets producing that EBITDA should be valued equally.

Consider Quest, which serves as the load-bearing wall of the entire business. Within Quest, internals are increasingly bifurcated. Through fiscal 2026’s third quarter, total retail consumption for Quest brands was still growing slightly. Household penetration was also rising, which means the brand is not losing its ability to recruit consumers.

Dig deeper and you’ll see where problems are emerging. Traditional protein bar sales cratered by about 5%. Protein chip sales, however, surged roughly 17%. This isn’t just a shift among SKUs. Quest is trying to trade out its older growth engine — protein bars, where the category is increasingly fragmented and consumer novelty is waning — for a newer engine: protein chips.

If chips fail to grow and become a bigger part of the overall portfolio, Quest will move from growth asset into negative territory. Low-single-digit expansion would be toast. However, if chip sales continue to surge while bars slowly erode, Quest can still grow at a low-single-digit rate.

Atkins couldn’t be more different. Revenue was down approximately 22% in H1 fiscal 2026 as management aggressively cut back on marketing spending, allowing the dwindling brand to maintain healthy near-term margins. That margin profile is not indicative of better brand quality. Most of the story is that the company is no longer investing in its future. As advertising, promotional support and consumer acquisition budgets are slashed, near-term cash generation can look impressive even as household penetration, shelf space and the future revenue stream continue to decline. Atkins should be viewed far more as a finite duration annuity than a mature consumer franchise that deserves a perpetual multiple. The cash flow it generates today is very real, but it’s becoming cash that is used to subsidize the repair of other brands instead of being invested into its own future.

OWYN Is Not Just an Impairment Story

SMPL paid roughly $282 million to acquire plant-based protein shake brand OWYN in 2024, based on the belief that its scale with mass-market retailers like Walmart, Amazon would help scale a brand that had historically sold strongest through natural and specialty outlets. The rationale made sense on paper. OWYN not only gave SMPL a foothold in ready-to-drink protein, but also appealed to dairy-free, allergen-conscious, and vegetarian consumers looking for a plant-based protein snack. However, timing is everything in grocery and OWYN ran into product fit issues — namely taste and texture — during the most crucial period of its expansion, alongside lackluster marketing support. First impressions matter enormously in food, and new consumers were turned off while retail velocity came in well below expectations, threatening some of the distribution gains OWYN had recently made. Approximately 21 months after acquisition, SMPL wrote down about $187 million against OWYN, amounting to roughly two-thirds of the brand’s original purchase price. The impairment itself is non-cash, so while noteworthy is not the main issue. More important is that OWYN exposed a flaw in a strategic thesis that up until that point had propped up SMPL’s valuation higher: Buying a smaller brand and inserting it into the company’s distribution channels is not a guarantee of growth. Quest had already proven product-market fit and was enjoying strong retail velocity prior to being acquired by SMPL. SMPL accelerated growth of something that had already been proven to work. OWYN was rapidly introduced into mass channels before its product quality had been stabilized and acceptance from consumers had been established. Both are characterized as “acquire and scale” deals on paper, but the risk profiles were vastly different. SMPL’s asset-light advantage works both ways. Third-party production and low fixed costs allow SMPL to turn profit into free cash flow during healthy years. But because production is outsourced, product consistency is only guaranteed to the extent that co-manufacturers don’t alter the recipe. Access to shelf space is dictated by large retailers who can replace poorly performing brands overnight. Walmart and Amazon account for nearly half of SMPL’s sales, and retail contracts typically don’t include minimum guarantees. Every product has to earn its shelf space through velocity at the store level. Not only is SMPL selling protein bars; it is selling retailers and consumers on why its products deserve to stay on the shelf. There are capital efficiency benefits to an asset-light structure, but meaningful control over the business is effectively outsourced as well.

The Current Valuation Is Pricing Stability, Not a Recovery

At roughly $13.17 per share, SMPL is trading with an enterprise value of about $1.5 billion. Based on adjusted EBITDA guidance of $220 million to $225 million, the enterprise trades for approximately 6.8x EV/EBITDA. That’s not a random number. For an asset-light company that should be able to convert roughly 68% of EBITDA to unlevered free cash flow, 10% required return and no long-term growth literally requires a fair multiple of approximately 6.8x. Less mathematically, the market is not pricing SMPL out of existence, but it’s not pricing any real recovery either. It’s saying that the company can tread water, but may not grow.

That’s why an “only” forward earnings multiple of seven or eight times isn’t a buying opportunity by itself. The market still believes that Quest has some brand strength, that the asset-light model can produce cash, and that the balance sheet doesn’t pose an immediate threat to the company’s survival. On the other hand, it’s apparently not assigning much value to an OWYN recovery or stabilization, an Atkins return to positive growth, or even broad-based growth at Quest. The critical factor isn’t the multiple itself, but the earnings base to which that multiple is applied. If somewhere near $220 million of EBITDA is likely to be a durable trough, then the stock is probably trading right around fair value. But if gross margins normalize and Quest continues to expand, then earnings could start to turn higher and today’s prices would look attractive. If Quest enters a sustained downturn, however, even 6.8x EBITDA might be too rich.

Debt-Funded Buybacks Highlight a Process Issue

SMPL repurchased roughly 9.6 million shares for approximately $188 million during the first six months of fiscal 2026 at an average price of about $19.62 per share. At the same time, it added a new $150 million term loan, which will increase annual interest expense by about $10 million. To say that taking out debt to buy back stock was dumb just because the stock is now trading below the buyback price would be outcome bias. Still, SMPL transformed what should have been a highly uncertain valuation call into a capital allocation decision with effectively no financial stop loss.

What’s most interesting about the timing is that on January 6, 2026, the board decided to increase the buyback authorization by $200 million. On January 8, SMPL reaffirmed full-year guidance. On January 18, CEO Geoff Tanner resigned. On January 20, former CEO Joe Scalzo returned to the company, and management reaffirmed guidance for the second time. At the point where buybacks were being increased and the company was publicly reaffirming its conviction, internal doubts about execution had apparently reached a point where the CEO needed to be replaced. Personally, I don’t think that implies malicious intent or a hidden agenda. In fact, the public statements weigh more heavily in favor of management sincerely believing the stock to be undervalued than believing anything else. But it does seem clear that the company did not have a good process for slowing or discontinuing buybacks as new information became available. Debt-funded buybacks can be value accretive when earnings are stable. Balance sheet capacity should be viewed as excess cash when it’s being used to retire shares. When you’re in trouble, it’s ammunition for brand repair, marketing support, and the option to wait until you have better information.

Conclusion

I estimate SMPL’s fair value under existing operating conditions to be around $13.50 to $14.50 per share. That implies that the stock isn’t terribly overvalued, but it also doesn’t leave much room for error. You’re essentially paying full value for Quest’s current cash generation and leftover harvest value at Atkins, while getting OWYN’s turnaround potential, future Quest chips expansion, and strategic transaction potential as lottery tickets.

For that reason, SMPL feels like a turnaround play that hasn’t yet earned its turnaround rather than a consumer compounder that can be aggressively bought just because the valuation looks low. The current price assumes that the bleeding will stop, but doesn’t give you much margin for error if efforts to repair the broader business don’t work. I’d want either a lower price to buy or better evidence that the operating trajectory is changing rather than simply watching the stock price fall.

Disclaimer: This article is intended for informational, research, and educational purposes only. It should not be considered investment advice, a recommendation to buy or sell any securities, an offer to buy or sell, or personalized financial advice. The information presented may be incomplete or inaccurate and may change at any time without notice. You should conduct your own due diligence and consult with a licensed financial professional before making any investing decisions. Your decisions should be based on your personal financial situation, investment goals, time horizon, and risk tolerance. I may buy or sell securities mentioned in this article at any time.

Hongkongers are heading north to spend money in Shenzhen. Restaurant brands from mainland China are heading south. Labour is tight. Rent is still too high. Tourists are not spending as much. Mall traffic is inconsistent. Restaurants are hard, low-margin businesses that rarely work for long periods of time.

But for exactly that reason, Taste Gourmet Group (08371.HK) is worth dissecting.

The company is not a typical restaurant company betting on one flagship brand, one celebrity chef, or one cuisine. Instead, think of Taste as a Hong Kong mall-based operator with restaurant portfolios. Its business involves moving capital not just across locations, but price points, cuisines, and table-turnover models.

All else equal, that is what makes Taste Gourmet different from a normal restaurant play.

1. Taste Gourmet is a mall portfolio operator…hidden inside a restaurant group

Taste operates Japanese, Chinese, Southeast Asian, and Western concepts, predominantly located within Hong Kong shopping malls. In the FY2026 annual report, Taste generated ~HK$1.35 billion in revenue and ~HK$117 million in profit attributable to shareholders, working out to ~8.7% net profit margin. The company ended the year with ~72 restaurants across Hong Kong, with a small remaining presence in mainland China.

It’s balance sheet we care about: no bank debt and ~HK$266 million in cash. At current prices (~HK$1.90), the entire company has a market cap that’s barely above HK$700 million. Put differently, investors are not exactly assigning lofty valuations to Taste Gourmet’s underlying operating business.

But here’s the thing: Taste Gourmet is not an “opening restaurants” story.

Take a step back. The basic unit of any restaurant business can be broken down into four components:

Revenue = seats × table turns × average spending × operating days

In FY2026, Taste Gourmet served ~5.94 million customers. Average spending was ~HK$227. Table turnover was roughly 2.4x. After you account for seating capacity and operating days, the economics break down to something like this:

For every HK$227 Taste Gourmet brings in, ~HK$60 goes to food costs. ~HK$70 goes to labour. Rent and occupancy take up another big chunk. Split up amongst other costs and taxes, Taste Gourmet retains ~HK$20 per customer after tax.

That’s it. The business model is about doing that same +HK$20 transaction millions of times over each day.

Sounds boring. But there is one huge benefit to the model: liquidity. Cash from customers is real. Inventory turns over fast. Supplier credit exists. Profits are not locked up in receivables. When you are a small-cap, GEM-listed, family-controlled company, unit economics that translate to actual cash in the bank matters far more than storytelling.

2. Here is why Taste Gourmet is not your typical restaurant stock

Restaurants, by nature, are often single-instance bets. Bad location? Brand gets stale? Chef quits? The kitchen cannot scale? One bad roll of the dice and your average restaurant business can wither and die.

Taste Gourmet has none of these issues because Taste Gourmet is not betting on one restaurant.

Across Japanese dining alone, Taste serves high-ticket, lower-turnover concepts such as yakiniku and hotpot, but also lower-ticket, higher-turnover concepts such as ramen and soba. Chinese dining brands offer scale and growth. Southeast Asian dining is your bread-and-butter dull-but-steady focus when it comes to low-ticket dining demand. Western dining is being pivoted towards bakeries, donuts, and lighter fare.

The deeper takeaway: restaurants that rely less on skilled kitchen labor are easier to scale.

Yakiniku and hotpot get away with this because cooking is largely done by the customers themselves. Built for efficiency, ramen allows for higher seat turnover and leans on standardized soup bases. Bakery and fried donuts are probably the best models in the entire portfolio: they don’t require customers to sit down. Revenue is driven by counter throughput and mall footfall.

Labour, not capital, is Hong Kong restaurants’ scarcest resource. Labour costs account for ~30% of revenue. Employee turnover is high. Operating models that do not require as much skilled labour, that are less complex, and that are easier to standardize should have far better replication economics. It’s not just about opening new restaurants. Taste Gourmet is tilting the portfolio towards higher labour productivity and faster throughput.

3. Hong Kong Dining Pressure Created a Window

Hong Kong dining has had a rough couple years.

Residents traveling to Shenzhen for consumption became routine life after the border reopened in 2023. The most immediate areas of the market to feel the pressure are weekends and dinner hours– prime time slots that full service restaurants rely on most for profitability. Concurrently, brands from mainland China are entering Hong Kong with stronger standardization, keener pricing, and better talent across social-media driven customer acquisition.

But pressure on the industry is not entirely negative news.

For leveraged, single-brand, cash-strapped restaurants, that is painful restructuring. For a net-cash, multi-brand operator with mall relationships and the ability to hold onto those prime stores… it’s also an opportunity transfer.

Hong Kong retail rents plunged after 2019. Logic around luxury / fashion tenants came undone and malls needed traffic drivers. Dining + experiences + light consumption took on more weight. Spaces that were traditionally reserved for global brands or luxury tenants started rotating over to local restaurant groups that could demonstrate stable operating histories.

Harbour City leases are a sign of that.

Hong Kong mall speak: Harbour City is not just another mall. It’s a status symbol. Harbour City means top-traffic, top-rent, top-landlord tiers. Taste Gourmet signing Harbour City leases means it crossed over from casual restaurant tenant into the realm of “restaurant operators that prime landlords seriously consider”.

That doesn’t create a permanent moat. But it does create a real cyclical window.

4. Store Closure Discipline Might Be The Most Important Thing To Look At On Management

The easiest expansion mistake to make in restaurants is to open stores and never close.

Once a location underperforms, management can trick themselves into thinking it just needs time. Tourists will return, the mall will get better, we already spent money on renovations, the brand hasn’t reached potential. Meanwhile, bad restaurants slowly bleed against a restaurant’s scarcest resources: team, management time, cash, brand halo.

2026 was when Taste Gourmet opened 11 stores and closed 5.

Did they close due to poor labor productivity? Did they close because they are strategically exiting high-cost fine dining? Did some of the closures come from mainland China malls that did not achieve traffic expectations? If so, these weren’t casual closures. They were reallocating capital within a portfolio.

Why does that matter in restaurants?

Most of the excess returns in restaurants accrue to landlords. Open a good store, and renewal rent is likely to increase. Landlords know traffic. Thanks to store visibility and lease structures, landlords often know your sales numbers too. Location is valuable, but most of those gains eventually get repriced by the landlord.

Store closure is one of the only credible threats a tenant has.

A restaurant group that is willing to close unprofitable stores, switch concepts, and move to other malls has leverage in negotiations. Taste Gourmet’s ability to close stores is not just about risk. It is also about having bargaining power with landlords.

5. Why Is it Cheap?

It’s not cheap due to liquidation value. It’s not cheap because of its structural moat.

It’s cheap for 3 straightforward reasons:

1. Fewer can own it.

This is a GEM-listed small cap with liquidity issues, concentrated family ownership, little institutional ownership, and no sell-side coverage. Some investors will steer clear of it once they look deeper. Many will never consider it at all.

2. Nobody wants to look.

“HK restaurant,” “GEM board,” and “family small cap” are three tags that typically push value investors away before they see the numbers. They don’t realize the company has cleaner cash flow than other small caps, pays a dividend, is net cash, and has better closure discipline.

3. Nobody can look.

It’s hard to screen restaurants fairly under lease accounting. Operating cash flow is separated from lease liability, right-of-use asset is isolated from the business, and rent expense is deferred on the income statement. The only number that matters is the cash left for shareholders after lease cash payments, capex spent on maintenance/renovations, and tax. Cash flow = truth.

Normalized free cash flow to equity > HK$110 million on a stable basis. Run that through a modest operating multiple + add back net cash + some visible optionality and you get neutral equity value of HK$1.5 billion, or about HK$4.0 per share.

That doesn’t assume Taste Gourmet becomes a world-class company. It doesn’t assume Hong Kong dining bounces back to pre-pandemic levels. It just assumes management continues to run this engine at relatively stable unit economics and stays disciplined with new openings, closures, and dividend policy.

6. I don’t think the largest risk is “Hong Kong people stop eating”. Instead, it’s how long Hong Kong lasts.

“Hong Kong people still need to eat.” is true, but it isn’t the whole story.

Here’s a more complete thought: Assuming a population and income base, there will always be a stable demand for dining out. But that population base, the outflow of people and ability to replace them with mainland visitors, talent retention/wage pressure, northbound consumption, confidence in Hong Kong’s future all impact the total pie.

Which means you shouldn’t be thinking of this as a forever-grower.

Where Taste Gourmet is different is that the balance sheet hasn’t been heavily allocated to Hong Kong real estate. Leases, brand, and operating knowhow are the key assets. And restaurant leases are only 3-6 years at most. Not decades-long mortgage payments on real estate.

If the long-term decline in Hong Kong accelerates, they can simply open fewer new stores, cease to renew bad leases, shutter poor performers, and return capital to shareholders. This is less of a long-term bet on Hong Kong and more like a short-term rolling portfolio of restaurant projects.

And that’s why I think of it as a cash-flow-based small-cap value play versus a conviction core holding.

Conclusion

My thesis on 08371.HK isn’t complicated:

I don’t think it’s a great company in a great industry. I think it’s an unexciting company in an unexciting industry with capital allocation you can trust appears meaningfully better than its peers.

The story isn’t “Hong Kong dining revival”. It’s much more fundamental: net cash + no bank debt + ongoing dividends + ability to shut loss-making stores + access to better mall space + portfolio of formats to help mitigate labor costs, rent, and foot traffic risk.

Neutral assumptions leave me with a fair value anchor for Taste Gourmet around HK$4.0/share. Accounting for GEM-board liquidity discount, family control, opaque same-store sales, food-safety risk, and opaque governance tail risk, a comfortable buying range is probably below HK$2.4–2.8.

The market is currently pricing in a pretty pessimistic outcome at HK$1.90. Even if you don’t get a rerating in valuation, you’re getting a nice return from the dividend itself. Stability in operations + smart new mall signings + rerating are all additional upsides.

Unlike many restaurant stories, this isn’t a story that needs faith.

It’s just a low multiple way to buy into a dividend paying, net cash restaurant machine that is continuing to reallocate stores and concepts through a tough Hong Kong dining cycle.

Locations. Table turns. Labor productivity. Rent. Price.

Disclaimer: This post is for discussion and research purposes only. It is not investment advice or a recommendation to buy or sell any security. Opinions, estimates, and assumptions herein may be inaccurate. The stock mentioned is typically a small-cap, low-liquidity stock that can be subject to substantial price volatility and risk. The author has no obligation to update/modify any statements. He may hold positions in the securities mentioned, and may buy and sell positions at any time. Please do your own due diligence. Talk to your advisor.

On paper, 01911.HK looks like a classic deep-value setup. Attributable equity is roughly 6.1 billion RMB, while the company’s market capitalization is only around 1.5 billion RMB. Put another way, investors are pricing the company at approximately 0.25x book value. That number naturally invites the conclusion that the market has overreacted.

But this stock cannot be analyzed like an ordinary low-P/B company.

How much of the asset base is genuinely recoverable? Does the operating platform still have sustainable earnings power? And will the controlling shareholders and management ever return that value to minority shareholders?

That is why what appears to be a simple valuation exercise ultimately becomes a combined analysis of governance, accounting, business quality, and capital allocation.

Start With Breaking the Company Apart

China Renaissance began its life (and earned its fame) as a “new economy boutique investment bank.” It specialized in financial advisory, mergers and acquisitions, private placements, and IPO underwriting during the golden age of China’s internet and venture capital bubble.

Today, however, it no longer makes sense to think of China Renaissance as one investment banking business.

Instead, a more useful way to think about the company is that it actually consists of four parts.

Part 1: The Proprietary Balance Sheet

This includes cash; cash-management products; listed bonds; private fund interests; unlisted equity; Level 3 financial assets; distressed debt portfolios; and digital assets.

Part 2: The Investment Management Business (aka GP Economics)

If we think about GP economics as its own business, then “value” is reflected in management fees and carried interest. Management fees are a function of fee-earning AUM. Carry is a function of fund exits, timing of distributions, and the % of carry ultimately paid to the listed group.

Part 3: Investment Banking

China Renaissance still has access to transactions and clients. However, transactions do not flow through to the bottom line nearly as much as they used to. A pickup in deals does not necessarily equate to a pickup in profits.

Part 4: China Renaissance Securities

The securities license is worth something on its own. But license value is not operating value. Increases in registered users are meaningless. What’s important is client assets, trading volume, commission rates, wealth-management revenue, and fixed-cost coverage.

Bottom line: Do Not Look at This as One Business. Do Not Apply an Earnings Multiple. Do Not Use Book Value.

As you can see, the proper way to think about China Renaissance is with SOTP, or sum-of-the-parts valuation: discounted asset NAV + GP economics value + operating value of IB & securities – minority interests – structured-entity claims – stock-based compensation – disposal costs – governance discounts.

The Framework Is Fair, But The Output Isn’t Neutral

I think the overall framework for valuing China Renaissance is sound: Discounted asset NAV, GP economics, and a small window for platform optionality should point us in the right direction.

It’s a much better starting point than plugging a trailing P/E into a calculator.

The income statement is too noisy. FY2025 restored reported profitability to the group, but most of that income was related to carried-interest accounting and harvesting legacy assets. Stripping out unrealized carry, the underlying operating story was ugly.

Carried interest itself also needs to be discounted. Gross carried interest is not earned by shareholders. A portion goes to the investment teams and other parties. The publicly listed group keeps only about 30% of that carry, economically speaking.

Translation: RMB 1 of gross carry is worth much less than RMB 1 to public shareholders.

And that’s important, because many lazy models take gross carry and put it directly on the balance sheet, which leads to astronomical valuations.

Mostly, the valuation framework takes a disciplined approach to accounting. It treats segregated client assets as they should be treated: not as corporate cash. It doesn’t double-count China Renaissance Securities’ net assets. It properly bifurcates the company’s LP interests from its GP rights. It also wisely steers clear of applying any conventional “earnings multiple” to FY2025 reported profit.

But a good framework doesn’t ensure objective or neutral output.

Presenting output as an “expected value” when it’s really a base-case point estimate is the biggest problem.

An expected value should incorporate weighted probabilities for bear, base, and bull cases. When the probabilities are subjective, or when a model leaves out the most important tail risks, the “expected value” can end up looking like a bullish base case masquerading as scientific objectivity.

Which is bad enough. It’s far worse when the model suggests that even its bear case still represents a large upside.

Because even that modeled bear case may have already accounted for many of the risks that investors fear.

The Market Isn’t Discounting Assets. It’s Discounting Trust.

Discounts happen when the market does not believe an asset will trade at its theoretical value.

This is as true in equity research as it is anywhere else.

The big discount at China Renaissance isn’t an asset discount. It’s a trust discount.

The Bao Fan situation. The extended trading halt. The qualified opinion. The restricted cash. The management changes. The family-controlled corporate structure. All those things are hard to put in a model. The market obviously thinks something about them, however. And that something is negative.

Hence the vast gap between theory and price.

Investors could view China Renaissance as merely a collection of hard assets, and it wouldn’t necessarily seem worthless. Cash, cash management products, and listed bonds comprise the Tier 1 of the balance sheet and provide a very defensive floor. Even if you take an ultra-conservative approach—only counting liquid assets; giving zero-value to Level 3 assets, private fund investments, unlisted equity, distressed debt, and crypto; and excluding non-client liabilities and minority interest—you come in close to where the market cap currently is.

Which is why it’s worth thinking about.

But you still have to prove a good amount of the book value.

Level 3 assets have no observable market price. Private fund interests need exits and distributions. Unlisted equity needs actual trades to confirm carrying values. Distressed debt needs a real collection period. Crypto adds more volatility to an already volatile portfolio.

It almost seems like the market is saying this: only liquid assets should be given full credit while everything else is heavily discounted or made discretionary.

That’s not necessarily true. And it doesn’t mean your model is incorrect.

They’re just two different ways of valuing China Renaissance.

The model values China Renaissance at orderly realization value.

The market is pricing in control, or lack thereof.

The difference between those is known as a capital-return mechanism.

China Renaissance’s Web3 Pivot May Become Negative Rather Than Positive

China Renaissance’s recent foray into Web3 and digital assets is one of the biggest variables in the entire thesis. From a market-narrative standpoint, it is clearly a positive. Circle, BNB, YZi Labs, RWA funds, and digital asset products are all powerful phrases when thrown into the mix of a small, illiquid Hong Kong-listed stock that has been stuck without a growth story for years.

However, from a value investing standpoint, that does not necessarily make it positive. At this point, Web3 and digital assets represent a stress test of management’s capital allocation discipline far more than a positive catalyst.

Here’s why.

Today, what China Renaissance lacks is not a story. What it lacks is trust from investors.

Investors are assigning low valuations because we haven’t yet seen audited clarity on the balance sheet, asset realization, lower governance risk, and credible cash returns to shareholders.

When that foundation is shaky, moving part of the proprietary balance sheet into high-risk digital assets naturally raises a question: are they fixing the balance sheet, or using a shiny new story to distract us from unresolved issues on the legacy asset base?

Notice that I am not saying Web3 investing is inherently unreasonable. Quite the contrary.

If China Renaissance can legitimately build on its existing experience in new-economy financial services, institutional connections, and product creation to make Web3 a client servicing solution, bona fide fund product, or regulated financial infrastructure, there is sound strategic logic to the move.

If it is instead purely speculative balance sheet exposure, we are talking about two very different decisions.

When trading at extreme discounts to NAV, minority shareholders would normally ask for cash returns over new rounds of balance sheet tinkering. They would welcome asset recovery and reduced risk before upgrading China Renaissance’s growth story.

Again, this is especially true given that dividends have yet to meaningfully resume, no material buybacks have been executed, and the company is unable to issue an unqualified audit opinion.

Until those issues are fixed, new initiatives will rightly be viewed through the lens of governance risk.

Will Web3 and digital assets work for China Renaissance? Many investors will simply want to see proven capital discipline and restored trust before giving management more optionality on the balance sheet.

Sequence matters.

Repair the trust first. Show capital discipline before you are rewarded with optionality. Until then, the Web3 pivot will be viewed with suspicion, and is more likely to become a negative rather than a positive.

Management Track Record: Execution Has Been Strong. Capital Allocation Has Not Been Tested

I don’t think it’s fair to write off the underlying management team and platform.

History shows that China Renaissance could spot macro trends, position its platform in the middle of complicated transactions, and create a network across China’s new economy landscape. China Renaissance’s investment banking connections, existing fund-management platforms, sector knowledge, and securities licenses don’t come overnight.

But what mattered in the past doesn’t mean it will lead to capital appreciation today.

Back when internet groups were ramping up in China, loads of U.S. dollar VC flowing into China, IPO windows were open, China Renaissance rode a bull market. It was an environment where capital appreciation was nearly automatic.

Fundraising dollars are no longer as robust. The platform economy peak has passed. IPO windows are narrow. LPs have less money to invest. Regulations are always changing. And more importantly, the distrust from Bao Fan’s founder-related incident hasn’t entirely gone away.

China Renaissance’s new management isn’t exactly catching a tailwind. It’s on a mission to turn things around.

As of now, I think we can say operating stabilization has occurred but capital allocation remains to be seen.

Trading resumed. Years of missing financial reports were accounted for. Top line rebounded. The investment management division continued to realize value from past investments. Securities business stopped bleeding as much. The company even restored the ability to talk to the market with a growth story.

These are positives that the platform is still alive.

But how the platform is allocating capital is still up in the air.

The company hasn’t paid a dividend. Authorized buybacks haven’t amounted to much. And frankly, the assets continue to sit inside the conglomerate, collecting fees while being shuffled around. Not to mention, management has been dipping its toes into new areas like distressed credit and cryptocurrencies.

Minority shareholders should care about capital allocation more than anything else.

When a company’s stock price trades at a significant discount to NAV, management should be focused on helping minority shareholders increase NAV per share first and foremost, not storylines.

It’s not how much the assets are worth. It’s who gets the value.

On a purely balance sheet level, China Renaissance looks attractive.

The share price today already prices in very low expectations. It also trades as if we’re at a point where only “hardest” assets are recognized and everything else is heavily discounted.

But if you look at this through the prism of minority shareholder rights, the story gets much more complicated.

NAV doesn’t equal value to minority shareholders.

Without consistent dividends/buybacks/cash returns after asset sales, a discount to NAV can be maintained for many years here in HK. And if management keeps moving money into risky new ventures, the asset base itself could erode.

This is the China Renaissance paradox.

It could be cheap. But being cheap won’t necessarily be the catalyst.

And for a company like this, I don’t think the modeled per share value matters as much as HKD 11, HKD 12, or HKD 16. That suggests a level of precision in the valuation that the inputs don’t deserve.

What we can say with confidence is this: China Renaissance seems to have a real asset floor. It hasn’t shown minority shareholders they can capture it, however.

Conclusion

01911.HK isn’t a straightforward low-P/B cigar butt.

It’s a messy special situation with a core asset base, some remaining platform value, a significant governance discount, and some outstanding questions relating to capital allocation.

I agree that SOTP makes sense as a valuation framework. And yes, this isn’t a company you should value using a conventional earnings multiple given its cash, bonds, proprietary fund interests, legacy carry, and financial licences that say the business isn’t worth zero.

But I don’t think a base-case valuation of HKD 11 to HKD 13 should be treated as your entry price anchor.

I understand that range to reflect a theoretical value assuming among other things: orderly realization of assets, no significant decline in risk, platform continuity and ultimate distribution to minority shareholders.

That is not a price to expect the market to think of today.

Valuation-wise, the Web3 pivot is a big negative for the company right now. Not because it’s destined to fail, but because it’s ill-timed.

If a company still has a qualified audit opinion, has yet to restore shareholder distributions, and trades at a big discount to NAV, it needs to demonstrate capital discipline before story-telling prowess.

My view is that China Renaissance deserves to be on your research watchlist, but you shouldn’t lazily tag it as “deeply undervalued”.

It has proven it isn’t worth zero. But it hasn’t yet proven that minority shareholders will see that value reflected in their share price in a reasonable timeframe.

The debate isn’t whether China Renaissance is worth more. It’s whether management will ever allow ordinary shareholders to realize that value.

Disclaimer: This article is intended for informational and research purposes only. It is not investment advice. It is not a recommendation to buy or sell any security. It does not constitute a projection of future share-price performance. Under no circumstances should you rely on this article alone to make an investment decision. Readers should do their own due diligence. Research carefully. Verify company filings, company financials, and understand risk factors before making any investment decisions aligned with your financial goals and risk appetite. Authors may or may not hold positions in the aforementioned securities. Authors’ opinions may also change as new information becomes available to the public.

Moments does not feel particularly ad-heavy. Video Accounts has also yet to be monetized like many other short-video platforms.

That restraint may be Tencent just refusing to monetize billions of user traffic. But for an enlightened company like Tencent, it may also be the single most important clue to value.

There are two ways to look at this situation. The negative lens is Tencent is old, risk-averse, and slow. The company may have missed the most lucrative window for short-video ads and social commerce.

The more positive lens is Tencent is purposefully safeguarding the most valuable plot of land in the Chinese internet.

WeChat is not a standard public content feed. It is an entire trust layer sitting on top of content, search, mini programs, payments, merchants and relationships within closed domains. That makes advertising decisions less straightforward. But it also makes those decisions potentially far more valuable.

Those two views will lead to drastically different valuations for 0700.HK. If Tencent is just your garden variety late-stage internet giant, then it should be valued for its low-growth cash flows. If Tencent can continue to increase eCPM and improve the efficiency of transaction loops without bursting the thin veneer of low ad-load, Tencent is no longer a defensive compounder. The company is a cash-flow machine where some of the highest-quality levers have not even been fully pulled yet.

All of this is why looking at Tencent’s group P/E is far too crude of a method to value Tencent. The company has to be broken down piece by piece. Advertising is where the entry point begins, but we also have to ask how does each major asset play a role in driving value for the whole conglomerate.

The Advertising Clue

The simple version of advertising is user time spent × ad load × eCPM = ad revenue

Time spent is self-explanatory. Ad load is how many ads are served against each unit of content. And eCPM is how much revenue you earn for each thousand ad impressions.

The standard path to growth for most internet companies then becomes: grow time spent, stuff more ads, use machine learning to charge more for each ad impression. Tencent? Not so much. WeChat deliberately hasn’t pulled the ad load trigger all the way.

Moments functions first and foremost as a social graph, instead of a pure entertainment content feed. When users open Moments, they are primarily interested in seeing what friends, colleagues, clients, relatives and other social connections are up to. Throw one more ad into this stream and you do not just risk losing click-through rates. You risk polluting one of the most important intangible assets of WeChat: the trust layer.

Video Accounts is another example. Outside of WeChat, short-video is primarily about mindshare and ad load within a self-contained app. Inside WeChat? Video Accounts plugs directly into Official Accounts, Mini Programs, WeChat Search, Mini Shops, Enterprise WeChat, and WeChat Pay. The highest value endgame is not necessarily keeping users in a short-video wormhole for as long as possible. The more powerful use case is when content plants the initial demand, search bars turn that intent into actionable queries, mini programs (or mini shops) help power the transaction, and merchants leverage WeChat’s private domain traffic to elicit repeat purchases.

As such, Tencent’s advertising valuation hinges less on how much additional ad load it can sensibly cram into WeChat. The real value comes from how much it can improve eCPM, optimize for ROI, and transact.

Automated advertising tool AIM+ is another reason. Advertisers set budget and conversion goals. Tencent’s AI algorithms do the rest. Seems simple? It’s not. By pushing more of the targeting, bidding and creative optimization to artificial intelligence, Tencent can slowly regain control of how advertisers allocate their budget. The more advertisers embrace automation, the more Tencent can position its algorithms to pick the advertiser with highest conversion rate at any given moment and the most rational bid price.

Needless to say, this is not just some sort of “AI gimmick.” AIM+ is one of the few products where AI can already directly impact Tencent’s income statement.

Closed loop advertising takes this concept even further. Tencent has historically struggled with advertising for transactional intent. Sure WeChat had tons of eyeballs. But if a user clicked on an ad and went somewhere else to complete a transaction, Tencent would only make money on the media fee. The transaction data points, payment value and repeat purchase relationship all slipped through WeChat’s fingers. This could change. Plant the demand with Video Accounts, capture intent with WeChat Search, complete the transaction with Mini Programs / Mini Shops, payment goes through WeChat Pay. After the sale is made, merchants can even use WeChat’s private domain relationships to fuel future purchases.

In this scenario, Tencent isn’t just earning ad dollars. The payment and tech service fees from these closed-loop transactions also pour into Tencent’s fintech and business services segment.

Remember how I said Tencent wants to regain more control over how advertisers allocate their budget? This also works in reverse.

The more integrated WeChat gets as an advertising platform, the more advertisers will eventually pay Tencent not for nebulous “exposure”, but for an actual measurable probability of conversion. That’s why Tencent’s advertising should not be valued like a generic media company’s ad business.

Games: the cash-flow ballast

Tencent cannot be valued just by advertising. 0700.HK’s full valuation comes from a few large assets, the first of which is games.

Games is Tencent’s ballast. There is less narrative “oomph” compared to advertising, but cash-flow quality is extremely high here. Domestic games are powered by evergreen IP, social distribution, and operating expertise; international games powered by years of investment and acquisitions across the global gaming ecosystem. Downside comes from regulation discount and industry maturity; upside comes from margins, deferred revenue, and long-cycle product strength.

On my bottom-up estimate, gaming after-tax profit is around RMB 110 billion. A 14-16x after-tax earnings multiple implies a value of roughly RMB 1.5-1.8 trillion, or around HKD190-225/share.

Advertising: the most elastic piece

Advertising is the second big piece. Tencent’s FY2025 advertising revenue was around RMB 145 billion, up about 19% on the year, with gross margin of around 57.5%. This gross margin doesn’t appear high on the surface, but keep in mind that advertising blends higher-quality WeChat-owned inventory with low-margin businesses such as ad networks, media advertising, and creator revenue share.

The opportunity for margin improvement here is incremental revenue shifting toward WeChat-owned inventory: Video Accounts, Moments, WeChat Search, and Mini Program-related advertising. Incremental revenue should ideally come from those locations as monetization matures. As a result, marginal profitability should exceed blended average.

On my rough estimate, I can see 2026E advertising revenue reaching about RMB 170-175 billion, with after-tax profit of roughly RMB 65-70 billion (Mid RMB 68 billion). Applying a 16-18x after-tax earnings multiple implies a value around RMB 1.1-1.25 trillion, or HKD138-157/share.

Advertising is admittedly the most elastic part of Tencent’s valuation, but it’s also the easiest to mischaracterize. Yes, low ad load suggests monetization headroom, but that doesn’t mean ad revenue can mechanically quadruple or sextuple. WeChat isn’t a standard content feed, and long-term user experience damage has real cost. Marginal growth has to come from better ROI, closed-loop commerce, and search monetization—not converting Moments into ad walls.

Social networks and digital content

Social networks and digital content, including music, long-form video, live streaming, online literature, memberships, virtual items, and some platform service fees comprise the third big piece. It is Tencent’s slowest-growing segment, but it is important not to miss. It powers content, user time, IP, and paid-user behavior for the broader ecosystem.

Tencent Music, China Literature, Tencent Video, and Video Accounts live streaming feel very, very imperfect viewed individually. Within Tencent’s WeChat ecosystem, however, they support advertising and games with content and traffic. On my rough estimates, I can see this entire segment generating after-tax profit of about RMB 32 billion. Apply an 11-13x multiple and we get roughly RMB 350-420 billion, or HKD44-53/share.

Admittedly, I would not put a high multiple here. Long video costs money to make, live streaming regulation is sensitive, online reading grows slowly. That said, it shouldn’t be ignored either. Music subscriptions, membership models, and IP pipelines support other parts of Tencent.

Fintech: the transaction layer

Last layer we have is fintech. Comprised of WeChat Pay/merchant services, wealth management, credit, and Video Accounts commerce-related technical service fees. Tencent fintech is the opposite of advertising in that it’s much less elastic and likely shouldn’t command a high multiple due to regulation-constrained payment take rates and financial-services expansion. It is, however, extremely sticky and built into the WeChat experience on a daily basis.

On my rough estimates, fintech likely generates about RMB 42 billion in after-tax profit. Use a 10-12x multiple and we get roughly RMB 420-500 billion, or HKD53-63/share.

Profit is just part of the value here. Look at Tencent as layers, where advertising, Mini Programs, Mini Shops, private-domain traffic, and payments all eventually reach into this layer. Fintech closes the loop on Tencent’s traffic monetization, moving it beyond “watch ads” into “complete transaction”.

Cloud and enterprise services

The last piece here is cloud and enterprise services. This shouldn’t be our main valuation anchor at present. Tencent Cloud has stopped “chasing scale” and is pivoting to improve margins and service quality, disclosure on cloud profit remains shallow, and Tencent’s AI infrastructure spending could weigh on near-term FCFF.

The easy way to value this segment is to use a rough revenue multiple. Cloud and enterprise-services revenue should be around RMB 100 billion, so using 2-3x revenue gets around RMB 200-300 billion, or HKD25-38/share.

Use this as an option, not core anchor. Enterprise WeChat, Tencent Meeting, databases, cloud services, and artificial intelligence tools all have favorable long-term strategic moats. Tencent’s core valuation today does not need to be dependent on them.

Investments, net cash, and AI

Sixth and finally, we have investments and net cash. Tencent’s investments probably should not get added back at 100%. Listed assets are volatile, while unlisted assets should get a liquidity discount. Fairly disciplined estimates would value listed investments at 75% of carrying value and unlisted investments at 50% of carrying value. All up, that gives us roughly RMB 590 billion, or about HKD74 per share.

You can add back net cash of ~RMB 147 billion at full value, worth about HKD18/share. The investment portfolio and net cash add up to roughly HKD92/share. They’re not Tencent’s growth story, but they’re part of Tencent’s valuation story.

One final thing not to overstate is new AI products. I would not give Yuanbao, Hunyuan, WorkBuddy, or other standalone AI products a lot of value just yet. If AI has meaningfully improved ad targeting, that should already be reflected in advertising profit and the applied advertising multiple. If AI has meaningfully lowered game-production costs, that should already be reflected in gaming margins. If Tencent plans to sell AI to enterprise customers, that should already be reflected in cloud and enterprise-services revenue. Giving AI a big separate valuation would be double counting.

Tencent’s most practically valuable AI products may not even be at the launch-event stage right now. Instead, they may already be inside Tencent’s advertising systems, content-production tools, and enterprise-services platforms.

SOTP and DCF cross-check

To summarize: Tencent is not one story. It is several assets. Games are worth roughly HKD190-225/share. Advertising is worth roughly HKD138-157/share. Social networks and digital content are worth roughly HKD44-53/share. Fintech is worth roughly HKD53-63/share. Cloud and enterprise services are worth roughly HKD25-38/share. The investment portfolio is worth about HKD74/share. Net cash is worth about HKD18/share.

If you add all of those pieces up, you get a full SOTP range of roughly HKD540-630/share, with a midpoint of HKD585.

This compares broadly in line with a DCF. Starting with owner free cash flow, FY2025 actual free cash flow was approximately RMB 183 billion. Normalizing to a base of ~RMB 210 billion once games, advertising, deferred revenue and capex cyclicality are considered seems reasonable. Growing that FCF over the next decade at gradually slowing rates (high single digits to mid-low single digits) with 3% terminal growth and a 10% discount rate gets us to approximate core operating value of roughly RMB 3.7 trillion. Including the discounted investment portfolio and net cash adjusts the per share anchor to approximately HKD555.

In short, both the SOTP and DCF roughly point to the same fair-value neighborhood. Tencent’s fair value is not defined by whether Tencent has AI.

Tencent’s fair-value midpoint is defined by its game cash flow, WeChat ad quality, fintech base, and investment portfolio.

Risks and conclusion

The risks here are also clear. First, you cannot start the DCF too high. AI infrastructure buildout and chip-related spending will likely increase Tencent’s capex and depress its near-term free cash flow. Second, do not ignore stock-based compensation. SBC is a cost to long-term shareholders even if it is not an immediate cash expense. Third, advertising growth should come from quality, not just clicks. If Tencent’s advertising growth comes primarily from packing more ads into each screen, rather than improving ROI and closed-loop efficiency, Tencent’s advertising multiple should be lower. Fourth, the China discount is real. Chinese companies trade at a discount to US names for good reasons. Consumption cycles matter more in China. Regulation matters more in China. Game approvals, payment take rates, ad budgets, and market risk appetite all influence how high investors are willing to bid.

As a result, my conclusion is that 0700.HK’s fair value is roughly HKD550-600/share, with a full SOTP range of HKD540-630. Tencent is not going to be a “multi-bagger” story for investors. However, it also does not feel like a pure defensive, utility-like stock. Tencent feels like a cash-flow machine that may still be undermonetized in certain areas.

For many investors, the easy mistake with Tencent is not whether Tencent has AI. The easy mistake is under-appreciating how high-quality WeChat’s monetization really is. Low ad load in Video Accounts and Moments is not the conclusion – that’s just the clue. The ultimate conclusion is that Tencent continues to own a high-quality advertising and transactions closed-loop asset, even if it is not fully valued as a standalone business today.

You do not need to buy into a grand AI thesis to own Tencent. Investing in Tencent mainly requires you to answer four questions: Can games continue to generate cash at this level? Can ads get more valuable without hurting the WeChat experience? Can fintech continue capturing transactions? And do Tencent’s investments and net cash provide some downside cushion?

If those four answers are yes, Tencent’s value comes not from the headline story. It comes from the fact that you can take Tencent apart, slice by slice, and every major business still has value.

Disclaimer: This article is for informational and research purposes only. It is not investment advice. It does not constitute a recommendation to buy or sell any security or an offer to transact in securities. All valuation estimates, assumptions, price targets/ranges, and segment-level calculations are rough estimates. They’re based on public information, personal assumptions, and could be wrong, incomplete, or outdated. I’m not a licensed investment adviser. Please do your own diligence and make your own decisions. Investing involves risks, including loss of principal. Security prices may fall as well as rise.

More specifically, BellRing Brands is incredibly dependent on Premier Protein ready-to-drink shakes. Think of the product most people know: Costco’s 11oz bottled shake sold by the case at Costco, Sam’s Club, Walmart, and Amazon. 30g of protein, low sugar, low calories, ready to drink.

This isn’t hardcore gym powder. It is positioned much closer to a daily nutrition tool. Think of it as a breakfast replacement, weight loss protein supplement, muscle-loss hedge for GLP-1 users, or quick meal alternative at the office.

That convenient positioning is also why BRBR is compelling. It trades directly on top of a genuine consumer trend. US consumers are increasingly focusing on their protein intake. GLP-1 drugs have amplified the trend telling them they may be eating less food, but they still need sufficient protein. Premier Protein has clear positioning, broad shelf penetration, strong repeat purchase behavior, and a history of high growth.

The market isn’t just asking if that protein trend can continue growing from here. The market is asking a much meaner question:

Can Premier Protein protect any semblance of its historical margin structure?

It’s Not Coca-Cola. It’s a Nutrition Spec Sheet.

Premier Protein’s core value prop is quite simple: 30 grams of protein, low sugar, low calories, at a relatively cheap price.

That is both its advantage and its vulnerability.

Coca-Cola doesn’t just sell soda. It also sells taste memory, identity, ritual, and supply/distribution network control. If Coke were $0.10 more expensive than private label at the supermarket, most consumers still would not switch. Premier Protein is not Coke.

Premier Protein’s value prop is simple “how much protein, how many calories, how much sugar, and how much does it cost?” The purchase decision is very functional.

When your go-to-buy specs become a spec sheet, private label loves what they see.

Costco’s Kirkland brand, Sam’s Club’s Member’s Mark, BJ’s Wellsley Farms, and other retailer owned brands are attacking directly on price by taking a similar protein count, calorie count, sugar count, and similar packaging/form-factor, then cutting prices on their store brands.

Premier does not need to be wiped out by private label for the shareholders to lose money. It just needs to be marginally taxed by private label.

That margin tax does not need to come from one dramatic private label shelf event. It happens slowly through deeper promotions, worse price/mix, higher shelf costs, and ultimately, a lower and weaker steady-state margin.

Asset-Light Is the Other Side of the Coin

BRBR is an asset-light company. It does not own much manufacturing capacity. Outsourced production through third party co-packers fuel most of its growth. BellRing owns the brand, owns the formulation, has relationships in the channels, spends on advertising, and determines promotion strategy. Production is contracted to third parties.

When times are good, this looks like a phenomenal business. Little capital intensity, high cash returns, and growth accelerates through the funnel quite well.

When times are bad, however, you see the other side of asset-light.

BRBR does not have its own direct-store-delivery trucks and drivers like Coca-Cola, Pepsi, or Monster. BRBR ships product into retailer distribution centers. After that, shelf placement, replenishment cycles, promotional timing, and even consumer level sales data lives predominantly in the retailer’s hands.

BRBR simply does not have eyes and hands on the shelf.

This wouldn’t be so bad if BRBR’s customer base was hyper diversified. However, Walmart/Sam’s Club, Costco, and Amazon are massive revenue drivers. While these are customers just like any other, they are also capable of becoming competitors.

Once Costco stocks a Kirkland branded protein shake next to Premier Protein, BRBR is no longer competing against a normal competitor. BRBR is going head-to-head with the landlord.

The Title Says It All: Demand Didn’t Die. Unit Economics Got Worse.

BRBR was a high-velocity consumer stock. Revenue grew in FY2025 and Premier Protein is still near the top of the category in terms of units. But coming into FY2026, the growth story has become muddied in investors’ minds. They’re beginning to see a margin-collapse story instead.

Volume has not died. However, the quality of revenue is getting washed out.

Premier ready-to-drink shakes are volume growing. More of that volume is sold on promotion versus clean price. Volume is being offset by negative price/ mix. This implies consumers are training themselves to wait on promotions, and retailers are extracting more promotion from the brand.

Costs are also becoming more aggressive. Dairy protein, whey, freight, tariffs, and inventory write-downs have all pressured gross margin.

The old BRBR was rewarded by the market because it believed in the story of a high-quality asset light growth curve with EBITDA margins near 20%.

The question now is whether FY2026 is a temporary trough or a new normal.

That is the valuation question.

Fairlife, Kirkland, and Nurri Loading Pressure From Three Sides

This pressure is especially impactful from a consumer perspective.

Occupying the premium spot on shelves is Fairlife. Owned by Coca-Cola, its milk base is ultra-filtered. The product actually tastes more like chocolate milk. In casual consumer conversations and online reviews, Fairlife has better taste equity. Users are consistently willing to pay up for the premium.

Occupying the value spot on shelves are Kirkland and the myriad of other private-label options. They do not need to win a taste test with Fairlife. They just need to be “good enough” and priced far cheaper. Given that it is a functional consumer product, that may be enough for retailers and consumers.

To the side are Nurri, Oikos, Muscle Milk, Quest, Atkins, Ensure, Boost, and dozens of other occasion-based competitors. The protein beverage category will continue to grow, but category growth does not inherently lead to monopoly economics. More growth just means more entrants, more shelf negotiations, and more promotions.

So investors should not worry about whether demand is dying for BRBR. I do not think demand is going away.

The issue is where the value goes as the category continues to grow. Does the brand owner capture it? Do retailers? The co-packer? The dairy protein supplier upstream?

Equity Looks Like a Call Option Behind Debt

Risk is further compounded by BRBR’s capital structure.

BRBR is not a net cash consumer staples company. It has $1.2 billion of debt plus legal reserves that sit above common equity. Common shareholders are behind those creditors and claims on the company. EV needs to first pay off creditors and other liabilities before equity holders see a dollar.

If Premier Protein’s margins recover, there is tremendous upside to equity. However, if margins are reset lower on a permanent basis, equity can decline very quickly.

The business could go from “great” to “good.” But with financial leverage in the capital structure, shareholders can experience outcomes that go from “multi-bagger” to “total loss.”

That is why I do not think investors should look at BRBR through a single-point DCF. The valuation is not linear. It is about probability and payoff.

How I Would Frame the Scenarios

I don’t believe BRBR should be viewed through the lens of one precise target price. I prefer to break it out into discrete scenarios.

Scenario 1: Near-Zero

The probability isn’t necessarily high, but we have to start with how a collapse could play out. If promotions are ever made permanent, margins keep compressing, cash flow continues to deteriorate, refinancing pressures mount, and litigation creates additional headwinds, there is a scenario where common equity could be wiped out and replaced with option value. In this extreme outcome, BRBR might trade at around $0–2, with an estimated median of $1.

Scenario 2: Structural Bear

The company limps along, Premier still sells product, but the Kirkland tax remains, and input costs stay elevated. In this world, EBITDA remains depressed and cash conversion is permanently weakened. If that happens, the stock may be worth around $4–6, with a center somewhere around $5.

Scenario 3: Partial Reset

While still severe, Premier’s problems don’t fully become permanent, but neither do past margins fully return. Advertising dollars, promotion expenses, and pressure from private label permanently take a few points off steady-state profitability. Margin expansion still occurs, but from a lower base than in the past. I view this as my most likely outcome. In this scenario the stock may be worth around $15–19, with a center somewhere around $17.

Scenario 4: Full Recovery

FY2026 suffers as an anomaly caused by temporary factors that converge at once: cost pressures, inventory issues, heavy promotion spending, distribution channel transition, etc. Dairy protein costs come down, Kirkland doesn’t gain brand equity and manage to replace Premier as a habitual purchase, and Fairlife’s higher price points give Premier room to rebound. Business returns to historical mid-cycle profitability. Shares may be worth $22–24 in this scenario, with a center somewhere around $23.

Scenario 5: Bull Case / Strategic Transaction

Premier not only recovers. It gets re-rated by a strategic purchaser with better direct-store-delivery muscle and relationships, or management successfully unlocks new channels like convenience, single-serve, chilled immediate consumption, or broader beverage distribution. Shares could trade $28–45 in this scenario, with a center around $34.

I’m willing to give these scenarios the following rough probability framework: 7% chance near-zero; 23% chance of structural bear; 40% chance partial reset; 20% chance full recovery; and 10% chance bull case/acquisition. Expected value under that framework comes out to roughly $16 per share. Against a reference price in the $13.44 neighborhood from the other piece of material, the odds look favorable to me, but not by a huge margin of safety.

Why I Would Not Assign a High Takeout Probability

BRBR does have M&A optionality. Protein ready-to-drink is a big category and Premier has real equity built up over the years in terms of brand, actual share, and shelf-space stake. For a buyer like KDP or Pepsi that already has direct-store-delivery relationships with key grocery retailers, Premier’s inability to control inventory effectively is actually one of their strengths.

The catch with takeouts though is that they aren’t quite as simple as “great asset, must have buyer.”

The buyer typically wants to see evidence that the business has stabilized before they are willing to pay an acquisition premium on top of a normal multiple. The seller typically doesn’t want to sell the business at the bottom of a major guidance collapse. Today we find ourselves in the awkward position where management wants valuation discussions to begin with mid-cycle profit levels while the buyer refuses to look past trough profits. When two sides can’t agree where to begin valuation discussions based on divergent price anchors, M&A deals don’t happen.

The buyer universe isn’t perfect either. Coca-Cola already owns Fairlife. PepsiCo has its own issues stabilizing margins in its sports nutrition business and has broader portfolio priorities to consider. KDP is working through a major coffee transaction and corporate separation at the same time. Private equity would need to underwrite the existing debt burden atop uncertain steady-state margins.

I view M&A as real upside optionality for BRBR, but should be treated as more of a low-frequency high-impact event than part of the base case.

Final Conclusion

BRBR is not a boring “cheap consumer leader” story. The fundamental payoff is going to be more structurally complex than that.

The core category is still attractive. But control over the supply/demand curve is being taken away from Premier and given to retailers, private label, co-packers, and dairy protein producers upstream.

The long case is not simply “protein shakes will grow.” Instead it’s a more narrow bet that FY2026 profit margins do not become the permanent new normal, and that Premier can continue to maintain acceptable unit economics despite pressure from Fairlife and private label.

The short case is not “consumers will stop drinking Premier”. Rather, it’s that consumers increasingly make their purchase decision like they would a spec sheet, retailers treat Premier like any other replaceable shelf item, and permanent margin compression ensues on the brand rent that used to be taken for granted.

BRBR strikes me as having positive expected value today, but not nearly high enough certainty as a compounder. The risk/reward feels better suited for a small position bet in your portfolio that you explicitly recognize has left-tail risk. It’s better viewed as an odds-based investment than a core consumer staples holding. The real margin of safety comes from being humble enough to recognize that even if the brand survives and thrives with consumers, shareholders might not see all the profit they once did.

Disclaimer: This article is being written for my own personal research and investment-framework purposes only. It is not intended to be investment advice, securities recommendation, or an offer to buy or sell any security. All valuation ranges, probabilities, and scenarios discussed represent my own subjective judgments and may have errors or omissions. Investing always involves risks. Readers should verify company filings, financial data, and market prices for themselves, and make their own investment decisions based on their own risk tolerances and objectives.

Two months ago I wrote this bear on BHR.

In that article, I argued Braemar was an oddity. Unlike most hotel REITs, it was not stock you held directly in the operating company. Instead you held a stub equity written on top of several luxury hotels.

Good assets. Bad structure.

Perched at the top were trophy assets like the Ritz- Carlton Reserve, Four Seasons, Park Hyatt and other luxury resorts. Wedged in the middle were layers of mortgage debt, preferred stock, transaction costs, and Ashford’s $480 million termination fee. Sprawled helplessly at the bottom was the common equity.

So the real issue was never “Are these hotels valuable?”

Instead, the question became “After the hotels are sold to private buyers, how much of that money actually gets distributed to common shareholders?”

That was my thesis in May. Good assets do not necessarily lead to a good stock. Between management and the shareholders is the capital stack, the contract stack, and an outsized management team with incentives completely divorced from shareholders.

Bennett’s tiny direct ownership of BHR common stock. Ashford-related parties were entitled to receive $480 million if BHR sold the hotels. Those two numbers alone illuminated a lot about the structure working against common shareholders.

Which is why my conclusion was “Wait.”

Yes BHR had cheap assets. But it was not a straightforward cheap asset story. This was equity reincarnated as a residual claim option. You could not assume the most bullish NAV and claim common shareholders would eventually receive that amount. Their stake was the final slice of a very long waterfall.

I still believe that framework is sound.

But the BHR ticker today is not the same security it was two months ago.

It’s not because the hotel portfolio suddenly improved. The hotels were great from day one.

The change involves who controls the company.

Old BHR was a sale waterfall obstructed by a massive termination fee.

New BHR looks like a governance play. A company that paid a hefty ransom but might actually survive free of the poison pill.

That is a very different security.

Before, the termination fee acted as a black hole parked in front of common shareholders. Before any sale proceeds could go to Berkshire Partners or Hillwood, before they could even hope to buy back stock or restart dividends, the first question was simple: “How much do we need to pay Ashford to let them leave?”

Now the $480 million fee still needs to be paid. But after it is paid, the external advisory agreement terminates. Bennett and the prior board members step aside. And suddenly BHR transforms from a something different into something else: a small-cap luxury hotel REIT with no obvious controlling shareholder, very few remaining assets, and a market capitalization of just $150 million or so.

That shift is the thesis.

The bullish case has flipped sides

The value argument for BHR is no longer “Look at these hotels!”

That story is too shallow. I covered it at length in May.

Instead let’s ask a different question: private-market buyers have already validated these assets. Is there a realistic scenario where the remaining “governance discount” can be resolved?

Park Hyatt Beaver Creek sold for $176 million. Sarasota, Hotel Yountville and Bardessono just sold for $437.5 million. Compared to where I thought the old model would price back in May, these are not firesale prices. They came in closer to the bullish end of my range.

That matters. A lot.

Suddenly we can cross off one side of an old binary: the value of BHR’s asset base is not purely theoretical. Real buyers are emerging who will pay low cap rates for these scarce luxury hotel assets. In other words, part of the bull case has been validated.

The private-market bid for trophy hotels is real.

The problem is private-market purchases do not hand free money to common shareholders.

All of those proceeds need to repay mortgage debt, extinguish mortgages, cover transaction costs, and flow down to the Ashford termination fee. Yes common shareholders see implicit asset value being unlocked. They do not however see that cash landing in their bank accounts.

It is why I am not writing a clean liquidation argument for BHR today.

I am also not writing about a normal REIT.

I am writing about a transition story.

For the next year or two, Braemar will operate like a de facto partial liquidation. Selling hotels, paying down debt, paying Ashford, and internalizing management.

Assuming no mistakes are made, investors should be left with a leaner, meaner REIT holding somewhere between six and eight luxury hotels.

How that equity gets valued in the future depends on one key question:

Will this new board want to return capital to shareholders?

Continuing operations can mean two very different things

Which is why the word “continuing” in continuing operations can actually have two totally opposite meanings.

Want BHR to return capital? Continuing operations does not mean standing pat. After buying back stock, cleaning up the capital structure, and lifting the poison pill, the new board could sell non-core hotels, initiate a common stock repurchase well below NAV, buy back preferred at discount, restart dividends, or even sell the whole company. In that scenario the market could begin pricing BHR stock closer to NAV. If you solve the governance structure there is now a credible path to distribute asset value to shareholders.

But what if you do nothing? What if continuing operations just means… well continuing operations?

Hotels continue to operate. These assets remain hard to replace. But common shareholders continue to own a tiny sliver of cash flow left over after debt interest, preferred dividends, corporate G&A, and “renovation reserves.”

That is not a trophy asset REIT. That is a low-multiple, no-dividend, governance impaired orphan REIT.

Same hotels. Different board. Completely different security.

The valuation framework

That’s the model I’m now working from for BHR:

Expected value per share ≈ (1 − q) × [ p × R + (1 − p) × F ] + L

Don’t overthink it.

p = probability of governance repair. Plain English translation: probability that a competent board emerges…or at least shareholder-friendly capital allocation. I would plug in something like 55%. That doesn’t mean Al Shams has a 55% chance of prevailing and winning everything. It’s a blend of possible outcomes: Al Shams wins, Al Shams settles for meaningful board seats, or the company’s own newly elected board is coerced into behaving-shareholder friendly by continued shareholder pressure.

R = value if door opens. I would plug in $4.0 to $4.5 per share. This is not assuming a door opens and BAM full liquidation happens today. It’s assuming the door opens and some process over time begins to unlock value: asset sales, buybacks, dividends, possible corporate sale, etc. Completed asset sales already signed and closed support this range.

F = value if door does not open. I would plug in $1.0 to $1.5 per share. Company continues to operate, but the cash never makes it to common shareholders. In that scenario, the common stock gets priced on thin distributable cash flow and a hefty governance discount.

q = deep, deep tail risk. I would plug in about 10%. Stuff like deal failure, hurricanes, refinancing stress, cash-bridge execution issues, etc. Some of that tail risk is less than it was in May (convertible notes gone, some debt extended, credible buyer quality on asset sales). But physical risk in the Caribbean and execution risk around the transition still loom large.

L = value of litigation option. I only give this $0.1 to $0.25 per share. Literally litigating for the $480 million termination fee gets you a headline number of greater than $6.50 per share. But legal odds are not great, and Maryland is not a favorable legal jurisdiction for this type of litigation. Litigation is better thought of as a proxy-fighting chip than as central to valuation.

Given those inputs, neutral expected value is around $2.7 to $2.8 per share.

With the stock trading around the low $2s, that’s definitely a positive expected value. Not “close your eyes, double your money” type of margin of safety, though.

And that is the important distinction.

Why NAV alone is not the answer

If you think about BHR as “static NAV is twice the stock price” you’re far too comfortable with your position. This is not a Graham-style net-net. Assets are big, but debt/preferred in front of common is also big. Common shareholders own the very rear of the capital structure. Percent changes in asset value get leveraged up and down by the capital structure.

The bullish case is not: “the assets back up and equal twice what we’re paying for the stock.”

The bullish case is: while the market is still pricing BHR stock as if Bennett-era governance/strategy was permanent, that structure is slowly being dismantled.

In the old thesis, the problem was $480 million termination fee coupled with Bennett/Ashford economics were completely misaligned with common shareholders.

In the new thesis, the problem is different: shareholders paid a very expensive ransom but the money-making machine that bleeds value away from common may finally be dismembered. Does the board that remains after the ransom is paid belong to shareholders?

Al Shams and the governance catalyst

That is where Al Shams comes in.

Al Shams doesn’t have to be perfect. They don’t even have to win every proposal outright. They just have to exist.

Without Al Shams, Company Narratives new “we have fixed the governance problem” story would be able to run unimpeded: “We have internalized management. We have refreshed the board. We have fixed the governance problem. Please give us time.”

With Al Shams, that statement has to survive a shareholder vote.

Fear of Al Shams also impacts how we think about the company selected new independent directors. I don’t believe they are all Bennett puppets. A better way to think about the company selected new independent directors is that they are reputation-maximizers. Compared to the old board they don’t have the same historical baggage. They don’t have the same Ashford fee stream. But they were selected through a process controlled by the old board and therefore face immediate legitimacy issues.

The quickest way for the new independent directors to solve that legitimacy problem is to prove to shareholders that Bennett’s replacement doesn’t just write lengthy public letters.

The best way to do that is through capital allocation.

If the first thing they do is buybacks, dividends, discounted preferred repurchases, truly review Ashford fees, or continue to sell non-core assets the market will start to believe there is a crack in the door.

If the first thing they do is build a new headquarters, set long term management incentives, or give speeches about creating a long term standalone platform BHR will trade back to orphan-REIT levels.

What BHR really is right now

So if you think about all of the above, BHR is not a hotel stock.

It is an event driven position on control, capital allocation, and time.

The May article covered the disease. Great assets wrapped in a bad stock.

This article is about how the disease may be progressing. This expensive external management buyout may have finally created a path for common shareholders to regain some value.

My takeaway:

BHR isn’t the “mathematically not cheap enough” stub equity that I wrote about back in May. Asset sale validation, outside mgmt. replacement, board refresh, and Al Shams pressure have created a positive-expected-value governance play.

That said, it is not a defensive value stock.

If the door does not open, shares are worth a bit north of $1.

If the door opens, shares are worth over $4.

Buying at today’s price, you are paying for the probability that the door opens.

Put differently: the central bet in BHR right now is not whether Dorado Beach is worth $500 million or $600 million. The central bet is whether the market is pricing BHR like a permanently discounted trophy- hotel shell that will continue to trade like an orphan-REIT forever.

Or whether the company is actually turning into a no controlling shareholder where management and the board are successfully pressured by activists to release asset value to shareholders.

Disclaimer: This article is for personal research and informational purposes only. It is not investment advice, nor is it a recommendation to buy or sell securities, or financial, legal, or tax advice. The valuation ranges, probabilities, and scenario analysis above are inherently subjective and may change rapidly as company filings, asset dispositions, market prices, legal proceedings, and governance events unfold. I may hold, buy or sell securities mentioned in this article at any time. Please do your own diligence and make decisions based on your own risk tolerance.

That is why attempts to value Zijin by simply multiplying current earnings by some multiple is overly simplistic. Doing so conflates cycle, commodity type, project execution, and capital allocation into one number. The better debate is how much of those profits can be underwritten (true value), how much of that profit is just price exposure (not real value), and how much of those profits have not yet earned the right to be capitalized into core value (option value)?

Copper: Zijin’s Hardest Base Case To Underwrite

Of the big three commodities, copper is the easiest to ground to reality. Copper is easiest to underwrite because it has a true cost anchor.

While gold is mainly a stock asset that serves as a portfolio diversifier, copper is a flow commodity. The copper used each year globally must be mined. Inventories are visible and thin. And unlike gold, long-term copper prices need to stabilize around a level that can incentivize new supply.

…the level is not the historical average. It is actually the incentive price needed by marginal new supply.

New copper supply is getting harder to build. Grades are lower. Capital intensity is higher. Permitting timelines are longer. Projects are becoming more complex. That means the long-term “centerline” copper price is not flat. Rather, it is actually adjusted higher as the global mining cost curve climbs.

As great as Zijin’s cost advantage is, it is not just a loose “we have low costs” story.

Kamoa-Kakula and the Serbian assets are a geological advantage (grade, resource strength, etc) coupled with acquisitions made at a great point in the cycle. Julong is less of a resource-driven advantage and more of an execution story. It is a low-grade, high-altitude, difficult project where Zijin is trying to drive costs through capital intensity, infrastructure execution, and scale.

It means Julong is more than simply advantageous orebody acquisition. Zijin has shown the capability to find great resources, but it is also showing it can create advantages through engineering. If replicable, that’s a big deal.

Given Zijin’s copper position, copper should trade at a higher-than-normal cyclical multiple. It isn’t a normal cyclical business where five times mid-cycle owner earnings is a natural ceiling. This is closer to a low-cost, long-life, expandable resource rent-collection asset. On a very rough sum-of-the-parts basis, copper is likely the most valuable and most underwritable part of Zijin. I value the copper segment at roughly RMB 290 billion.

Gold: Neither A Cost Story, But A Monetary Warrant

Gold cannot be valued like copper.

Global mine supply is miniscule relative to the overall stock of gold above ground. This means gold’s price is not dictated by the cost to mine it. Gold is primarily valued based on how much of global wealth wants to own gold at any given time.

Gold is best thought of as a preference asset, monetary asset, and trust asset.

This is why using a ten-year historical gold price to value gold mines can be outright dangerous. Gold can drift meaningfully above or below production cost for decades. Gold tends to trend with money supply, real interest rates, central-bank reserve adoption and de adoption, and trust in the global fiat currency system.

So when it comes to Zijin Gold, the discussion shouldn’t be about whether Zijin’s gold mines are cheap. The debate is what long-term gold price do you believe in?

If you plug in a conservative historical gold price average, the value of Zijin’s gold enterprise collapses. If you plug in a higher long-term price target that’s closer to historical gold monetization ratios, Zijin gold is suddenly very valuable.

But let’s be honest, Zijin does not have a cost moat in gold like it does in copper. In fact, on a blended basis Zijin’s gold costs probably sit near the global gold mining cost curve average. That is great leverage to gold prices continuing to rise. But it does not provide much protection if gold collapses.

So while I ascribe meaningful value to Zijin’s gold assets, I treat them very differently than copper. Gold is not a cost-based rent collector for Zijin. It is better viewed as a leveraged warrant on the role gold continues to play in the global monetary system. Assuming a reasonable long-term gold price and production profile, I value Zijin’s gold business at roughly RMB 250 billion.

Lithium: Price Is Not the Biggest Issue — Production Delivery Is

Lithium may be one of the most controversial aspects of Zijin’s valuation. But on a per-share basis, lithium is materially less important than copper and gold.

Don’t value lithium like copper. Copper deals with ore depletion, capital intensity inflation, and an upward incentive-price curve. Lithium is younger, behaves more like chemicals, and is more supply-side responsive. Growth on the demand side will remain strong, but the supply response plus technology learning plus sodium- ion substitution plus recycling all create substantial downward pressure on the long-term price trendline.

That is why you shouldn’t apply copper-like multiples to lithium.

On the contrary, a long-term LCE price of RMB 100,000/ton seems fairly modest to me. However, what is less clear is whether Zijin can execute and deliver the planned production at attractive costs.

Zijin’s lithium portfolio is complex. Brine, hard rock, mica, African projects all carry different cost profiles and execution risks. While low-cost brine resources could be partly underwritten to some extent, Manono and Xiangyuan shouldn’t be valued under one simple low-cost assumption.

As such, I don’t view lithium as a mature cash-flow base. I view it as a risk-adjusted growth option. To keep it simple, I only assign RMB 45 billion to Zijin’s lithium business. It has value. But it hasn’t proven yet that it can operate as a long-term cash-flow engine like copper.

Other Assets: Keep Them Small

Zinc, lead, silver, and molybdenum all have value. But they don’t matter that much on a stand-alone basis. Especially when doing DCF-type valuation, silver and molybdenum often end up in the “other” bucket because they are frequently by-products of copper and gold mines. If you value them too aggressively as if they are standalone segments, you are going to double count those metals.

Smelting and trading deserve even less value.

Zijin derives a large percentage of its revenues from smelting, processing, and trading-related businesses. But the margins are thin. Working-capital needs are high. Cycle positioning is poor. Large revenue doesn’t translate to large value.

Smelting might even deserve some platform value considering the industry dynamics. Trading might deserve negative adjustments if it truly erodes capital at low returns.

After stripping away the noise, smaller metals, smelting, trading, and corporate/non-operating adjustments really don’t matter that much compared to copper and gold.

So What Is Zijin Worth?

My overly simplified framework looks something like this:

• Copper is worth about RMB 290 billion.

• Gold is worth about RMB 250 billion.

• Lithium is worth about RMB 45 billion.

• Smaller metals and smelting contribute to value.

• Trading, corporate overhead, rehab liabilities, non-operating items, and net debt subtract from equity value.

On that basis, total operating value comes to roughly RMB 610 billion. Subtract net debt, capitalized share-based compensation, and other equity bridge items to arrive at common equity value of approximately RMB 545 billion.

That comes out to about RMB 20/share, or roughly HK$22/share.

The above is not intended to be a precise target price. Consider it a cleaner estimate of mid-cycle value. The point is not the number, but what that number implies:

• Zijin is a high-quality resource company with a powerful copper machine and meaningful gold optionality

• If the market price trades meaningfully above mid-cycle value, investors are paying for two big narratives to play out: (1) gold’s monetary premium moving to a permanently higher plateau and (2) copper’s structural shortage persisting for longer

Both can prove correct. Neither outcome is free.

Conclusion

Zijin Mining’s most valuable asset is copper. I don’t say that because spot copper is high. Rather, it’s because Zijin’s copper portfolio has low cost, long life, and the engineering repeatability typical of top-quality copper producers.

The gold segment is valuable too, but it really functions more like a leveraged play on gold’s monetary narrative than another copper-style cost moat. Lithium obviously has option value, but it shouldn’t be capitalized as a mature stream of cash flow just yet.

Which brings me to my thesis on 02899.HK. Zijin is:

• An excellent resource company

• A compelling investment only if there is a sufficient margin of safety

If the share price falls enough to where I can credibly underwrite ownership based on mid-cycle cash flow, it becomes highly attractive. If you buy today, you’re not just buying a world-class asset. You’re buying a narrative.

Disclaimer: This article is strictly an objective discussion for your personal research/trade ideas and is not intended to be investment advice or solicitation. Please do your own diligence before taking any actions based on this information. Valuation estimates and assumptions are inherently uncertain and actual results may differ materially due to factors such as commodity prices, foreign currency exchange rates, project execution, changes in policies or laws, changes in financing conditions or other factors beyond our control. There are risks involved with investing.

It’s one of France’s hottest-ever June days since 1947. Germany’s household AC penetration JUST crossed 13% to 19%. UK homes with AC have doubled in three years.

While news feeds were full of Northern hemisphere humidity, one Chinese brand popped up again and again in German, French, and English forums. Weirdly, it wasn’t advertising. People were searching everywhere for it. And ***could not buy it. ***

Meet Midea’s latest air conditioner innovation, PortaSplit. You can’t drill holes to install it. No sweaty professional installers. The outdoor unit hangs quietly on your window bracket. It went to zero inventory across 1,178 tracked German retail channels. Secondhand prices hit double the retail tag. Fake websites impersonating Midea’s official store popped up. Google Trends showed German searches for “Midea Split” running at roughly six times last year’s peak.

Behind this sits a much bigger narrative about European AC penetration rates, Chinese manufacturing going global, and a potential rerating of a conglomerate’s valuation.

Europe’s “Installation Friction” Problem

Europe isn’t underserved because people enjoy sweating through summer. Under IEA’s definition, European households owning AC hover near 20%, versus the US, Japan, or China. It’s mostly friction: you can’t drill your apartment walls. Landlords don’t allow it. The homeowners association might let you but not where you want to place the outdoor unit. Then you find out all installers have a weeks-long wait. And F-gas regulations require certified technicians to handle refrigerant systems.

Traditional portable ACs are noisy, inefficient, and leak hot air back through their exhaust hoses.

PortaSplit cracks the package.

Mount the compressor outside. Keep the evaporator + fan assembly indoors. Run a flat 2.7cm refrigerant hose through the window. Close your window almost all the way. Enjoy 39dB(A) noise levels indoors. No certified tech required. Go drill-free. Landlord approval? It’s not the most “legally invisible” option — there’s still a small outdoor unit on the windowsill. But it may offer the best ratio of cooling performance to installation friction available to consumers today.

Air conditioner shopping is a pain point. Comment threads on r/MideaPortaSplit don’t discuss specs, they share life hacks. How do I keep my attic apartment cool? How can I protect my aging parents during summer spikes? Does it seal on sliding windows? The building manager demands removal. Is Slovenia my only hope to find stock left? ?

Got told by living roommates you couldn’t install it? Fabricate foam sealing boards to seal off window gaps. Cross the border to Slovenia JUST to hunt for leftovers. Pay €1000 for boxed unused resale.

This kind of spontaneous user ecosystem is harder evidence of product-market fit than any commissioned market study.

How much profit can ONE AIR CONDITIONER really drive?

It feels like this should move margins this quarter. Algebra says it can’t.

Revenue for Midea Group in 2025 was RMB 458.5 billion. Net profit attributable to shareholders was RMB 43.95 billion.

The Smart Home segment contributed about RMB 300 billion of that revenue alone, and accounts for a lion’s share of Group profit.

Even if PortaSplit sells several hundred thousand units across Europe, with Midea recognizing perhaps RMB 4,000–5,500 per unit, total revenue contribution lands somewhere between RMB 1–2 billion. For a group this size, that’s a highlight, not a transformation.

What matters isn’t unit volume this year (or next). It’s what PortaSplit proves.

If Germany (19%), France (25%), UK (14%) converge to something closer to Italy’s (56%) household ownership rate, that 8-country basket represents ~50-58 MILLION households needing air conditioning. 60-80 million units. Cumulative manufacturer-level revenue of RMB 2–5 trillion. Not a one-year story.

But it does change the question: Is Group AC “doing business overseas” cyclically-export driven, or do we start treating penetration-rate uplifts AS structural growth?

Smart Home: Not Cheap Appliance Stock. Not Yet Premium Brand.

Assessing Midea begins with Smart Home.

Smart Home represents about 70% of the groups aggregate operating asset value.

Last year’s segment profit was ~37.1 billion on gross margins of ~30%+. Overseas business represented ~50% of total revenue. Overseas OBM take RATE for Smart Home passed 45%.

OBM exceeding 45% of overseas Smart Home revenue is THE metric of the past five years. It’s what that reclassifies Midea from another white-goods contract manufacturer to a trusted brand consumers actually buy MIDEA branded appliances from. Sure, they stock Toshiba. Sure, they make compressors for fridge brands you’ve heard of. But Midea is catching up. Brand is being built. On their own channels. Serving their own after-sales users.

Revenue recognition on Air Conditioners is immaterial to asking how much of this business is structurally sticky.

Keeping that in mind, we still can’t just take RMB 37.1 billion and multiply by 15. Supportive industry policies massively skewed year-on-year growth.

Trade-in subsidies spanned 12 categories. “Top tier product purchases” (highest energy efficiency) earned consumers purchase price subsidies of up to 20%. Air conditioners qualified for up 3 purchases per household.

China finished the year with over 129 MILLION traded-in appliances.

Needless to say, 2025 demand was redistributed forward. Whichever brand benefited most from subsidy-driven uplift will see service fade quickly as high-efficiency penetration climbs toward saturation. Channel execution will only get tougher.

After adjusting for policy tailwinds, elevated margins, and cyclical factors, normalized owner earnings land around RMB 26.5–28.0 billion.

What is that worth?

Domestic China is a mature cash cow — high-end upgrades and channel efficiency might add one to two percentage points annually. Overseas OBM is the real engine: if the share climbs from 45% toward 55–60%, profit growth can outpace revenue growth. Europe and PortaSplit are optionality — the demand signal is validated, but the absolute base is still small. Blended together, owner earnings growth over the next five years is probably around 4–5%, which at a 10% discount rate and 2.5% terminal growth implies roughly a 15x owner earnings multiple.

My math comes out to an owner earnings multiple of roughly 15x. That puts Smart Home at just over RMB 400 billion, or approximately HK$460–470 billion.

Building Tech is the real second act

Split off Smart Home, what’s left?

Building Technology covers commercial HVAC, building energy management, heat pumps, chillers, data center cooling, and elevators. Revenue hit RMB 35.8 billion in 2025, up 25.7% year-on-year, BUT that includes consolidation of Arbonia Climate, a European HVAC platform acquisition worth roughly EUR 760 million in enterprise value. Stripping out M&A, organic growth was still high single digits to low double digits. Gross margin clocks in at 30.6%, which actually exceeds Smart Home’s. Aftermarket service revenue surpassed RMB 2 billion while doubling year-on-year.

Not the biggest business. But if management discourse around HVAC “full lifecycle ops and maintenance,” building energy management, as a SERVICE wins out over selling equipment, I want in. Sell equipment? I’ll give you a 12x enterprise multiple. Service install-hooks on the world’s buildings? That’s an operating infrastructure platform with incredible upsides.

Valuing at 20x after-tax op profit, something more appropriate for sticky software recurring revenue streams, gives Building Technology ~RMB 75 billion enterprise value.

Midea Industrial Technology

The GMCC/Welling compressor and motor platform, plus NEV thermal management components and robotics parts. It holds the global number-one share in residential AC compressors, AC motors, and washing machine motors.

Gross margins are only 17.5%, capital expenditure runs heavy, and growth requires continuous capacity investment. It’s a “hidden champion” manufacturer — solid quality, but not a high-ROIC compounding asset. Stick 12–13x on this and we get roughly RMB 53 billion.

KUKA/Robotics

KUKA brought in nearly RMB 40 billion in revenue last year. But EBIT margin was just 1.5%, with an after-tax loss.

China is the bright spot — shipments exceeded 32,000 units, market share reached 9.6%, and its share in heavy-payload robots above 300kg hit 47.4%. But European costs are high, systems integration projects create margin volatility, and automotive capex is cyclical.

It’s not a cash cow; it’s more like a “hard brand, soft margins” turnaround asset plus an AI/robotics strategic option.

Using a probability-weighted payoff approach — base industrial value around RMB 250–300 billion plus RMB 150–200 billion in option value for AI-driven robotics — the total comes to roughly RMB 45 billion.

What Is This Company Actually Worth?

Smart Home at roughly RMB 400 billion, Building Tech at RMB 75 billion, Industrial Tech at RMB 53 billion, KUKA at RMB 45 billion. The total is approximately RMB 580 billion, or about HK$670 billion, implying roughly HK$88 per share for the H-share listing 0300.HK.

Conclusion

The stock currently trades around HK$80. This means the market is pricing a “mature appliance leader plus normal non-core businesses” narrative, without yet paying much of a premium for the European AC S-curve, Building Tech as a genuine second pillar, or a KUKA turnaround.

If Smart Home were rerated from 15x to 18x — which requires visible improvement in overseas OBM profitability and proof that European channels and branding are sustainable — Smart Home alone would be worth RMB 480–500 billion, pushing per-share value from HK$88 past HK$100.

If you’re looking for a “no-brainer price” — roughly half of expected value, where you don’t need any thesis to play out and are protected purely by cash flow floor and margin of safety — that’s around HK$45–50. At HK$80, the stock isn’t expensive, but it’s far from “close your eyes and buy.” It’s priced for believers in continued overseas OBM delivery and Building Tech execution.

The real nonlinearity doesn’t come from selling a few extra tens of thousands of PortaSplits this year. It comes from three things happening simultaneously: European consumers start treating air conditioning as a household necessity, Midea captures a high share of first-time buyers through its own brand, and the market re-categorizes Smart Home from “mature Chinese white goods stock” to “global climate adaptation beneficiary.” If all three come together, what changes isn’t EPS — it’s the valuation multiple.

PortaSplit selling out is not an investment thesis by itself. But it is an exceptionally high-quality signal: given the right product, the right pain point, and the right timing, a Chinese manufacturer can command brand premium in developed markets. That’s the thing worth tracking over the long term.

Disclaimer: This article is a personal research and learning exercise only and does not constitute investment advice or a recommendation to buy or sell any security. All companies, stocks, and valuation analyses discussed are based on publicly available information and personal judgment, and may contain biases, omissions, or errors. Investing involves risk; past performance is not indicative of future results. The author may hold or may in the future buy or sell securities mentioned in this article. Readers should make independent judgments and bear full responsibility for their own investment decisions.

If the pipeline’s probability-weighted expected value does come through, which I estimate at roughly RMB 13 billion, fair value would be closer to HKD 16.3 per share. The important caveat is that the bottom of the range is also zero.

This article breaks down each segment of United Laboratories, looks at what the pipeline may really be worth, reviews management’s governance record, and explains why the stock went from HKD 15 back to HKD 8.7.

Company Structure: A Vertically Integrated Supply Chain

United Laboratories is not a typical pharmaceutical company. A better way to think about it is as a vertically integrated factory that turns corn into finished pills. The chain runs from corn to fermentation, penicillin industrial salt, enzymatic cleavage, 6-APA, chemical synthesis, amoxicillin API, formulation, and finally Amoxil capsules.

The company has three operating segments and one pipeline asset.

The upstream platform, made up of intermediates and APIs, has 6-APA capacity of 18,000 tonnes per year, or roughly 45% of global supply. The top three producers, United, Veyong, and Kelun-Biotech’s Chuanning, control 89% of the market. This is an oligopolistic commodity market. Prices are cyclical, but they have a cost floor: all three historical troughs have landed around RMB 135-145/kg.

Finished drugs include insulin analogues, anti-infective formulations, and animal health. Insulin analogues were a Category A winner in China’s national volume-based procurement program, or VBP, which is the government’s centralized drug purchasing system that pushes generic drug prices down through competitive bidding. That category had 2025 revenue up 57%. The anti-infective portfolio includes Amoxil, Tazocin generics, and Imipenem/Cilastatin, each with very different VBP outcomes. In animal health, Muyuan Foods accounts for 65.8% of segment revenue.

The pipeline is anchored by UBT251, a GLP-1/GIP/glucagon triple-receptor agonist licensed to Novo Nordisk for ex-Greater China rights in a deal valued at up to USD 2 billion.

Operating Asset Valuation: RMB 14.8 Billion = HKD 8.7/Share

Upstream Platform: RMB 5.5 Billion

The 6-APA pricing history shows a clean cycle: a 2016 trough at RMB 135/kg, a 2022 peak at RMB 370/kg, year-end 2025 at RMB 180/kg, and an early 2026 rebound to RMB 222/kg. A reasonable mid-cycle range is RMB 200-230/kg.

At mid-cycle pricing, combined upstream EBIT is about RMB 1.1 billion. I apply a 6x EV/EBIT multiple. That is above the 5x multiple I would use for a pure commodity business, because United has 45% market share, a low-cost position, 60% internal consumption, and regulatory barriers to entry. It is also below the 8x multiple I would reserve for a business with real pricing power. This business has no pricing power, 40% excess industry capacity, and very high operating leverage.

That operating leverage matters. When 6-APA prices fell from RMB 300 to RMB 180 in 2025, intermediate segment revenue declined 31.4%, but segment profit collapsed 79.4%. The amplification works in both directions.

Finished Drugs: RMB 6.5 Billion

Third-generation insulin analogues are worth around RMB 3.2 billion. Current revenue is around RMB 1.5 billion, normalized profit is roughly RMB 210 million, and a 14-16x multiple is fair. This is the only structurally growing business inside finished drugs. VBP Category A selection is driving volume-for-price substitution and taking share from multinationals. H1 2025 revenue grew 74.5% year over year. The catch is that the growth is volume-only because prices are locked by VBP, and Gan & Lee Pharmaceuticals and Tonghua Dongbao are direct competitors.

Amoxil and amoxicillin capsules are worth around RMB 450 million. United did not win the 2020 Batch 2 VBP tender and instead chose to sell through non-VBP channels, including retail pharmacies, private clinics, and self-pay markets. Revenue has held at roughly RMB 500 million per year, but it is declining at 5-6% annually, with H1 2025 down 6.3%. Amoxicillin has semi-OTC characteristics and naturally high retail channel exposure, so VBP hurt less than it would have for a pure hospital product. Still, long-term brand erosion is hard to reverse.

The Tazocin generic, piperacillin-tazobactam, is worth only around RMB 70 million. Revenue collapsed from roughly RMB 670 million to RMB 294 million, down 56.5%, after United won the Batch 8 VBP tender in 2023. Profit is now close to zero. United’s winning bid was RMB 27.65 per unit, while NCPC bid RMB 15.63. United is not the lowest-cost producer here, so the product is effectively negligible in valuation.

Imipenem/Cilastatin is worth about RMB 200 million. Current revenue is roughly RMB 270 million, and the product is expected to be included in the upcoming Batch 11 VBP. MSD currently dominates the market with a 64% share, while United has passed bioequivalence testing. If United can take share from MSD after VBP, the medium-term setup could be positive, similar to the insulin story.

Animal health is worth roughly RMB 1.4 billion. Mid-cycle revenue is around RMB 1.5 billion, EBIT is about RMB 180 million, and a 7-9x multiple is reasonable. Three new manufacturing bases, in Inner Mongolia, the Henan joint venture with Muyuan, and Zhuhai, are coming online in H2 2025. Muyuan owns 40% of the Henan JV, which reduces key customer concentration risk. The core weakness is still cyclicality.

The remaining products add approximately RMB 1.2 billion.

VBP + AMR: Two Structural Headwinds

VBP compresses prices. Antimicrobial resistance policy, or AMR policy, compresses volumes. Together they create an irreversible squeeze on United’s anti-infective business.

China’s inpatient antibiotic utilization rate fell from 59.4% in 2011 to 36% by 2019. VBP procurement quotas for antimicrobials are set 10-30% lower than for other drug categories. The renewal mechanism is also now institutionalized: Batches 1-8 have been consolidated into a unified renewal cycle ending in late 2028. Once prices come down, they do not go back up.

United’s anti-infective formulations can survive because of integrated cost advantages. They cannot thrive.

Equity Bridge: RMB 2.8 Billion

At year-end 2025, United had RMB 10.6 billion in cash plus RMB 630 million in pledged deposits, for total cash and pledged deposits of RMB 11.2 billion. Subtract bank borrowings of RMB 5.0 billion and supplier finance arrangements of RMB 2.2 billion, and you get the company’s self-reported “net bank balance” of RMB 4.0 billion. After further deducting lease liabilities of RMB 10 million, minority interests of RMB 80 million, proposed dividends of RMB 510 million, and roughly half of contracted but unpaid capex commitments at RMB 650 million, the adjusted bridge comes to about RMB 2.8 billion.

The RMB 2.2 billion supplier finance arrangement is easy to miss. Economically, United is using bank-intermediated bills to delay payments to suppliers. Management itself deducts the amount when calculating net cash.

The UBT251 Pipeline: Expected Value RMB 13 Billion, But the Range is Zero to RMB 32.3 Billion

Clinical Data

The China obesity Phase II study enrolled 205 patients over 24 weeks and showed maximum mean weight loss of -19.7% versus -2.0% for placebo. The China T2D Phase II study enrolled 211 patients over 24 weeks and showed maximum HbA1c reduction of -2.16% versus -1.77% for semaglutide 1mg, with weight loss of -9.8% versus -4.8% for semaglutide.

On glucose lowering, UBT251 at 6mg numerically outperformed Eli Lilly’s retatrutide at 12mg in Phase II, with -2.16% versus -2.02%. But milligram comparisons across different molecules are not meaningful. Molecular weight, receptor affinity, and pharmacokinetics all differ, so “6mg versus 12mg” is pharmacologically meaningless. The right comparison is clinical outcome at each molecule’s optimal dose.

On weight loss, retatrutide has already shown -28.7% in Phase III at 68 weeks. UBT251 only has 24-week data at -19.7%. Longer-duration data will have to come from Phase III.

The Novo Deal Structure

United retains Greater China, meaning mainland China, Hong Kong, Macau, and Taiwan. It is responsible for its own Phase III, manufacturing, and commercialization there. Novo Nordisk gets the rest of the world and is responsible for its own development and commercialization outside Greater China.

United receives three forms of economic return from Novo: a USD 180 million upfront payment already received, equal to RMB 1.44 billion and recognized in 2025 financials; future milestone payments of up to USD 1.8 billion, tied to development and commercial progress; and tiered royalties on ex-Greater China net sales. The royalty rates were not disclosed, but industry comparables suggest 6-9%.

The strategic context is clear. Novo’s own CagriSema, a semaglutide plus cagrilintide combination, failed to meet the primary non-inferiority endpoint against tirzepatide in Phase III. UBT251 is Novo’s answer to Lilly’s retatrutide.

Global Competitive Landscape

UBT251 is not competing only against retatrutide. Already approved therapies include semaglutide, with about -15% weight loss; tirzepatide, at -22.5%; and oral orforglipron, at -12.4%. Phase III competitors include retatrutide at -28.7%, CagriSema at -23%, and survodutide at -18.7%. At the Phase II stage alongside UBT251 are amycretin, Novo’s own GLP-1/amylin co-agonist; VK2735 from Viking Therapeutics, an oral dual agonist; and MariTide from Amgen, a monthly injection with about -20% weight loss.

The China market will be even more crowded. By the time UBT251 launches, likely around 2028-2029, semaglutide, tirzepatide, mazdutide, ecnoglutide, and multiple semaglutide biosimilars will already be on the market.

Scenario Valuation

Based on BIO industry statistics, the historical success rate from Phase II to approval for metabolic-class drugs is about 25%. I adjust UBT251’s probability upward to 40-50% because it has two positive Phase II readouts, retatrutide validates the mechanism, and Novo Nordisk is backing the program. I do not push the probability higher because long-term safety is still unknown, competition is intense, and Novo’s internal priorities could change.

The probability-weighted pipeline expected value is about RMB 13 billion. UBT251 accounts for roughly RMB 11.2 billion of that, made up of Greater China rights of around RMB 5-6 billion, ex-China milestones of around RMB 3 billion, and ex-China royalties of around RMB 3 billion. Other pipeline assets contribute approximately RMB 800 million.

The bottom of the range still matters. There is a 15-20% probability of a complete write-off. If Phase III fails or Novo abandons the project, the pipeline value goes to zero. Pipeline valuation is an option, not a certainty.

Management Governance: Valuable Business, But Minority Shareholder Protection Needs a Discount

United Laboratories is not a fraudulent shell company, but management’s behavior pattern is not especially friendly to minority shareholders. The evidence chain is not hard to follow.

First, the buyback signal did not match the placement reality. In April 2025, the company announced plans to repurchase up to HKD 200 million of shares for cancellation. No cancellation-type buybacks were executed during the year. In July 2025, United placed 156 million new shares at HKD 14.16, a 7.9% discount, to no fewer than six unnamed placees, raising net proceeds of HKD 2.17 billion. The signal was a HKD 200 million buyback. The action was HKD 2.2 billion of dilution. In June 2026, the company issued another buyback announcement with almost the same language.

Second, management chose a directed placement instead of a rights issue. The 156 million shares were sold to six people. Existing minority shareholders were diluted by 7.9% with no chance to participate on equal terms. Controlling shareholder Heren Far East was diluted from 45.91% to 42.28%, so this was not the controlling family directly enriching itself. Still, choosing a placement over a rights issue suggests management prioritized funding convenience over shareholder fairness.

Third, the company raised equity despite having ample cash. At the time of the placement, net cash stood at RMB 4 billion, and borrowing costs were minimal. A cash-rich management team voluntarily selling shares at a discount at HKD 14 implies it considered that price at least fair value. Compared with my pipeline-inclusive fair value of HKD 16.3, that suggests management’s internal pipeline valuation is materially lower than external analysts’ numbers.

Fourth, there is the Evergrande receivable. The annual report discloses litigation related to an investment cooperation with Chengdu Evergrande, with a final court ruling of approximately RMB 167 million that remains uncollected. The amount is small, but it shows management was willing to expose company assets to real-estate-linked counterparties outside the core pharmaceutical business.

The key question is not only whether UBT251 can succeed. It is whether the value from that success will stay in per-share equity, or be redistributed through placements, stock-based compensation, and other capital allocation decisions.

Stock Price Narrative: From HKD 2 to HKD 15 to HKD 8.7

In 2022-2023, the stock traded at HKD 2-3. That was not really about United’s fundamentals. 2023 net profit was about RMB 2.7 billion, implying a PE of only 1.5-2x. The Hong Kong market was in systemic collapse, hit by COVID lockdowns, China panic, and global rate hikes. Everything was priced at absurd levels. For United to trade there, two things had to happen at the same time: its own earnings cycle had to trough, and Hong Kong-wide valuations had to crash. That combination happens perhaps two or three times in twenty years.

From 2023 to 2025, the stock moved from HKD 2 to HKD 15. Hong Kong valuations normalized from extreme lows, with PE expanding from 1.5x to 6-8x. 6-APA entered a high-cycle phase, with prices rising from RMB 200 to RMB 300+. The March 2025 Novo deal added a powerful catalyst. Most of the rally was Hong Kong beta reversion, not United-specific alpha.

From 2025 to 2026, the stock fell from HKD 15 to HKD 8.7 because the narrative broke. The March 2026 profit warning showed that 2025 net profit of RMB 2.09 billion included RMB 1.44 billion of one-time Novo license fee income. Strip that out, and core operating profit was only RMB 700 million. Intermediate segment profit fell 79.4%, and API segment profit fell 53.4%. The market abruptly realized that United’s profit engine is 6-APA, a commodity chemical, not insulin and not innovative drugs. The innovation premium disappeared, and the stock repriced to operating asset fair value.

Total Valuation

The sum of the parts is straightforward: upstream plus intermediates at RMB 5.5 billion, finished drugs at RMB 6.5 billion, the equity bridge at RMB 2.8 billion, and the pipeline at RMB 13 billion. That gives a total of RMB 27.8 billion, or about HKD 16.3 per share.

The current share price of HKD 8.72 is basically operating asset fair value plus zero pipeline value.

If you believe the UBT251 pipeline is worth RMB 13 billion on a probability-weighted basis, the current price implies 87% upside. If the pipeline is ultimately worth zero, you are buying at operating asset fair value with limited downside: HKD 7-9 in normal conditions, HKD 7 in a mild downturn, and HKD 5-6 in an extreme single-event scenario.

The core bet is not on the operating assets. Those are already fairly priced. The bet is whether the 2027 Novo global Phase 1b/2a data and United’s China Phase III will deliver. Until then, a sustainable 3-4% dividend yield is a holding subsidy, not a reason to buy.

Disclaimer: This article does not constitute investment advice. The author may or may not hold positions in the securities mentioned. All valuations are based on public information and subjective judgment. Actual outcomes may differ materially from expectations.

The following attempts to prove or disprove that thesis.

The Three-Layered Structure of American Television

Before we dig into SSP, let’s define some frequently-conflated TV basics: ABC, NBC, CBS, FOX are not your local TV station.

There are three layers to the U.S. television industry. The first layer are the national networks: ABC, NBC, CBS, FOX. They supply prime-time programming, sports rights, and national news. But those networks don’t actually own the station that broadcasts their signal in most cities.

The second layer: companies like SSP, Nexstar, Gray, Sinclair. These are local TV station groups. Your “NBC 5” station is affiliated with NBC and owned by one of these station groups. Local stations hold FCC broadcast licenses, run local news operations, sell local advertising, and negotiate retransmission fees with downstream distributors.

Third are the MVPDs — Multichannel Video Programming Distributors. These companies aggregate channels into bundles and sell directly to customers: Comcast, DirecTV, YouTube TV, etc.

Money flows through the system like this: Monthly MVPD bill paid by customers → Monthly retrans fees paid by MVPD to local station → Affiliate fees (aka reverse compensation) paid by local station to ABC/NBC/CBS/FOX. SSP sits between Local Stations and MVPDs.

…but it’s not like a pure middleman business. Those local stations have scarce FCC licenses to actually USE broadcast spectrum in their market. They own local news infrastructure. And most importantly, only local stations can grant (or withhold) “retransmission consent” to MVPDs. Legally, the MVPD cannot rebroadcast a commercial TV station’s signal without explicit consent from that station.

SSP’s Two Operating Segments

Alright, back to SSP. SSP has two operating segments:

Local Media is its collection of local stations. ~95 full-power TV station licenses spread across ~60 markets, mostly affiliated with ABC, NBC, CBS, FOX, and others. Revenue streams are split between core/national advertising, political advertising, and retransmission fees.

Scripps Networks consists mostly of just ION. SSP acquired ION in 2021 for $2.65 billion, along with similar free ad-supported channels like Bounce, Grit, Laff, etc. ION is a national free TV network with coverage to ~96% of U.S. households, airing crime dramas, classic reruns, women’s sports, etc. ION is your lean-back, always-on TV. Targets cord-cutters and older/lower income viewers that still watch some TV, but in the background.

Valuation: How Much Are SSP’s Segments Worth?

Local Media has one tricky valuation issue: political advertising revenue. Political revenue spikes during presidential election years to over $340 million for SSP. In non-election years, it falls to around $20 million. Using peak year political advertising revenue alone would significantly overstate value. Using off-cycle-year political revenue would significantly understate it.

What’s needed is averaging across a four-year political cycle. Local Media segment profit was $386M, $287M, $513M, $194M from 2022 through 2025, working out to around $345 million annualized.

Multiples? Local Media is blatantly a declining asset. Core advertising revenue is shrinking year-over-year ($626M in 2022, down to $566M in 2025). While nominal retrans growth looks impressive, keep in mind pay-TV subscriberships are down ~5%/year. Rate increases are harder to come by these days too. I use 5x. That gets us to approximately $1.7 billion in gross value.

Scripps Networks’ profit has ranged from $190M to $237M annually for the last 3 years. Simple math to normalize to a rough midpoint gives us ~$220 million annual profit. This segment is a pure ad-supported broadcast asset, with none of the contractual bargaining power that local station groups have to extract retransmission fees from MVPDs. I don’t see any justification for a higher multiple here. I’ll keep it simple at 5x as well. That’s about $1.1 billion.

Almost done! Remember how I said summing the two segments’ profits doesn’t equal consolidated earnings? SSP has roughly $115–125 million per year in corporate overhead and Other segment losses that need to be allocated. Allocating those proportionally to each segment, Local Media’s after-corporate profit comes down to ~$271M, while Scripps Networks comes down to ~$176M. Apply my 5x multiples to each and we get:

Local Media: ~$1.36 billion Scripps Networks: ~$0.88 billion

Total operating enterprise value, pre-debt: ~$2.24 billion.

Capital Structure: What Sits Ahead of Common Equity

OK, now for the bad part.

SSP’s capital structure is genuinely toxic.

SSP had ~$2.6 billion in gross debt as of Q1 2026. They also have $84 million in cash. That’s ~$2.51 billion net debt. Plus there’s a Berkshire Hathaway preferred with a roughly $766 million redemption value. On top of that preferred, there’s $133 million in unpaid cumulative dividends — and it compounds annually at 9%.

Total senior claims ahead of common equity: ~$3.25–3.3 billion.

Operating enterprise value: $2.24 billion. Gross debt + preferred: $3.3 billion. Common equity residual? Negative one billion dollars.

Absent any spectrum monetization, SSP common equity shouldn’t trade for anything on a strictly operating basis.

So, What Is the Spectrum Actually Worth?

This right here is the entire bet behind SSP common stock.

Each full-power TV broadcast channel uses 6 MHz of radio-frequency bandwidth. If broadcast spectrum could be reallocated to mobile broadband use — 5G, for instance — its theoretical value would be enormous.

Back in 2017, the FCC conducted an incentive auction that repurposed 84 MHz of broadcast spectrum, generating $19.8 billion in forward auction revenue.

SSP holds one of the largest portfolios of broadcast spectrum in the country. Hence the narrative.

Except there are a lot of locks on that door.

Lock #1: Broadcasters don’t “own” spectrum. U.S. communications law spells it out clearly: broadcast spectrum is a public resource. The government grants licenses to TV stations to operate within these frequencies, it does not sell private property that they’re free to sell to T-Mobile.

Lock #2: Monetization requires FCC or Congressional action. Sure, the FCC ran the 2017 incentive auction. But Congress had to actually authorize the FCC to conduct it. The FCC’s auction authority lapsed and was only recently restored. And the short-term pipeline for spectrum auction revenue is primarily mid-band spectrum (1.3–10.5 GHz), not broadcast TV frequencies.

Lock #3: Monetization destroys operating value. If SSP gave up its spectrum licenses and shut down stations, annual Local Media and ION segment profit — and corresponding EBITDA supporting the ~$2.24 billion operating valuation — would go to zero. The “incremental” value of monetizing spectrum is not gross auction proceeds. It’s auction proceeds minus the operating business you’re giving up to monetize that spectrum.

Lock #4: Family control. SSP is majority controlled by the Scripps family through Common Voting Shares. Regular Class A shareholders have very little say. Sinclair once offered $7 per share and was rejected. The controlling family may not optimize for common equity IRR.

Lock #5: Time is working against common equity. Berkshire’s preferred dividends compound annually at 9%. Even if SSP were to monetize its spectrum in five to eight years, the value consumed by the preferred over that timeline is enormous.

Station-by-Station Verification: Just How Large Is SSP’s Spectrum Footprint?

I didn’t want to take someone else’s word for it. I cross-referenced SSP’s publicly disclosed list of stations from its 2025 10-K with each station’s entry in the FCC’s FY2026 Regulatory Fee Appendix, which tells you each full-power TV station’s total service area population as calculated by TVStudy using noise-limited contour analysis based on 2020 Census data. I also cross-referenced the FCC’s 2017 incentive auction winning-bid records to flag any stations that went “off-air” and now operate under channel-sharing agreements — they still have full-power licenses and service area populations, but their original independent 6 MHz RF channel was relinquished.

SSP holds ~95 full-power TV station licenses. Of those 95, 90 have independent 6 MHz RF channels. Their combined independent spectrum footprint comes to roughly 1.894 billion MHz-POP. If the pending INYO reacquisition of 23 ION stations closes, the independent footprint rises to ~2.224 billion MHz-POP.

How does that translate into dollars?

In the 2017 incentive auction, broadcasters received an average of ~$0.37/MHz-POP on the reverse auction side. Doing the math: 1.894B x $0.37 ≈ $700 million gross. After a 35% haircut for taxes, transaction costs, and liquidation friction, you’re looking at roughly $460 million net to the company.

Even at the more aggressive mobile spectrum secondary market reference of $0.67/MHz-POP: 1.894B x $0.67 ≈ $1.27 billion gross, or approximately $820 million net.

Add up all the buckets of capital, that gap between debt and common equity comes to approximately $1 billion. Even in this bull case, net monetizable value from spectrum helps bridge, but does not close, the hole in SSP’s capital structure. At more conservative transaction prices for broadcast spectrum, it’s nowhere close.

Retransmission Fees: How Long Can the Price-Up-Volume-Down Game Last?

SSP’s Local Media segment distribution revenue grew from $221 million in 2016 to $752 million in 2023. By raw dollar growth, fantastic. Dig behind the curtain and it’s much less impressive. Distribution growth can be attributed to four mutually-reinforcing tailwinds: a 2019 acquisition spree that increased portfolio size, one-time contract resets that brought legacy below-market contracts up to current-market levels, huge contract renewals with Comcast and Dish that caused massive step-function increases to distribution revenue, and normal year-over-year rate escalators built into contracts.

In 2023, SSP completed renewals across ~75% of subscriber households with an overall rate impact of +20%. That is not sustainable growth. That was a one-time contract-reset dividend. Rate resets on contracts renewed in 2024 are running at +8%. Contracts renewed in 2025 are running at just +3.6%. Not high enough to meaningfully offset mid-single-digit subscriber declines. SSP’s distribution revenue was down 2% year-over-year in 2025.

From first principles, the price ceiling is approaching. FCC data shows average retransmission fees paid per subscriber rose from ~$2/month in 2013 to ~$22/month in 2023 — for content that’s literally available free over-the-air with an antenna. That’s now 20% of the average cable TV bill.

It doesn’t even all stick, either. ABC/NBC/CBS/FOX levy their own extraction through affiliate fees and reverse compensation. Management has suggested affiliate fees may decline in 2026, allowing net distribution margins to expand. But that’s a margin expansion story, not something that suggests the underlying subscriber business is coming back.

Local TV stations do have one tool somewhat analogous to tobacco’s “volume down, price up” strategy: local licensing scarcity, limited market substitutes (local market oligopoly), political ad time scarcity, and contractual annual rate increases. It’s not as effective as tobacco, though. Viewers and advertisers can circumvent it. Upstream networks claim a share of the value. And the overall bundle being distributed is shrinking.

What SSP Common Stock Actually Is

At the end of the day, SSP common stock is not a conventionally cheap stock. SSP common stock is a deeply out-of-the-money option.

On an operating basis, the two segments (after corporate overhead allocation) are worth roughly $2.24 billion, against $3.3 billion of debt plus preferred. Common equity has a negative operating residual.

On a spectrum basis, yes, there is latent value. But the pathway to monetization is narrowly-defined: either the FCC or Congress has to initiate another spectrum reallocation process, or an industry buyer has to come along and pay SSP a standalone premium for spectrum coverage, or ATSC 3.0 datacasting begins to see commercial-scale contracts. The five-year probability-weighted outcome of these incremental spectrum scenarios is roughly $250–350 million — meaningful, but not enough to close the gap with any reliable degree of confidence.

The best way to think about SSP is not to watch the share price looking for a buy signal. Watch for catalysts. Watch for meaningful FCC easing of the national TV ownership cap or local ownership restrictions, broadcast spectrum auction legislation, signs of commercial ATSC 3.0 or EdgeBeam contracts, signals of Berkshire preferred restructuring or redemption, and whether 2027 off-cycle-year EBITDA can reach $400 million — which would prove the business has genuine deleveraging capacity. Until then, a falling stock price is just making an out-of-the-money option even more out-of-the-money.

Disclaimer: This article is a personal research record and opinion only. It does not constitute investment advice. The author may or may not hold positions in securities mentioned herein, and such positions may change at any time without notice. All data is sourced from SEC public filings, FCC public databases, and company public disclosures. The author makes no representation as to the completeness or accuracy of any data. Investing involves risk. Readers should conduct their own due diligence and bear full responsibility for their own investment decisions. Past performance is not indicative of future results.

There’s just one problem. If all you care about is “cheap,” you’re focusing on the wrong thing.

To understand why MED trades where it does, you have to look beyond “consumer products company.” You have to recognize Medifast for what it really is: a faltering MLM distribution network.

That distinction determines whether this is deep value or a value trap.

What is OPTAVIA, really?

OPTAVIA is Medifast’s flagship brand. They’re not your run-of-the-mill subscription meal replacement service. Their business model is powered by independent “coaches.”

Medifast coaches are independent marketers that sell meal replacements. The company acquires clients through coaches. Clients pay coaches for their time (to develop a customized weight loss plan, stay motivated, etc) and buy Fuelings meal replacement products. Coaches get commissions on their clients’ purchases. Easy enough so far.

But commissions are just the beginning. Medifast’s official Integrated Compensation Plan notes three tiers: Client Support, Coach Sponsoring, and Team Building / Leadership Development.

Put more plainly: You earn commissions by serving customers. You earn more commissions by recruiting new coaches down your “team.” And you earn bonuses by building a large downline team, recruiting teammates into management ranks (“Leadership Development”), and collecting a slice of their incentive payouts.

TLDR: Medifast is not “a food brand that happens to have coaches.” It’s a direct- selling company running an MLM sales organization.

TINA.org placed Medifast/Optavia on its MLM income-claims investigation list, and a 2026 BBB/DSSRC case flagged coaches’ social media posts promoting “financial freedom” and “six-figure income.” The company had the posts taken down after the fact — which suggests field compliance is reactive, not proactive.

This isn’t an outside label. OPTAVIA’s own Integrated Compensation Plan lays out the three-tier structure in black and white. The company’s 10-K defines itself as a direct-selling business.

Do coaches make money?

OPTAVIA publishes an official Income Disclosure Statement every year. In 2025, 23.28% of OPTAVIA’s independent coaches made $0.

Total.

A cumulative 82.21% earned less than $2,500 per year. 92.64% earned less than $10,000. Only 1.37% earned more than $50,000. Only 0.45% topped $100,000.

And these figures are gross earnings — before expenses, time costs, product consumption, and taxes.

Cross-checking with ARPAC (average revenue per active earning coach) from the financials confirms the picture. Q1 2026 ARPAC was roughly $5,432 per quarter, or about $1,811 per month in client purchases. At the compensation plan’s standard front-line commission rate of 10%-15%, an active coach earns roughly $181 to $272 per month. Even at the higher 20%-28% tier, that’s $362 to $507 per month.

That is not a living. It’s a side hustle.

First-person accounts from former coaches on Reddit line up with this: one said she made about $5,000 coaching over two years but spent close to $10,000 on product, so she didn’t break even. Another said client support was small money — the real leverage was in recruiting downlines, but that’s something most people can’t pull off.

Here’s the interesting part: this isn’t new. Go back to OPTAVIA’s peak in 2021, when there were nearly 60,000 active coaches. Even then, 88.14% earned less than $10,000 per year. The typical coach was never making a living from this.

The difference is that back then, the network was still expanding. Clients were easier to find, before/after weight-loss stories were more persuasive, and new coaches could see their uplines earning thousands or tens of thousands per month. The combination of “side hustle plus upside lottery ticket” still worked: most people earned little, but they stayed in because hope was real.

Now that hope has faded.

GLP-1 drugs medicalized weight loss. The first door in a consumer’s mind shifted from “find a coach to help me lose weight” to “see a doctor or go to Hims/WW/Noom to get on medication.” The identity premium of an OPTAVIA coach declined. New recruits who see active coaches drop from 60,000 to 14,000 and the share of high-earners fall from 4.89% to 2.90% will naturally ask: is this opportunity still worth my time?

This is the first principle of MLM valuation: it’s not about revenue, and it’s not about gross margin. It’s about whether the expected value for ordinary participants can still sustain network reproduction. If the average coach’s expected value turns negative, the recruitment engine dries up. A network that cannot replicate itself does not generate capitalizable perpetual cash flow — it generates a melting stock of revenue.

How does management frame the story?

They emphasize that revenue per active earning coach is improving. In Q1 2026, ARPAC rose 19.2% year-over-year. That sounds like unit economics recovery. But break it apart and a different picture emerges: each surviving coach’s revenue did go up, but each coach’s contribution profit after variable SG&A barely changed. ARPAC rose 19%, but gross margin fell from 72.8% to 68.1% over the same period. The revenue gain was eaten by margin compression.

The bigger issue is aggregate math. Each coach’s pre-fixed-cost contribution runs about $1,280 per quarter, but the company’s quarterly fixed and semi-fixed SG&A is roughly $22.5 million. At current contribution rates, MED needs approximately 17,000-18,000 active coaches to break even. Q1 2026 had 14,000.

ARPAC rising is not recovery. It’s survivorship bias. After low-producing coaches exit, the denominator shrinks and the average mechanically improves. But company-level per-coach economics are actually deteriorating, because fixed costs are being spread over fewer heads.

The 2026 proxy statement reveals that 60% of executive incentive weighting is tied to Coach Productivity. Management is measuring its own performance with a metric that can mechanically improve as the denominator shrinks. That’s not a good signal.

What about the new business?

MED’s new narrative: we’re no longer just selling diet food — we’re building the nutrition and behavioral support layer for the GLP-1 era. Products include OPTAVIA ASCEND high-protein mini meals, a GLP-1 Nutrition Support Plan, daily nutrient packs, a three-phase metabolic health system, and a medical collaboration with LifeMD.

The direction itself isn’t baseless. GLP-1 users genuinely face protein deficiency, muscle loss, post-discontinuation rebound, and long-term maintenance challenges. But real demand doesn’t mean MED captures the value.

GLP-1 shifted the customer entry point. The first door to weight loss is no longer an OPTAVIA coach — it’s a physician, a telehealth platform, a pharmacy, or an insurance formulary. Hims occupies the “I want fast, private access to medication” prescription gateway. WW occupies the brand-awareness and weight-loss community gateway. Noom occupies the behavioral-change and psychology gateway. OPTAVIA coaches sit further down this decision chain, more like an ancillary service layer after the user is already on a path, not the first navigation point.

More critically: the new GLP-1 products have not detached from the legacy coach network. ASCEND product sales still flow through OPTAVIA coaches, and orders enter OPTAVIA’s compensation volume. The LifeMD Support Bonus FAQ explicitly states that if a client signs up for LifeMD through a coach’s referral link, the coach receives a $25 commission adjustment and a 60 PQV adjustment — the latter feeding into monthly bonus and rank calculations.

So the new business is not an independent digital health segment. It is a GLP-1 plug-in for the legacy MLM network. It may boost surviving high-producing coaches’ ARPAC, but it is not a new customer-acquisition engine that operates independently of the coach system.

If the legacy MLM is worth zero, and the GLP-1 option is deeply discounted because it’s still embedded in the old network, what does MED have left?

Cash.

As of Q1 2026, the company holds approximately $169 million in cash and investments with no funded debt. After adjusting for leases and other items, the net cash bridge is roughly $158 million, or about $14.20 per share.

But cash can’t be taken at face value. It’s not in your pocket — it’s under management’s control. Whether that cash ultimately reaches shareholders depends entirely on management’s capital discipline.

On track record, management hasn’t tunneled or looted the company, and they’ve maintained the debt-free balance sheet — that’s a positive. But they also haven’t shown the kind of owner-mindedness that says “if the business isn’t working, return the cash.” The new CEO, Nicholas Johnson, comes from OPTAVIA field operations and the Nu Skin direct-selling world. The former CEO, Dan Chard, stepped down but remains Chairman. This looks more like continuity than a clean break. The annual meeting also approved a new equity incentive pool.

The good news is an activist has arrived. Steamboat Capital holds about 6% of shares, and its founder Parsa Kiai and Jeffrey Rose were elected to the board at the May 2026 annual meeting. Steamboat’s open letter argued the company trades below cash value and should pursue cost-cutting, right-sizing, and restoring profitability. This reduces the risk of management burning cash freely — but Steamboat also signed a standstill, so a proxy fight or push for liquidation is unlikely in the near term.

Weighing management quality, activist oversight, and cash-burn risk together, the cash probably deserves a 20-30% discount.

So what is MED actually worth?

If legacy OPTAVIA is valued at zero — because ordinary coach economics have collapsed, the network can no longer reproduce, and revenue is a melting stock rather than capitalizable perpetual cash flow. If the GLP-1 option is also deeply discounted — because it remains tethered to the legacy MLM coach system, not a standalone new platform. If cash is haircut — because management is not owner-operator quality, even with an activist watching.

Then MED looks more like a discounted cash shell plus a very dirty option.

This is not the classic value-investing setup of “great company, cheap price.” It is a special situation defined by the question: “Is there enough hard cash protection inside a bad asset?” If there’s a buy case, it’s built on liquidation math, not conviction. The margin of safety has to be very thick — thick enough to absorb continued MLM network decay, continued management experimentation, and the possibility that cash gets consumed.

If MED one day proves three things — active coaches stabilize, GLP-1 products show repeat-purchase evidence independent of the coach network, and cash isn’t being burned inefficiently — the story changes entirely. But until then, it looks more like a right-skewed lottery ticket with a cash floor, not a proven value recovery.

Disclaimer: This article reflects personal research and analysis of publicly available information only. It does not constitute investment advice, a buy or sell recommendation, or any form of financial advisory opinion. The author may or may not hold positions in the securities mentioned. Views expressed may contain errors or omissions, and company fundamentals, share prices, and risk factors are subject to change at any time. Investing involves risk. Please conduct your own research and make independent decisions based on your own risk tolerance.

In May 2026, the company shared early clinical data: 71% ACR50 response rate (defined as 50% or greater improvement in joint swelling, tenderness, and other disease activity markers) among 7 refractory RA patients with 6-month follow-up. It also announced FDA alignment on a single ~150-patient randomized controlled Phase 3 study as the registration pathway, and concurrently closed a $300 million equity raise.

The stock has moved from a 52-week low of $1.47 to over $14, and has since pulled back to current levels (~$9). What does the market think is going to happen? And are they right?

Starting with the biology: what AlloNK actually does

RA is caused by a rebellion of B cells in the immune system. These B cells produce misdirected antibodies that attack the synovial membrane lining your joints, causing chronic inflammation, swelling, and ultimately joint destruction.

The predominant approach to RA therapy today is “continuous suppression”: taking medications daily or weekly that dial down your immune system. Most patients find some point on the RA treatment ladder where things improve enough to live normally. But for about 13% of patients who have tried biologic drugs and failed two or more medications with different mechanisms of action, these drugs don’t work. They are labeled D2T-RA, for difficult-to-treat rheumatoid arthritis.

Instead of forcing patients onto another suppressive medication, AlloNK attempts to reboot their immune system completely. First, rituximab marks the bad B cells for destruction by binding to CD20 proteins on their surface. Then a large infusion of donor-derived NK cells finds and kills the rituximab-coated B cells in a process called ADCC (antibody-dependent cellular cytotoxicity). If the depletion is thorough enough, the immune system may regenerate without the autoimmune memory, effectively patching the bug.

There is one important caveat: prior to infusion, patients must receive low-dose chemotherapy conditioning (specifically cyclophosphamide plus fludarabine) to temporarily suppress their own immune system, creating a survival window for the donor NK cells. The need for chemotherapy conditioning is the single biggest bottleneck in ARTV’s commercial story. You have to convince patients who are not at risk of dying from rheumatoid arthritis to receive chemotherapy.

Early data: tiny sample, enormous delta

71% from 7 patients is statistically worthless. Right?

Except: even at the low end of the 95% confidence interval (~29%), AlloNK plus rituximab still beats the high end of external literature control (~27%) for rituximab monotherapy.

So we know it’s better than the standard of care. We just don’t know by how much.

Running 500,000 Monte Carlo simulations with empirically calibrated open-label-to-RCT shrinkage factors (historical RA programs suggest shrinkage of roughly 12 to 20%, lower than many assume) and literature-anchored control arm assumptions (rituximab only ACR50 of approximately 20 to 27%), we calculate a 77 to 85% likelihood that AlloNK plus rituximab achieves statistical significance in Phase 3. After down-stepping for risks not captured by the model (enrollment population differences, clinical meaningfulness thresholds, safety signals, and execution risk), we use 60% as our composite probability that the Phase 3 data will be positive and large enough to re-rate the stock meaningfully.

The core of the valuation chain: how many patients will actually use this drug

This is the fundamental investable question. It isn’t whether or not Phase 3 works (it’s probably going to work). It’s how much the drug can make if it does work.

Artiva management says there are 150,000 to 200,000 eligible patients in the United States. This figure is featured prominently in the May 8, 2026 8-K filing (Exhibit 99.3, slide 12), complete with four footnoted citations of underlying medical literature. We tracked each paper down to the original study.

Paper 1: Roodenrijs 2021 (Ann Rheum Dis 2021; 80:31-35). This paper is actually the EULAR consensus on what D2T-RA means. A group of doctors sitting down and deciding on diagnostic criteria. Nothing in the paper talks about prevalence or how common D2T-RA is. It contributes zero to answering the question “how many patients is 150,000 to 200,000.”

Paper 2: Watanabe (KURAMA cohort, Immunol Med 2022; 45:35-44). This is a Kyoto University cohort study. They report the prevalence of D2T-RA as 7.9% of all RA patients, the lowest of the 4 papers cited by Artiva. If we apply that percentage to the United States: 7.9% x 1.5 million = 118,500. That doesn’t even reach management’s low end of 150,000 possible patients. This number is not mentioned at all in any of the company presentations. It was cited, but Artiva ignored its actual number.

Paper 3: Jung 2023 (KOBIO registry, Arthritis Res Ther 2023; 25:174). In plain English: “Among 2,321 RA patients treated with b/tsDMARDs, 271 (11.7%) were diagnosed with D2T RA.”

The denominator of that sentence: 2,321 patients who are currently taking biologic meds. NOT all patients with RA. The 11.7% figure presented by management is a percentage of patients taking biologics, yet Artiva used the 1.5 million total RA population as the denominator.

Applying the numbers correctly: 11.7% x 575,000 Americans currently treated with biologic medications = 67,000 patients. Still nowhere close to the range management presented on its slides.

Paper 4: Paudel 2024 (BRASS cohort, Rheumatology 2025; 64(3):1102-1110). This came from Brigham and Women’s Hospital in Boston. It has the highest percentages of any paper cited: 14.4% prevalence of D2T among all RA patients, and 22.3% prevalence of D2T among biologic-treated patients. But Paudel himself writes explicitly in the discussion section that BRASS is a single academic medical center with a 65% b/tsDMARD exposure rate, far above the national average of ~38%, and that the results “may not be applicable to other patient populations.” Using the highest value from an academic referral center whose own author warns against generalization, as an anchor for national market sizing, is selective citation.

So management took the 14.4% from BRASS (the highest academic single-center figure) and the 11.7% from KOBIO (whose denominator is actually the biologic-treated population, not all RA), combined them into a “10 to 15%” range, and multiplied by 1.5 million total RA patients to arrive at 150,000 to 200,000. A definition paper with no data was cited for legitimacy. A study yielding 7.9%, the lowest estimate, was cited but its number was buried.

Do the math, and it breaks.

150,000 to 200,000 eligible patients divided by 575,000 Americans currently taking biologics = 26 to 35% of biologic patients are D2T.

In plain English: if management’s number is true, then approximately one out of three patients taking a biologic medication qualifies for treatment with AlloNK.

The KOBIO registry says only 11.7% are D2T. The meta-analysis of international biologic-treated RA patients says only 13.2% are D2T. Even the BRASS study from Boston shows only 22.3% of their patients were D2T-RA.

Zero sources come close to the 26 to 35% implied by management.

The correct approach requires three filtering steps, each grounded in a specific published source.

A recent meta-analysis published in Annals of the Rheumatic Diseases in 2025 by Xie et al. (Ann Rheum Dis 2025; 84(12), PMID 41188120) pooled 23 individual studies from 13 countries with a total of 27,987 patients with RA. The paper reports two critical subgroup figures: D2T prevalence of 10.9% in studies using an all-RA denominator, and 13.2% in studies restricted to b/tsDMARD-exposed populations. The full text, on page three of the methods section, explicitly states that the treated subgroup includes “patients exposed to b/tsDMARDs.” In clinical epidemiology, “exposed to” is standard terminology for ever-used, not currently-on.

Step one: 1.4 million Americans are diagnosed with RA. Only about 37% (~520,000) have ever used a biologic medication or JAK inhibitor. That number comes from the Optum Clinformatics database (biologic point-prevalence ~20% in 2016 to 2021, with cumulative ever-use higher), cross-validated against Artiva’s own 8-K slide deck figure of 575,000/1,500,000 = 38%. The EULAR D2T definition requires failure of at least two distinct-mechanism b/tsDMARDs. Patients who have never used a biologic drug cannot have failed two of them. Exclude them from the denominator.

Management multiplied 11.7% (the pooled average of both subgroups) by 1.5 million total RA patients to get their figure of 150,000 to 200,000. This is a mismatch that can be algebraically proven wrong.

If the 23 studies pooled by Xie et al. really represent a 10.9% D2T rate among all RA patients, and a 13.2% D2T rate among those who’ve ever been exposed to biologics, then the implied biologic-treated proportion = 10.9% / 13.2% = 83%. But the actual proportion of Americans who’ve ever used biologics to treat their RA is only 38%. The 83% vs. 38% gap reveals that the all-RA studies in the meta-analysis must be coming from populations where an above-average proportion of patients have used biologics, typically academic centers or highly established registries. The BRASS cohort (Paudel 2024, Rheumatology 64(3):1102) confirms this: its biologic-treated proportion is 65%, and 65% x 22.3% (D2T among treated) = 14.5%, matching its measured all-RA D2T rate of 14.4%. Internally consistent, but Paudel himself cautions that these results “may not be applicable to other patient populations.”

Step two: 520,000 biologic-treated x 13.2% = approximately 69,000 D2T patients. Here, the denominator (ever-used) and the rate (from the ever-used subgroup studies) are properly matched. The KOBIO biologic registry (Jung 2023, Arthritis Res Ther 25:174) independently reports 11.7% D2T among treated patients, in the same range as the meta-analysis 13.2%, reinforcing confidence in this estimate.

Step three: within the same meta-analysis by Xie et al., 5 studies (3,516 RA patients including 319 with D2T-RA) used musculoskeletal ultrasound with power Doppler imaging to separate out two categories of D2T patients. If power Doppler signal was detected (active blood flow in joint synovium = genuine ongoing inflammation), they called it PIRRA (persistent inflammatory refractory RA), at 47.1% (95% CI 33.3 to 61.4%). When there was no signal, the patients were labeled NIRRA (non-inflammatory refractory RA), at 52.9%. NIRRA patients’ elevated DAS28 scores reflect central pain sensitization and comorbid fibromyalgia inflating subjective pain components, not active joint inflammation. An independent 2024 ultrasound study in 85 patients validated a similar split: 56% PIRRA vs. 44% NIRRA. AlloNK’s mechanism is clearing B cells to eliminate inflammation. It has no rationale in NIRRA patients.

Eligible U.S. population: 520,000 x 13.2% x 47% ≈ 32,000 to 35,000. Roughly one-fifth of management’s figure.

From 35,000 patients to peak sales

Of those 35,000 eligible patients, roughly 5% per year would actually undergo treatment (benchmarked against CAR-T’s real-world penetration of 5.4% per SEER-Medicare data in oncology; AlloNK’s outpatient, off-the-shelf profile lowers the access barrier but RA is non-fatal, and the two forces roughly offset). That translates to approximately 1,750 patients per year. Net price per treatment course: approximately $105,000 (below CAR-T’s $300,000 to $500,000, above the ~$50,000 to $60,000 annual net cost of biologics; requires 18+ months of treatment-free durability to justify to payers). Ex-U.S. revenue from Artiva’s territory (excluding Asia-Pacific, which belongs to licensor GC Cell; primarily Europe) adds roughly 25%.

Global peak net sales: approximately $230 million, one-seventh of the $1.64 billion implied by management’s assumptions.

Platform optionality: narrative or substance

If RA succeeds, AlloNK could theoretically expand to other B-cell-driven autoimmune diseases: Sjogren’s disease (SjD), systemic sclerosis (SSc), lupus (SLE), and others.

Two external facts heavily constrain the value of these options.

Novartis has a drug called ianalumab which has reported positive results in two Phase 3 trials in SjD, received FDA Breakthrough Therapy Designation, and is expected to file for approval imminently. It is a once-monthly subcutaneous injection requiring no conditioning whatsoever. If approved in 2027, the vast majority of SjD patients will choose this option. The treatment burden is orders of magnitude lower than AlloNK. AlloNK’s positioning in SjD shrinks to a second-line niche of patients who fail ianalumab, a population that will take years to accumulate after ianalumab’s launch.

Hematopoietic stem cell transplantation (HSCT) in SSc has three positive randomized controlled trials behind it, the highest level of clinical evidence, and is formally recommended by both EBMT and EULAR. Yet in 2023, only 51 autologous HSCTs for SSc were performed globally. A therapy with Grade 1 evidence and guideline endorsement has a global annual volume of 51. Our original assumption of 10% annual penetration for AlloNK in SSc, implying 2,500 U.S. patients per year, was off by a factor of 50 relative to this reality.

After adjusting for competitive dynamics and real-world penetration benchmarks, total platform option expected value comes to approximately $225 million. The most robust component is label expansion within RA itself (same disease, same mechanism, broader patient eligibility). The two largest options, SjD and SSc, were significantly compressed by external competition and historical penetration data.

Conclusion

The probability-weighted expected value of the RA-only indication, at a 60% success probability, is approximately $370 million. Adding platform optionality of $225 million brings the total to roughly $595 million.

Current fully diluted market capitalization is approximately $550 million.

The market is pricing this name close to our independently verified expected value. The scientific bet underlying the pipeline (that Phase 3 will likely read out positive) is real. But the addressable market embedded in management’s narrative is overstated by roughly five-fold. This is not fraud; it is the kind of selective citation that biotech founders routinely engage in during capital raises. Investors need to run their own funnel to correct for it.

Disclaimer: This article is a personal research note and does not constitute investment advice. The author may or may not hold positions in the securities mentioned and may buy or sell at any time without notice. Biotechnology investing carries extreme risk; clinical trial outcomes are highly uncertain; and all probability estimates and valuation calculations herein are based on public information and subjective judgment that may contain material errors. Readers should conduct their own due diligence and consult a licensed professional before making any investment decisions. No sell-side analyst views were cited in this analysis.

In December 2025, the company running this show, Impression Dahongpao Co., Ltd. (02695.HK), listed on the Hong Kong Stock Exchange at HK$3.60 per share. It closed its first day at HK$2.33. Down 35%.

Three questions worth answering: what is this business, why does it look absurdly cheap, and why does cheap not mean buy.

The economics of a single show

The business model fits in one formula: annual show count times seats times ticket issuance rate times net realized ticket price equals revenue. Plug in the numbers (roughly 520 shows per year, 2,099 seats, 75% issuance rate, about RMB 160 per ticket) and you get approximately RMB 130 million in annual revenue. That matches the reported figures for 2024 and 2025 after stripping out new projects.

One pitfall: you cannot use the sticker price to model revenue. The standard ticket is listed at RMB 238, with VIP options up to RMB 688. But over 92% of tickets are sold through local ground-handling travel agencies in bulk at settlement prices far below face value. The number that matters is the net realized price of roughly RMB 160.

After normalizing for the core show’s true gross margin of about 60% and deducting IP royalties, allocated overhead, and roughly RMB 4 million per year in maintenance capex (stage equipment, lighting, sound, content refreshes), the normalized owner earnings come to approximately RMB 41 million per year. That is the valuation bedrock.

Why is the conversion rate so high? In 2024, the core show pulled in over 800,000 viewers, converting roughly 18.7% of Wuyishan scenic area visitors. The industry average is about 1.5%. The reason is not artistic superiority but structural monopoly: Wuyishan has virtually zero alternative nighttime entertainment. After a day of hiking and bamboo rafting, tourists either watch Impression Da Hong Pao or go back to their hotels. The show is embedded in the visitor flow. No advertising required. But this also means the ceiling is visible.

“Impression” does not belong to this company

The core show pulls tourists largely because of two names: “Zhang Yimou” and “Impression.” Neither belongs to 02695.

The “Impression” brand, trademarks, and performance rights are owned by Impression Art Development Co., Ltd., a wholly owned subsidiary of A-share listed Sanxiang Impression (000863.SZ). 02695 pays a directorial authorization service fee equal to 10% of pre-tax ticket revenue, with an annual cap of approximately RMB 14 million. The 2025 actual payment was RMB 13.44 million, nearly at the cap.

The prospectus shows this is structured as a “Continuing Connected Transaction Framework Agreement” under HKEX Listing Rules Chapter 14A. Framework agreements must include annual caps and typically run for three years. Since the company listed in December 2025, the initial agreement likely covers through approximately late 2027. Within this period, the fee rate and cap are locked. Sanxiang Impression cannot unilaterally raise prices.

But when the framework agreement expires around late 2027, Sanxiang Impression has the right to renegotiate. Sanxiang Impression is in trouble: it reported a net loss attributable to shareholders of RMB 134 million in 2025, weighed down by its real estate business. Zhang Yimou and the other two core directors all departed by 2019. The original controlling shareholder is reportedly preparing to sell the company to Hubei provincial state-owned assets. A persistently loss-making, leadership-depleted IP owner whose control is about to change hands may well demand harsher terms at renewal.

HKEX rules provide one layer of procedural protection: if the renewed terms change materially, independent shareholders (H-share holders) must vote to approve. But the choice facing independent shareholders would not be “accept the price hike vs. maintain the status quo.” It would be “accept the price hike vs. lose the IP entirely.” In that kind of negotiation, minority shareholders have no real leverage.

Moonlight Wuyi: a “second curve” running at 12% occupancy

In May 2025, the company launched a new show called Moonlight Wuyi, an indoor immersive performance about Neo-Confucian philosophy, staged in what was certified as the “world’s largest single indoor water-curtain stage.”

The numbers look bad. Over seven to eight months, the show ran 380 performances and attracted 91,700 viewers, an average of 241 people per show. The theater held over 2,000 at its opening ceremony. Regular occupancy runs at roughly 12%. In the off-season, it drops to about 8%. Eighty-eight percent of seats sit empty every performance.

Revenue was RMB 11.81 million against RMB 17.41 million in incremental operating costs, producing a gross profit drag of RMB 5.6 million. The company’s blended gross margin dropped from 56.60% to 47.24%, a nearly 10-percentage-point decline driven almost entirely by this one project. The theater comes with a 20-year lease at a minimum annual rent of RMB 5 million, regardless of ticket sales.

The deeper problem is the absence of a brand hook that actually works. Impression Da Hong Pao sells itself through “Zhang Yimou + tea culture + nothing else to do at night.” Moonlight Wuyi’s director, while respected in industry circles, is unknown to ordinary tourists. Neo-Confucian philosophy has a fraction of the mass-market appeal of tea culture. Daytime visitors have plenty of alternatives: hiking, tea plantations, bamboo rafting. A show without a strong name, competing for the same tourist budget in the same town as the flagship.

The Lijiang market provides a quantified precedent for same-city cannibalization. After Romance of the Eternal City (a Songcheng Entertainment production) opened in Lijiang in 2014, Impression Lijiang’s revenue fell 34% and net profit fell 36% within two years. Moonlight Wuyi has far weaker product appeal than Songcheng’s offering, so it is unlikely to fatally wound the core show. But it damages the company in a different way, by continuously consuming the cash flow the core show generates.

What does the local government actually want?

Tracing through the equity structure, the ultimate controller is the Wuyishan Municipal State-Owned Assets Operation Service Center, holding 78.1% pre-IPO.

This company does not need money. The core show generates RMB 41 million per year. There is RMB 199 million in cash on the balance sheet. Zero bank debt. The IPO raised a net RMB 95 million, less than 2.5 years of core show owner earnings. Yet the company spent six to seven years, pivoted across three capital markets (NEEQ, then Beijing Stock Exchange, then HKEX), and burned over ten million renminbi in advisory fees to get listed.

Wuyishan’s 2023 general public budget revenue was RMB 1.096 billion against expenditures of RMB 3.157 billion, a RMB 2 billion gap filled by transfer payments and borrowing. The Wuyishan scenic area itself cannot be listed due to regulatory restrictions on scenic spots. Impression Da Hong Pao became the local government’s vehicle for gaining access to the capital market by proxy. Labels like “Fujian Province’s first tourism IPO” and “China’s first live-action show stock” carry zero economic value for shareholders but enormous political value for local officials.

This explains why capital allocation looks irrational. When the previous operator of the Impression Jianzhou food street failed, the company did not walk away. Instead, it spent RMB 13.126 million to buy back the assets (valued using the cost approach, meaning even the seller could not justify an earnings-based valuation), committed another RMB 25 million for renovation, and embedded a clause requiring the company to pay up to RMB 50 million to acquire 51% of the project company if performance targets are met. The Chatan Hotel runs at 10-25% occupancy with a gross margin of negative 142%.

Every new project fails a standalone NPV test. But every one fits the narrative of “building out Wuyishan’s cultural tourism ecosystem.” The core show’s cash flow is being systematically reinvested into projects with returns far below the cost of capital.

Dividends: the only return channel and its fragility

For a company where the controlling shareholder holds 78.1%, the Hong Kong-listed stock has no liquidity, and minority shareholders have no structural protection, dividends are the only source of investor return. Share price appreciation requires catalysts and liquidity, neither of which exist. Retained cash is being reinvested at negative returns.

During its NEEQ era, the company was generous. The 2024 annual report declared RMB 0.38 per share, a payout ratio approaching 96%. But two structural changes followed the Hong Kong IPO: total shares outstanding expanded from 108 million to 144 million (a 33% dilution), so the same total dividend now yields roughly 25% less per share; and the local SASAC, having gained a “capital market platform,” now has a structurally stronger incentive to retain cash for new projects.

Neither the HKEX nor NEEQ imposes a mandatory minimum payout ratio. China’s push for state-owned enterprise value management and dividend discipline primarily targets centrally controlled SOEs and A-share listed companies. Policy enforcement attenuates at every level from central to provincial to municipal to county. By the time it reaches a county-level SASAC overseeing a Hong Kong micro-cap, the practical binding force may be negligible.

The contrast with Brilliance China (1114.HK) is useful. Brilliance’s high dividends were sustained because its parent was forced by a court-approved restructuring plan to repay RMB 16.4 billion in debt, and dividends from the listed subsidiary were the only compliant channel. Minority shareholders rode a legally enforceable free ride. Impression Da Hong Pao has no such mechanism. No court order, no repayment schedule, no binding performance assessment. Dividends are entirely at the SASAC’s discretion.

What the 35% first-day drop actually told you

The retail public offering was oversubscribed 3,397 times. The institutional placement was subscribed just 1.91 times. Retail investors piled in; institutions stayed away. There were no cornerstone investors. The final price of HK$3.60 was set near the bottom of the indicative range (HK$3.47 to HK$4.10). There was no effective greenshoe stabilization.

The 3,397x retail oversubscription reflects standard Hong Kong IPO lottery behavior: small-ticket punters betting on a first-day pop with leveraged margin accounts. The 1.91x institutional placement is the real signal. The bookrunners could not find a single institution willing to lock in a cornerstone commitment.

The first-day collapse was not “market sentiment.” It was a one-time correction between the IPO’s politically negotiated price and the market’s true clearing price. HK$3.60 was the face-saving number acceptable to the bookrunners and the SASAC. HK$2.33 was what the market thought the company was actually worth.

Conclusion

Impression Da Hong Pao has a real, 15-year-proven, RMB 41 million-per-year cash-generating core asset. That fact is not in dispute.

But between “the core asset is valuable” and “shareholders get a return,” there is a pipeline controlled by the local SASAC. Inside that pipeline sit Moonlight Wuyi’s RMB 10 million-plus annual cash drain, Jianzhou’s RMB 38 million sunk cost, the Chatan Hotel’s perpetual losses, potential future projects yet to be conceived, and the uncertainty of the IP licensing framework agreement’s renewal around late 2027.

The investability of this stock does not hinge on valuation. On valuation, it is genuinely cheap. It hinges on a governance question: will the SASAC allow the core show’s cash flow to pass through to minority shareholders as dividends? There is currently no hard mechanism guaranteeing that it will.

Pricing off the dividend anchor is the only honest approach. Your expected sustainable dividend divided by your required yield equals your entry price. If the result is far below the current market price, this stock is simply not in your investable universe. Not every cheap asset deserves your capital. Some things are cheap for a reason.

Disclaimer: This article represents the author’s personal research notes only and does not constitute investment advice of any kind. The author and affiliated parties do not hold positions in any securities mentioned. All information is based on publicly available sources, and no guarantee is made as to its accuracy or completeness. Any analytical frameworks, scenario assumptions, and price discussions are academic in nature and should not be construed as buy or sell recommendations at any specific price level. Investing involves risk. All decisions should be made independently. Gains and losses are your own.

This article ignores sell-side consensus and builds entirely from public data and completed transactions to break down VNET’s business model and valuation framework.

This Is Not a Tech Company

VNET sells power capacity and physical space. Someone buys GPUs and suddenly needs to plug them in, cool them down, and turn them on. VNET is selling that somewhere. They don’t design chips. They don’t build algorithms. They don’t write software. VNET is a landlord renting out factory floors to AI training clusters.

Except it’s not your typical landlord. In a data center, ~20-30% of total construction cost is spent on the concrete shell. The other ~70-80% is mechanical and electrical; transformers, UPS systems, precision cooling, chillers, backup generators. Equipment with 10-15 year useful lives. Annual D&A of roughly RMB 24-25 billion eats most of the EBITDA.

ROIC hovers around 9-13%, leaving only 1-3 percentage points of excess return above the cost of capital. Each additional MW of capacity requires the same capex. This isn’t a tech business benefiting from scale economies. It’s a toll road. It’s a power plant.

What VNET Looked Like Before AI

From 2021 to 2023, revenue grew 2-3% per year. EBITDA margins declined from 28.3% to 26.5%. Cabinet utilization sat at 55-59%. The wholesale business barely existed. A mediocre company with no moat.

Then AI happened. Wholesale revenue grew from 19% of total in Q1 2024 to 39.5% by Q1 2026, growing 58% year-over-year. Wholesale capacity expanded from less than 200MW to 907MW. EBITDA margin recovered back up to 33%.

This transformation was 100% driven by an external demand shock. AI compute demand exploded, creating a supply-demand gap, and VNET happened to have some land, power quotas, and a relationship with at least one major customer. It’s not selling irreplaceable capability — it’s selling a time arbitrage. Self-building takes 18-30 months; leasing from VNET takes 3-6. Time arbitrage has an expiration date.

A One-Customer Story

Of the 517MW in new wholesale orders signed year-to-date in 2026, approximately 510MW came from a single “leading internet customer.” Over 98% of incremental demand from one buyer. This isn’t a broad market undersupply story — it’s one specific customer’s explosive demand landing on VNET’s doorstep.

What Three REIT Deals Reveal

VNET completed three data center securitization transactions in 2025-2026 totaling roughly RMB 7.2 billion in issuance, with underlying assets in a tier-1 city, Taicang in Jiangsu (~210MW), and Ulanqab in Inner Mongolia.

Here’s the data point that jumped out at me: in late 2024, strategic investor Dajia Holdings paid to acquire a 49% interest in the Taicang project at an implied valuation of RMB 5.74 billion for 210MW, or approximately 10.1x EV/EBITDA. You can back into EV/MW directly (~RMB 27.3 million) without needing to estimate EBITDA margins or pick your own multiple. This isn’t a hypothetical; an actual institutional buyer paid real money for an equity stake. By the time the REIT listed in March 2026, management said the multiple had risen to 13-14x. That’s 30-40% expansion on the identical asset in eighteen months, reflecting rising institutional appetite for data center assets.

GDS’s P-REIT revealed its full economic waterfall: EV of RMB 2.9 billion to ~RMB 1.2 billion project-level debt (~41% LTV) to RMB 1.7 billion equity consideration, with GDS retaining 30%, leaving just RMB 500 million cash received upfront and RMB 700 million contingent on milestones. A headline EV of RMB 2.9 billion ultimately translated into roughly RMB 500 million of net cash for the parent — a 17% conversion rate. VNET’s management guided total 2026 REIT-related cash proceeds of “no less than RMB 2 billion” against RMB 6.36 billion in total issuance — roughly 31%. The capital recycling is real, but far slower than the headlines suggest.

The 10x Leverage Amplifier

VNET’s total operating asset base is valued at roughly RMB 30-45 billion. Add up all the senior claimants ahead of common equity — bank loans, finance leases, convertible bonds, minority interests — and you get approximately RMB 26-29 billion. Common equity isn’t a large number. It’s the razor thin difference between two very large numbers.

If you move from EV/EBITDA of 10x to 17x, it looks like a ~70% change on the surface. Account for leverage amplification, and the value of common equity can differ by a factor of 5-7x. This isn’t a hard math problem — anyone can subtract. It is however a great example of extreme sensitivity to input assumptions.

And the single most impactful variable in the entire debate — wholesale segment EBITDA — has never been separately disclosed. The weakest piece of evidence drives the largest swing in output.

Steady-State Earnings Under GAAP

What if you skip adjusted EBITDA and start from GAAP?

Annualized EBITDA is roughly RMB 3.57 billion. Once you account for D&A (~RMB 2.4-2.5 billion), interest (~RMB 0.8-1.2 billion), taxes, and minority interests, net income attributable to common shareholders is approximately zero. FY2025 GAAP net loss was RMB 133 million. EBITDA looks decent; net income is negative. The gap is entirely consumed by depreciation and interest.

Even assuming all capacity under construction is completed and fully leased at 90% utilization, company-wide steady-state GAAP net income comes to roughly RMB 7-8 billion per year. But the wholesale segment won’t turn genuinely profitable until around 2028 — new capacity triggers immediate D&A and interest while revenue waits for customer move-in. Once it crosses breakeven, though, operating leverage hits hard: a 50% revenue increase could drive a 400-500% profit increase. The reverse is equally true.

Two Anchors

I price VNET from two completely different directions.

The defensive valuation asks: what if the REIT window closes, AI growth falters, and VNET is left collecting rent from existing assets? Using GAAP steady-state net income in a DCF that incorporates gradual construction delivery and the profit inflection, total equity value comes to roughly RMB 6-7 billion. About $3/ADS. This is the floor — paying only for cash flows that have already occurred or can be verified, with zero premium for expectations.

The offensive valuation asks: what if the REIT window stays open and multiples hold? Anchoring EV/MW to the Pre-REIT transaction price, adjusting for liquidity discount and multiple expansion, and probability-weighting across scenarios, then subtracting all claims, common equity comes to roughly RMB 16 billion. About $8/ADS. This requires everything to go right — a hot REIT market, stable multiples, a loyal anchor customer, and sustained AI demand.

What $9.23 Is Paying For

$3 to $8 is the range that public data can support. $8 already requires the REIT window to stay open, multiples to hold, and Pre-REIT liquidity discounts to fully correct. The current price of $9.23 sits above even the offensive estimate — meaning the market is paying for the 1,056MW future development option, continued REIT arbitrage, or higher-than-observed multiples.

All of that might materialize. But the pre-AI track record — 2-3% growth, declining margins, 55% utilization — shows exactly what this company looks like when the tailwind stops. And the capital structure guarantees that any disappointment gets amplified, not cushioned.

$3 is the floor. $8 is the ceiling with full tailwinds. Above $9, you’re paying for faith.

Disclaimer: This article reflects personal research notes only and does not constitute investment advice of any kind. The author may or may not hold positions in the securities mentioned. All data is sourced from public filings (SEC, Shanghai Stock Exchange), company earnings calls, and publicly available news reports. Accuracy and completeness are not guaranteed. Investing involves risk. Please exercise independent judgment and assume full responsibility for your own decisions. This article does not represent the views of any institution.

Subscribe now

This article cites no sell-side analyst opinions. All conclusions are drawn from TTD’s public filings, industry trade press, and first-principles reasoning.

To understand TTD, you first need to understand how a dollar of ad budget travels from a brand CMO’s pocket to the screen in front of a consumer.

When a major brand like Procter & Gamble decides to spend a hundred million dollars on programmatic advertising across the open internet, the CMO doesn’t operate the campaigns personally. The budget goes to an advertising agency, whose traders sit in front of a DSP — a demand-side platform — every day, deciding which of trillions of bidding opportunities are worth pursuing, how much to bid, and what creative to show to whom.

TTD is that DSP. The total budget advertisers route through TTD is called gross spend; TTD keeps a portion as revenue. In 2025, clients spent $13.4 billion through the platform, and TTD kept $2.9 billion — roughly 21.6%.

A 21.6% take rate is remarkably high for an intermediary platform that owns no media content and no ad inventory. For context, e-commerce marketplaces typically take 3–5%.

TTD can charge this much because the 21.6% isn’t purely a “toll” — it blends platform fees, third-party data costs, AI optimization tools, and supply-chain services. The problem is that even Publicis, one of TTD’s largest clients, couldn’t untangle this 21.6%. In early 2026, Publicis commissioned a third-party audit of TTD’s fee structure. The dispute escalated to a public rupture, with Publicis advising clients to stop using TTD. The two sides reconciled in June, but the settlement terms remain undisclosed.

TTD is now fighting two wars simultaneously.

The first is the Amazon war. Over the past year, Amazon DSP has onboarded ad inventory from Netflix, Disney, Roku, and Spotify, claiming to reach 90% of U.S. households. Amazon charges just 1–4% for open-internet ad buying — it can afford to because DSP isn’t a profit center for Amazon. It’s a customer-acquisition tool that pulls advertisers into the broader Amazon ecosystem of retail search ads, Prime Video ads, and first-party purchase data.

TTD charges 20%. Amazon charges 4%. If the gap in service quality is narrowing, the price gap becomes indefensible. And the evidence suggests the gap is indeed narrowing. In 2024, TTD’s revenue growth still led Amazon’s advertising business by 6 percentage points. By Q1 2026, TTD trailed by 12 points. The scissors have crossed, and the gap widens every quarter.

What makes this particularly dangerous is that over half of TTD’s revenue comes from CTV and video advertising — and CTV happens to be the most “pipe-like” ad format. Placing a 30-second spot in front of a million households is a commodity function. TTD can do it; Amazon can do it; the incremental value of the DSP is close to zero. When Amazon offers the same CTV inventory at 1% fees, TTD’s 20% becomes very hard to justify.

The second is the agency war. Over the past few years, TTD has rolled out a suite of “Open” products — OpenPath bypasses intermediaries to connect directly with publishers, OpenAds provides an auction system, OpenSincera scores publisher quality. On the surface, these make the supply chain more transparent. In practice, they transfer margin from SSPs and agencies to TTD.

Agencies aren’t naive. WPP and Dentsu quietly exited OpenPath in early 2026. Publicis launched its fee audit. Omnicom was reported to have shifted a double-digit share of programmatic spend from TTD to Amazon DSP. These aren’t isolated incidents — they’re a collective response from agencies who see TTD using the banner of “transparency” to encroach on their economics.

There’s a layer most people miss: agencies’ motivation for auditing TTD isn’t purely about saving advertisers money. Agencies have their own business model called “principal media buying” — they bulk-purchase inventory from publishers and resell it to advertisers at a markup. TTD’s transparency initiatives are making this markup harder to sustain. So when agencies attack TTD’s fee opacity, they’re partly defending their own.

But more fundamental than either war is TTD’s cost structure.

In 2025, TTD’s stock-based compensation was $1.26 billion — 43% of revenue. For every dollar of revenue earned, 43 cents went to employees in the form of stock. For comparison, Google’s SBC-to-revenue ratio is 12%. Meta’s is 15%. TTD’s revenue base ($2.9 billion) is simply too small to support this level of equity compensation.

Many investors value TTD on “free cash flow” — $796 million in 2025, which looks healthy. But FCF adds back SBC as a “non-cash expense,” effectively pretending that stock issued to employees is free. In reality, TTD spent $1.4 billion on share buybacks in 2025 to offset SBC dilution — more than its entire FCF. The company was drawing down its cash reserves to maintain the illusion of a stable share count.

If you measure what shareholders can actually take home — what Buffett calls “owner earnings” — TTD generates roughly $340 million per year, not the $800 million the market seems to believe. And that $340 million sits on a 21.6% take rate. A decline of just 3.6 percentage points to 18% would push owner earnings to zero.

TTD’s strategic ambition is to become the infrastructure layer for open-internet ad transactions — identity resolution (UID2), supply path (OpenPath), auction system (OpenAds), quality scoring (OpenSincera). Stack all four together and the goal is to have every ad transaction run on TTD’s rails. It’s a Visa-like vision.

But Visa charges 2%. TTD charges 20%. Visa became payment infrastructure because 2% was low enough for every merchant to accept. TTD is trying to build infrastructure that requires 2% pricing to achieve ubiquity, while charging 20% because it has no other revenue source to subsidize the buildout. Amazon has e-commerce. Google has search. Meta has social. TTD has nothing but its take rate.

This is TTD’s most fundamental contradiction: it wants to be infrastructure but can only operate as a high-margin intermediary. What it says and what it does don’t align. It talks about “making the industry more transparent,” but in practice it’s replacing the agency’s opaque margin with its own opaque margin.

One industry observer put it bluntly: if you charge a 20% take rate, you should provide the same level of transparency you demand from everyone else. When a product built on “openness” feels opaque, criticism is inevitable.

TTD won’t go to zero. Large advertisers need an independent DSP to counterbalance Amazon and Google — no one wants all their eggs in one basket. Joint Business Partnerships with brands already account for over half the business, insulating it from agency actions. The company holds $1.4 billion in net cash with zero interest-bearing debt, so near-term insolvency isn’t a concern.

But “won’t go to zero” and “worth the current price” are very different statements. Both of TTD’s wars — Amazon’s price war and agencies’ control war — point in only one direction: down. There is no plausible scenario where take rate rises to 25% or growth re-accelerates to 20%+. The distribution is left-skewed: upside is capped near current levels, while downside remains wide open.

This asymmetric risk-reward profile is the real reason TTD fell from $91 to $19. Not a single piece of bad news, but the market’s gradual realization that the best case for this company is roughly “more of the same” — while the worst case hasn’t been priced in yet.

Disclaimer: This article is for informational and educational purposes only and does not constitute investment advice, a recommendation, or a solicitation to buy or sell any security. The author may hold positions in the securities discussed. All analysis is based on publicly available information and the author’s independent interpretation; it may contain errors or omissions. Past performance is not indicative of future results. Readers should conduct their own due diligence and consult a qualified financial advisor before making any investment decisions.